BioMedLib Search Engine
[ goto HOMEPAGE ]
Find more relevant answers, faster!
Skip to content
Advanced Search
Search History
MeSH Query
Page Format
Query is expanded
Login
Skip to content
Export Citations
Search Results
RSS
Email
Articles' Details
Start new query
Reset All
Refine your query
(more in Advanced-Search):
Search all of MEDLINE
Focus on the recent 5 years
Focus on the current year
Focus on the last 30 days
More choices ...
Focus on articles with free fulltexts
More choices ...
Do simple 'keyword' search (no query expansion)
[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click
here to
RESET
all values
Click
here to
GO BACK
without resetting any value
Advanced Search
Submit one or more of the following items, and they will be searched along with your query in the search box above.
Any submit button will submit all of the items you have changed.
+
Publication-Date
Published in the last:
30 days
60 days
90 days
6 months
12 months
this year
2 years
3 years
5 years
10 years
Or published in the following date range: From (yyyy/mm/dd - month and day are optional)
to ('to' is optional)
+
Full Text
Retrieve articles with hyperlinks to:
full text (either free or subscription)
free full text
subscription full text
no full text link
+
Sort-Order
Sort the retrieved articles by:
relevance
publication date
+
Language
And with languages:
English
French
German
Italian
Japanese
Russian
Spanish
More languages:
Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Bengali
Bosnian
Bulgarian
Catalan
Chinese
Czech
Danish
Dutch
Esperanto
Estonian
Finnish
Georgian
Scottish Gaelic
Greek, Modern
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Kinyarwanda
Korean
Latin
Latvian
Lithuanian
Macedonian
Malayalam
Maori
Malay
Multiple languages
Norwegian
Persian
Polish
Portuguese
Pushto
Romanian
Sanskrit
Serbian
Croatian
Slovak
Slovenian
Swedish
Thai
Turkish
Ukrainian
Undetermined
Urdu
Vietnamese
Welsh
+
Publication-Type
And with publication types:
Clinical Trial
Editorial
Letter
Meta-Analysis
Practice Guideline
Randomized Controlled Trial
Review
More publication types:
Addresses
Bibliography
Biography
Case Reports
Classical Article
Clinical Conference
Clinical Trial, Phase I
Clinical Trial, Phase II
Clinical Trial, Phase III
Clinical Trial, Phase IV
Comment
Comparative Study
Congresses
Consensus Development Conference
Consensus Development Conference, NIH
Controlled Clinical Trial
Corrected and Republished Article
Dictionary
Directory
Duplicate Publication
English Abstract
Evaluation Studies
Festschrift
Government Publications
Guideline
Historical Article
Interactive Tutorial
Interview
Introductory Journal Article
In Vitro
Journal Article
Lectures
Legal Cases
Legislation
Multicenter Study
News
Newspaper Article
Overall
Patient Education Handout
Periodical Index
Portraits
Published Erratum
Retracted Publication
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Retraction of Publication
Scientific Integrity Review
Technical Report
Twin Study
Validation Studies
+
Species
And for:
Humans
Animals
+
Gender
And for:
Male
Female
+
Age
And for these age groups:
Newborn: birth to 1 month
Infant: 1 to 23 months
Preschool child: 2 to 5 years
Child: 6 to 12 years
Adolescent: 13 to 18 years
Adult: 19 to 44 years
Middle aged: 45 to 64 years
Aged: 65+ years
80 and over: 80+ years
+
Title
And for this query matching the titles:
+
Transliterated-Title
And for this query matching the title in original language:
+
Abstract
And for this query matching the abstratcs:
+
Major-Mesh
And for this query matching the MeSH-Major terms:
+
Mesh
And for this query matching any MeSH terms:
+
Journal
And for one or more of these journal abbreviated names:
OR
OR
(see
title abbreviations
)
+
Volume
And with journal volume number:
+
Issue
And with journal issue number:
+
Page
And with page number:
+
ISSN
And with ISSN:
+
Publication-Place
And with journal's country of publication:
+
Author
And for...
all these author names:
AND
AND
(see
help
)
one or more of these author names:
OR
OR
but not having any of these unwanted author names:
NOT
NOT
+
Affiliation
And with affiliation to:
+
Has-Abstract
Find MEDLINE records with the abstract status:
has abstract
does not have abstract
include both record types
include both record types but rank higher the records having abstract (the default BML behavior)
+
PMID
Show me only articles for these PMIDs (PubMed IDs):
+
Semantic-Type
And with semantic types:
A. Entity
A1. Physical Object
A1.1. Organism
A1.1.1. Archaeon
A1.1.2. Bacterium
A1.1.3. Eukaryote
A1.1.3.1. Animal
A1.1.3.1.1. Vertebrate
A1.1.3.1.1.1. Amphibian
A1.1.3.1.1.2. Bird
A1.1.3.1.1.3. Fish
A1.1.3.1.1.4. Mammal
A1.1.3.1.1.4.1. Human
A1.1.3.1.1.5. Reptile
A1.1.3.2. Fungus
A1.1.3.3. Plant
A1.1.4. Virus
A1.2. Anatomical Structure
A1.2.1. Embryonic Structure
A1.2.2. Anatomical Abnormality
A1.2.2.1. Congenital Abnormality
A1.2.2.2. Acquired Abnormality
A1.2.3. Fully Formed Anatomical Structure
A1.2.3.1. Body Part, Organ, or Organ Component
A1.2.3.2. Tissue
A1.2.3.3. Cell
A1.2.3.4. Cell Component
A1.2.3.5. Gene or Genome
A1.3. Manufactured Object
A1.3.1. Medical Device
A1.3.1.1. Drug Delivery Device
A1.3.2. Research Device
A1.3.3. Clinical Drug
A1.4. Substance
A1.4.1. Chemical
A1.4.1.1. Chemical Viewed Functionally
A1.4.1.1.1. Pharmacologic Substance
A1.4.1.1.1.1. Antibiotic
A1.4.1.1.2. Biomedical or Dental Material
A1.4.1.1.3. Biologically Active Substance
A1.4.1.1.3.1. Neuroreactive Substance or Biogenic Amine
A1.4.1.1.3.2. Hormone
A1.4.1.1.3.3. Enzyme
A1.4.1.1.3.4. Vitamin
A1.4.1.1.3.5. Immunologic Factor
A1.4.1.1.3.6. Receptor
A1.4.1.1.4. Indicator, Reagent, or Diagnostic Aid
A1.4.1.1.5. Hazardous or Poisonous Substance
A1.4.1.2. Chemical Viewed Structurally
A1.4.1.2.1. Organic Chemical
A1.4.1.2.1.5. Nucleic Acid, Nucleoside, or Nucleotide
A1.4.1.2.1.6. Organophosphorus Compound
A1.4.1.2.1.7. Amino Acid, Peptide, or Protein
A1.4.1.2.1.8. Carbohydrate
A1.4.1.2.1.9. Lipid
A1.4.1.2.1.9.1. Steroid
A1.4.1.2.1.9.2. Eicosanoid
A1.4.1.2.2. Inorganic Chemical
A1.4.1.2.3. Element, Ion, or Isotope
A1.4.2. Body Substance
A1.4.3. Food
A2. Conceptual Entity
A2.1. Idea or Concept
A2.1.1. Temporal Concept
A2.1.2. Qualitative Concept
A2.1.3. Quantitative Concept
A2.1.4. Functional Concept
A2.1.4.1. Body System
A2.1.5. Spatial Concept
A2.1.5.1. Body Space or Junction
A2.1.5.2. Body Location or Region
A2.1.5.3. Molecular Sequence
A2.1.5.3.1. Nucleotide Sequence
A2.1.5.3.2. Amino Acid Sequence
A2.1.5.3.3. Carbohydrate Sequence
A2.1.5.4. Geographic Area
A2.2. Finding
A2.2.1. Laboratory or Test Result
A2.2.2. Sign or Symptom
A2.3. Organism Attribute
A2.3.1. Clinical Attribute
A2.4. Intellectual Product
A2.4.1. Classification
A2.4.2. Regulation or Law
A2.5. Language
A2.6. Occupation or Discipline
A2.6.1. Biomedical Occupation or Discipline
A2.7. Organization
A2.7.1. Health Care Related Organization
A2.7.2. Professional Society
A2.7.3. Self-help or Relief Organization
A2.8. Group Attribute
A2.9. Group
A2.9.1. Professional or Occupational Group
A2.9.2. Population Group
A2.9.3. Family Group
A2.9.4. Age Group
A2.9.5. Patient or Disabled Group
B. Event
B1. Activity
B1.1. Behavior
B1.1.1. Social Behavior
B1.1.2. Individual Behavior
B1.2. Daily or Recreational Activity
B1.3. Occupational Activity
B1.3.1. Health Care Activity
B1.3.1.1. Laboratory Procedure
B1.3.1.2. Diagnostic Procedure
B1.3.1.3. Therapeutic or Preventive Procedure
B1.3.2. Research Activity
B1.3.2.1. Molecular Biology Research Technique
B1.3.3. Governmental or Regulatory Activity
B1.3.4. Educational Activity
B1.4. Machine Activity
B2. Phenomenon or Process
B2.1. Human-caused Phenomenon or Process
B2.1.1. Environmental Effect of Humans
B2.2. Natural Phenomenon or Process
B2.2.1. Biologic Function
B2.2.1.1. Physiologic Function
B2.2.1.1.1. Organism Function
B2.2.1.1.1.1. Mental Process
B2.2.1.1.2. Organ or Tissue Function
B2.2.1.1.3. Cell Function
B2.2.1.1.4. Molecular Function
B2.2.1.1.4.1. Genetic Function
B2.2.1.2. Pathologic Function
B2.2.1.2.1. Disease or Syndrome
B2.2.1.2.1.1. Mental or Behavioral Dysfunction
B2.2.1.2.1.2. Neoplastic Process
B2.2.1.2.2. Cell or Molecular Dysfunction
B2.2.1.2.3. Experimental Model of Disease
B2.3. Injury or Poisoning
Page Format
Any submit button will submit all of the items you have changed.
[theme]
Use this page design theme:
original
twenty ten
[shown]
Results per page:
5
10
20
50
100
200
500
[expand/collapse]
show these sections expanded by default:
Advanced search
MeSH query
Search history
Page format
Query expansion
Articles details
Export citations
Email
[text size]
use this font size for text:
25%
50%
75%
100%
125%
150%
200%
or enter your choice of font size:
[page width]
use this page width (relative to the default initial value):
25%
50%
75%
100%
125%
150%
200%
or enter your choice of page width:
[highlight color]
use this color to highlight query words in the articles:
red
green
blue
black
purple
yellow
orange
navy
olive
maroon
none
[query history]
maximum number of queries shown in the history section:
[annotate]
Annotate these parts of each article:
title
abstract
both
none
Reset all values
Find best MeSH terms for
Search History
1
adenocarcinoma of head of pancreas diagnosis 2005:2010[pubdate] *count=100
134 results
Searchbox
Export
PDF
RSS
Email
Delete
Email this search result to the following email address:
[X] Close
Expand the query
'
adenocarcinoma of head of pancreas diagnosis
' expanded to all its synonyms;
details
Email the results to the following email address:
Export the checked citations in RIS format (RIS format is used by RefWorks, Endnote, among others).
Items 1 to 100 of about 134
1.
Zou YP, Li WM, Zheng F, Li FC, Huang H, Du JD, Liu HR:
Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer.
World J Gastroenterol
; 2010 Oct 28;16(40):5104-10
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable
pancreatic cancer
.
AIM: To evaluate the feasibility, efficacy and safety of intraoperative radiofrequency ablation (RFA) combined with (125)iodine seed implantation for unresectable
pancreatic cancer
.
METHODS: Thirty-two patients (21 males and 11 females) at the age of 68 years (range 48-90 years) with unresectable locally advanced
pancreatic cancer
admitted to our hospital from January 2006 to May 2008 were enrolled in this study.
The tumor, 4-12 cm in diameter, located in
pancreatic
head of
23 patients and in
pancreatic
body and tail of 9 patients, was found to be unresectable during operation.
Diagnosis of
pancreatic cancer
was made through intraoperative biopsy.
CONCLUSION: Intraoperative RFA combined with (125)iodine seed implantation is a feasible and safe procedure for unresectable
pancreatic cancer
with acceptable minor complications, and can prolong the survival time of patients, especially those at stage III.
[MeSH-major]
Adenocarcinoma
/ therapy. Catheter Ablation / methods. Iodine Radioisotopes / therapeutic use.
Pancreatic
Neoplasms / therapy. Radiotherapy / methods
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
MedlinePlus Health Information.
consumer health - Radiation Therapy
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Cancer. 2003 Feb 1;97(3):554-60
[
12548596.001
]
[Cites]
Breast Cancer. 2003;10(1):4-9
[
12525756.001
]
[Cites]
Cancer. 2003 Mar 1;97(5):1346-52
[
12599244.001
]
[Cites]
Eur J Surg Oncol. 2004 Feb;30(1):85-7
[
14736529.001
]
[Cites]
N Engl J Med. 2004 Mar 18;350(12):1200-10
[
15028824.001
]
[Cites]
Pancreas. 2004 Apr;28(3):219-30
[
15084961.001
]
[Cites]
Lancet. 1974 Nov 9;2(7889):1127-31
[
4139420.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1989 Nov;17(5):931-5
[
2808054.001
]
[Cites]
Ann Surg. 1990 Aug;212(2):132-9
[
1695834.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1992;23(2):305-11
[
1587751.001
]
[Cites]
Lifetime Data Anal. 1999;5(1):81-90
[
10214004.001
]
[Cites]
Gastrointest Endosc. 1999 Sep;50(3):392-401
[
10462663.001
]
[Cites]
Minim Invasive Neurosurg. 2004 Dec;47(6):325-8
[
15674746.001
]
[Cites]
Clin Liver Dis. 2005 May;9(2):301-14, viii
[
15831275.001
]
[Cites]
Hepatogastroenterology. 2005 Jul-Aug;52(64):1281-92
[
16001679.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1345-50
[
16029791.001
]
[Cites]
Expert Rev Anticancer Ther. 2005 Aug;5(4):657-66
[
16111466.001
]
[Cites]
Invest Radiol. 2005 Sep;40(9):583-90
[
16118551.001
]
[Cites]
Prostate. 2005 Nov 1;65(3):260-7
[
16015591.001
]
[Cites]
Eur J Radiol. 2005 Dec;56(3):403-8
[
15964164.001
]
[Cites]
JOP. 2006;7(1):1-4
[
16407612.001
]
[Cites]
JOP. 2006;7(1):74-8
[
16407624.001
]
[Cites]
J Surg Oncol. 2006 May 1;93(6):485-90
[
16615151.001
]
[Cites]
Langenbecks Arch Surg. 2007 Jan;392(1):55-60
[
17089173.001
]
[Cites]
J Clin Oncol. 2007 May 20;25(15):1960-6
[
17452677.001
]
[Cites]
Semin Oncol. 2007 Aug;34(4):327-34
[
17674961.001
]
[Cites]
Ann Oncol. 2008 Jul;19(7):1224-30
[
18381371.001
]
[Cites]
J Clin Oncol. 2009 Nov 20;27(33):5513-8
[
19858379.001
]
[Cites]
Pancreas. 2000 Jan;20(1):14-20
[
10630378.001
]
[Cites]
J Natl Cancer Inst. 2000 Feb 2;92(3):205-16
[
10655437.001
]
[Cites]
Arch Surg. 2000 Mar;135(3):332-5
[
10722037.001
]
[Cites]
Acta Chir Iugosl. 2002;49(3):19-24
[
12587443.001
]
(PMID = 20976848.001).
[ISSN]
2219-2840
[Journal-full-title]
World journal of gastroenterology
[ISO-abbreviation]
World J. Gastroenterol.
[Language]
eng
[Publication-type]
Evaluation Studies; Journal Article
[Publication-country]
China
[Chemical-registry-number]
0 / Iodine Radioisotopes
[Other-IDs]
NLM/ PMC2965288
2.
Nimura Y:
[Treatment of pancreatic cancer--surgical point of view].
Gan To Kagaku Ryoho
; 2007 Jul;34(7):993-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Treatment of
pancreatic cancer
--surgical point of view].
Although surgical techniques for
pancreatic cancer
have developed in a high level, the treatment results have not been improved and the 5 year survival rates after curative operation has been about 15% in Japan.
Retrospective studies on extended lymphadenectomy for ductal
adenocarcinoma of
the
head of
the
pancreas
revealed that extended surgery prolonged the survival for resected patients.
Finally, the clinical advantages of extended lymphadenectomy for
pancreatic cancer
was denied by several RCTs from Italy and U.S.A.
Further development of multidisciplinary treatments for
pancreatic cancer
is expected.
[MeSH-major]
Carcinoma,
Pancreatic
Ductal / surgery. Lymph Node Excision / methods. Pancreatectomy.
Pancreatic
Neoplasms / surgery
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17637533.001).
[ISSN]
0385-0684
[Journal-full-title]
Gan to kagaku ryoho. Cancer & chemotherapy
[ISO-abbreviation]
Gan To Kagaku Ryoho
[Language]
jpn
[Publication-type]
English Abstract; Journal Article; Review
[Publication-country]
Japan
[Chemical-registry-number]
0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine
[Number-of-references]
24
3.
Adsay NV, Basturk O, Thirabanjasak D:
Diagnostic features and differential diagnosis of autoimmune pancreatitis.
Semin Diagn Pathol
; 2005 Nov;22(4):309-17
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Diagnostic features and differential
diagnosis of
autoimmune pancreatitis.
In about 15% to 20% of patients, the clinical stigmata of autoimmune conditions are present at the time
of diagnosis
, and in many others, discovered subsequently.
Most patients present with a
pancreatic
head
mass, often with an accompanying stricture of the distal common bile duct, which thus radiologically resembles "
pancreas
cancer
."
Elevated serum IgG4 levels are characteristic and may be very helpful in the differential
diagnosis
from tumors and tumor-like lesions of the
pancreas
which seldom result in levels above 135 mg/dL.
[MeSH-major]
Autoimmune Diseases /
diagnosis
. Pancreatitis /
diagnosis
[MeSH-minor]
Adenocarcinoma
/ pathology. Adrenal Cortex Hormones / therapeutic use. Adult. Biopsy, Fine-Needle.
Diagnosis
, Differential. Female. Humans. Male. Middle Aged
Genetic Alliance.
consumer health - Pancreatitis
.
MedlinePlus Health Information.
consumer health - Autoimmune Diseases
.
MedlinePlus Health Information.
consumer health - Pancreatitis
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16939059.001).
[ISSN]
0740-2570
[Journal-full-title]
Seminars in diagnostic pathology
[ISO-abbreviation]
Semin Diagn Pathol
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Adrenal Cortex Hormones
[Number-of-references]
91
Advertisement
4.
Matsubara N, Baba H, Okamoto A, Kurata M, Tsuruta K, Funata N, Ashizawa K:
Rectal cancer metastasis to the head of the pancreas treated with pancreaticoduodenectomy.
J Hepatobiliary Pancreat Surg
; 2007;14(6):590-4
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Rectal
cancer
metastasis to the
head of
the
pancreas
treated with pancreaticoduodenectomy.
We report a case of a 50-year-old man who developed metastatic
pancreatic cancer
from a primary rectal
cancer
that had been curatively removed 3 years previously.
The patient presented with a tumor that occupied the
head of
the
pancreas
, associated with obstructive jaundice, but the main
pancreatic
duct was not dilated.
The patient was initially diagnosed as having primary
pancreatic cancer
.
Cytological examination of the bile was conclusive for the presence
of adenocarcinoma
.
For 1 year, local disease progression was slow and no distant metastases developed; therefore, the initial
diagnosis of
pancreatic cancer
was questioned.
On histology, including immunohistochemical staining for cytokeratin 20 (positive) and cytokeratin 7 (negative), the tumor was shown to be a metastatic
pancreatic
carcinoma that had originated from the original rectal
cancer
.
[MeSH-major]
Pancreatic
Neoplasms / secondary.
Pancreatic
Neoplasms / surgery. Pancreaticoduodenectomy. Rectal Neoplasms / pathology
[MeSH-minor]
Angiography. Cholangiopancreatography, Magnetic Resonance.
Diagnosis
, Differential. Fatal Outcome. Humans. Immunohistochemistry. Male. Middle Aged
Genetic Alliance.
consumer health - Rectal Cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18040627.001).
[ISSN]
0944-1166
[Journal-full-title]
Journal of hepato-biliary-pancreatic surgery
[ISO-abbreviation]
J Hepatobiliary Pancreat Surg
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Japan
5.
Demirkan B, Unek IT, Eriksson B, Akarsu M, Durak H, Sağol O, Obuz F, Binicier C, Füzün M, Alakavuklar M:
A patient with nonfunctional pancreatic neuroendocrine tumor and incidental metachronous colon carcinoma detected by positron emission tomography: case report.
Turk J Gastroenterol
; 2009 Sep;20(3):214-9
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
A patient with nonfunctional
pancreatic
neuroendocrine tumor and incidental metachronous colon carcinoma detected by positron emission tomography: case report.
Pancreatic
neuroendocrine tumors constitute about 2% of all gastrointestinal neoplasms.
Approximately half of the
pancreatic
euroendocrine tumors are nonfunctional.
Due to lack of specific symptoms, most patients with nonfunctional
pancreatic
neuroendocrine tumors present with locally advanced or metastatic disease.
Colon carcinoma ranks third in frequency among primary sites of
cancer
in both men and women in western countries.
Presence of a metachronous colon
adenocarcinoma
in a patient with nonfunctional
pancreatic
neuroendocrine tumor has not been reported before.
We present a patient who had an asymptomatic mass in the
head of
the
pancreas
, detected by ultrasonography in 1996.
In 2002, after the
diagnosis of
an unresectable, nonfunctional
pancreatic
neuroendocrine tumor, interferon alpha- 2b and octreotide were started.
[MeSH-major]
Adenocarcinoma
/ radionuclide imaging. Colonic Neoplasms / radionuclide imaging. Neoplasms, Second Primary / radionuclide imaging. Neuroendocrine Tumors / radionuclide imaging.
Pancreatic
Neoplasms / radionuclide imaging. Positron-Emission Tomography
Genetic Alliance.
consumer health - Pancreatic islet cell tumors
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19821205.001).
[ISSN]
2148-5607
[Journal-full-title]
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
[ISO-abbreviation]
Turk J Gastroenterol
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Turkey
6.
Delpero JR, Turrini O:
[Ductal adenocarcinoma of the head of the pancreas: a critical study of R1 resection rates].
Bull Cancer
; 2008 Dec;95(12):1193-8
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Ductal
adenocarcinoma of
the
head of
the
pancreas
: a critical study of R1 resection rates].
Complete resection (R0) remains the only potentially curative treatment of ductal
adenocarcinoma of
the
pancreas
.
[MeSH-major]
Carcinoma,
Pancreatic
Ductal / pathology. Carcinoma,
Pancreatic
Ductal / surgery.
Pancreatic
Neoplasms / pathology.
Pancreatic
Neoplasms / surgery
[MeSH-minor]
Humans. Neoadjuvant Therapy. Neoplasm Recurrence, Local. Neoplasm, Residual.
Pancreas
/ pathology.
Pancreas
/ surgery. Pancreatectomy. Prognosis
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19091653.001).
[ISSN]
1769-6917
[Journal-full-title]
Bulletin du cancer
[ISO-abbreviation]
Bull Cancer
[Language]
fre
[Publication-type]
English Abstract; Journal Article; Review
[Publication-country]
France
[Number-of-references]
29
7.
Kuroki T, Tajima Y, Tsutsumi R, Mishima T, Kitasato A, Adachi T, Kanematsu T:
Inferior branch-preserving superior head resection of the pancreas with gastric wall-covering method for intraductal papillary mucinous adenoma.
Am J Surg
; 2006 Jun;191(6):823-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Inferior branch-preserving superior
head
resection of the
pancreas
with gastric wall-covering method for intraductal papillary mucinous adenoma.
Intraductal papillary mucinous neoplasm (IPMN) of the
pancreas
showed significantly less aggressive pathologic features compared with common
pancreatic cancer
.
Therefore, several organ-preserving techniques, including duodenum-preserving
pancreatic
head
resection, have been advocated in surgical procedures for IPMN.
We describe a surgical technique of superior
head
resection of the
pancreas
with inferior branch preservation followed by a gastric wall-covering method for the prevention of
pancreatic
leakage in patients with IPMN of the
pancreas head
.
[MeSH-major]
Adenocarcinoma
, Mucinous / surgery. Carcinoma,
Pancreatic
Ductal / surgery. Pancreatectomy / methods.
Pancreatic
Neoplasms / surgery. Stomach / surgery
[MeSH-minor]
Abdominal Pain /
diagnosis
. Abdominal Pain / etiology. Aged. Anastomosis, Surgical. Cholangiopancreatography, Endoscopic Retrograde / methods. Follow-Up Studies. Humans. Immunohistochemistry. Male. Neoplasm Staging. Risk Assessment. Treatment Outcome
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16720158.001).
[ISSN]
0002-9610
[Journal-full-title]
American journal of surgery
[ISO-abbreviation]
Am. J. Surg.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
8.
Obana T, Fujita N, Noda Y, Kobayashi G, Ito K, Horaguchi J, Takasawa O, Tsuchiya T, Sawai T:
Small pancreatic cancer with pancreas divisum preoperatively diagnosed by pancreatic juice cytology.
Intern Med
; 2009;48(18):1661-6
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Small
pancreatic cancer
with
pancreas
divisum preoperatively diagnosed by
pancreatic
juice cytology.
We present a case of small
pancreatic
head
cancer
with
pancreas
divisum preoperatively diagnosed by
pancreatic
juice cytology.
A 60-year-old woman was referred to our hospital for evaluation of a dilated main
pancreatic
duct (MPD).
A small and poorly reproducible low-echoic lesion in the
pancreas
was suspected by ultrasonography (US) and endoscopic ultrasonography (EUS).
Magnetic resonance cholangiopancreatography (MRCP) failed to visualize the ventral
pancreatic
duct, and the upstream dorsal
pancreatic
duct was dilated.
Endoscopic retrograde cholangiopancreatography (ERCP) was indicative
of pancreas
divisum, and complete obstruction of the MPD in the
pancreatic
head
was seen.
Cytology of
pancreatic
juice obtained from the dorsal
pancreas
after minor papilla sphincterotomy revealed the presence
of adenocarcinoma
cells.
Pancreatoduodenectomy was performed under the
diagnosis of
pancreatic
head
cancer
with
pancreas
divisum.
Histological examination revealed moderately-differentiated tubular
adenocarcinoma
20 mm in diameter, located in the
pancreatic
head
.
Dilatation of the dorsal
pancreatic
duct is sometimes observed in cases with
pancreas
divisum without the presence of tumors.
When
pancreatic
duct stenosis also exists in such cases, even if a tumor is not clearly visualized by diagnostic imaging, vigorous examinations such as
pancreatic
juice cytology are recommended to establish an accurate
diagnosis
.
[MeSH-major]
Pancreas
/ abnormalities.
Pancreatic
Neoplasms /
diagnosis
[MeSH-minor]
Adenocarcinoma
/
diagnosis
.
Adenocarcinoma
/ pathology.
Adenocarcinoma
/ ultrasonography. Cholangiopancreatography, Endoscopic Retrograde. Female. Humans. Middle Aged.
Pancreatic
Juice / cytology
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19755770.001).
[ISSN]
1349-7235
[Journal-full-title]
Internal medicine (Tokyo, Japan)
[ISO-abbreviation]
Intern. Med.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Japan
9.
Tomimaru Y, Ishikawa O, Ohigashi H, Eguchi H, Yamada T, Sasaki Y, Miyashiro I, Ohue M, Yano M, Uehara H, Nakaizumi A, Imaoka S:
Advantage of pancreaticogastrostomy in detecting recurrent intraductal papillary mucinous carcinoma in the remnant pancreas: a case of successful re-resection after pancreaticoduodenectomy.
J Surg Oncol
; 2006 May 1;93(6):511-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Advantage of pancreaticogastrostomy in detecting recurrent intraductal papillary mucinous carcinoma in the remnant
pancreas
: a case of successful re-resection after pancreaticoduodenectomy.
Recently there has been an increase in the number of case reports detailing the recurrence of
cancer
in the
pancreatic
remnants following surgical resection of intraductal papillary mucinous carcinoma (IPMC) of the
pancreas
.
A 68-year-old man underwent PD for IPMC of the
pancreatic
head
, and the cut margin of the
pancreatic
duct was diagnosed as having no
cancer
but moderately dysplastic epithelium by an intraoperative frozen section of histology.
Eight years and 6 months later, during a routine follow-up examination, duct dilation of the remnant
pancreas
was detected by magnetic resonance imaging (MRI).
Upon examination by endoscopic gastroscopy, the anastomotic site was found to be covered with a large amount of mucin from which we easily obtained both cytologic and biopsied specimens, which subsequently proved positive for
cancer
.
In line with our
diagnosis of
recurrent IPMC, the patient underwent a second surgery (resection of the remnant
pancreas
, total pancreatectomy) and postoperative histology confirmed that indeed the patient had experienced recurrent IPMC with no nodal involvement or invasion beyond the
pancreatic
confines.
Based on this experience, we decided to recommend PG for all patients deemed to be at high risk for the recurrence of
cancer
in the
pancreatic
remnants following PD for IPMC of the
pancreatic
head
.
[MeSH-major]
Carcinoma,
Pancreatic
Ductal / surgery. Gastrostomy. Neoplasm Recurrence, Local / surgery.
Pancreatic
Ducts / surgery.
Pancreatic
Neoplasms / surgery. Pancreaticoduodenectomy
[MeSH-minor]
Adenocarcinoma
, Mucinous /
diagnosis
.
Adenocarcinoma
, Mucinous / surgery. Aged. Carcinoma, Papillary /
diagnosis
. Carcinoma, Papillary / surgery. Follow-Up Studies. Gastroscopy. Humans. Magnetic Resonance Imaging. Male. Pancreatectomy. Reoperation
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2006 Wiley-Liss, Inc.
(PMID = 16615155.001).
[ISSN]
0022-4790
[Journal-full-title]
Journal of surgical oncology
[ISO-abbreviation]
J Surg Oncol
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
10.
Tapper EB, Martin D, Adsay NV, Kooby D, Kalb B, Sarmiento JM:
An MRI-driven practice: a new perspective on MRI for the evaluation of adenocarcinoma of the head of the pancreas.
J Gastrointest Surg
; 2010 Aug;14(8):1292-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
An MRI-driven practice: a new perspective on MRI for the evaluation
of adenocarcinoma
of the
head of
the
pancreas
.
OBJECTIVES: The purpose of the study was to describe the MRI-driven management of masses at the
head of
the
pancreas
.
RESULTS: Between 2004 and 2008, we have treated 124 patients for a radiographic
diagnosis of adenocarcinoma of
the
head of
the
pancreas
.
This
diagnosis
was correct in 96.0% of the time.
CONCLUSION: MRI is a useful tool in the preoperative imaging of
pancreatic
head
lesions that is highly sensitive and very specific for resectable disease.
[MeSH-major]
Adenocarcinoma
/
diagnosis
. Magnetic Resonance Imaging / methods.
Pancreatic
Neoplasms /
diagnosis
[MeSH-minor]
Aged.
Diagnosis
, Differential. Female. Follow-Up Studies. Humans. Male. Middle Aged. Pancreaticoduodenectomy. Prognosis. Reproducibility of Results. Retrospective Studies. Sensitivity and Specificity. Time Factors
MedlinePlus Health Information.
consumer health - MRI Scans
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
AJR Am J Roentgenol. 2002 Sep;179(3):717-24
[
12185052.001
]
[Cites]
Br J Surg. 2001 Mar;88(3):325-37
[
11260096.001
]
[Cites]
J Comput Assist Tomogr. 2005 Jul-Aug;29(4):438-45
[
16012297.001
]
[Cites]
Abdom Imaging. 2005 Jul-Aug;30(4):488-500
[
15759205.001
]
[Cites]
N Engl J Med. 1992 Feb 13;326(7):455-65
[
1732772.001
]
[Cites]
J Am Coll Surg. 2008 Mar;206(3):445-50
[
18308214.001
]
[Cites]
J Gastrointest Surg. 1999 Sep-Oct;3(5):506-11
[
10482707.001
]
[Cites]
Clin Gastroenterol Hepatol. 2008 Dec;6(12 ):1301-8
[
18948228.001
]
[Cites]
Ann Surg Oncol. 2006 Aug;13(8):1035-46
[
16865597.001
]
[Cites]
Ann Surg. 1996 Feb;223(2):134-40
[
8597506.001
]
[Cites]
Am J Surg. 2006 Dec;192(6):888-93
[
17161114.001
]
[Cites]
J Gastrointest Surg. 2004 Mar-Apr;8(3):280-8
[
15019924.001
]
[Cites]
J Am Coll Surg. 2008 May;206(5):833-46; discussion 846-8
[
18471707.001
]
[Cites]
Radiology. 1995 May;195(2):327-32
[
7724748.001
]
[Cites]
Arch Surg. 2000 Apr;135(4):409-14; discussion 414-5
[
10768705.001
]
[Cites]
Radiology. 2002 Jul;224(1):34-41
[
12091659.001
]
(PMID = 20467829.001).
[ISSN]
1873-4626
[Journal-full-title]
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
[ISO-abbreviation]
J. Gastrointest. Surg.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
United States
11.
Jung JY, Kim YJ, Kim HM, Kim HJ, Park SW, Song SY, Chung JB, Kang CM, Pyo JY, Yang WI, Bang S:
Hepatoid carcinoma of the pancreas combined with neuroendocrine carcinoma.
Gut Liver
; 2010 Mar;4(1):98-102
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Hepatoid carcinoma of the
pancreas
combined with neuroendocrine carcinoma.
The most common sites of extrahepatic carcinoma are the stomach and ovary, but nine cases of hepatocellular differentiation of the
pancreas
have been reported in the literature.
We report another case of hepatoid carcinoma of the
pancreas
that was associated with the development of a
pancreatic
endocrine carcinoma in a 46-year-old man.
Serum alpha-fetoprotein (AFP) was elevated to 262.49 IU/mL and radiological examinations revealed a mass measuring 7.5 cm in diameter in the
head of
the
pancreas
.
He underwent a conventional Whipple operation, and light microscopy showed
adenocarcinoma
that was immunopositive for AFP, hepatocyte antigen, cytokeratin, chromogranin, synaptophysin, and alpha-1 antichymotrypsin.
Although hepatoid differentiation was not shown unequivocally histologically, other immunohistochemistry findings supported the
diagnosis of
hepatoid carcinoma combined with neuroendocrine carcinoma.
This report describes why hepatoid carcinoma should be considered as a differential
diagnosis of
a
pancreatic
mass, especially when serum AFP is elevated.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Am J Surg Pathol. 2007 Jan;31(1):146-52
[
17197931.001
]
[Cites]
Cancer. 2000 Apr 1;88(7):1582-9
[
10738216.001
]
[Cites]
Am Surg. 2004 Nov;70(11):1030-3
[
15586521.001
]
[Cites]
Am J Gastroenterol. 1999 Jun;94(6):1658-63
[
10364040.001
]
[Cites]
Mayo Clin Proc. 1997 Dec;72(12):1154-60
[
9413299.001
]
[Cites]
Cancer. 1993 Sep 15;72(6):1827-35
[
7689918.001
]
[Cites]
Cancer. 1993 Jan 15;71(2):293-6
[
7678544.001
]
[Cites]
Hepatogastroenterology. 1992 Jun;39(3):282-6
[
1380476.001
]
[Cites]
Cancer. 1986 Jul 1;58(1):119-26
[
2423220.001
]
[Cites]
Cancer. 1985 Aug 15;56(4):840-8
[
2410093.001
]
[Cites]
Cell Differ. 1986 Mar;18(2):109-17
[
3513967.001
]
[Cites]
Am J Clin Pathol. 1987 Nov;88(5):639-45
[
3673946.001
]
[Cites]
Lab Invest. 1990 May;62(5):552-61
[
2342330.001
]
[Cites]
Ann N Y Acad Sci. 1983;417:105-7
[
6200025.001
]
[Cites]
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2577-81
[
6941311.001
]
[Cites]
Cancer Res. 1972 May;32(5):979-82
[
4111729.001
]
[Cites]
J Gastroenterol. 2006 Oct;41(10):1011-9
[
17096071.001
]
(PMID = 20479919.001).
[ISSN]
2005-1212
[Journal-full-title]
Gut and liver
[ISO-abbreviation]
Gut Liver
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Korea (South)
[Other-IDs]
NLM/ PMC2871600
[Keywords]
NOTNLM ; Hepatoid carcinoma / Neuroendocrine carcinoma / Pancreas
12.
Jamieson NB, Glen P, McMillan DC, McKay CJ, Foulis AK, Carter R, Imrie CW:
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas.
Br J Cancer
; 2005 Jan 17;92(1):21-3
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal
adenocarcinoma head of pancreas
.
The aim of the present study was to examine the relationship between the clinicopathological status, the pre- and postoperative systemic inflammatory response and survival in patients undergoing potentially curative resection for ductal
adenocarcinoma of
the
head of
the
pancreas
.
Patients (n = 65) who underwent resection of ductal
adenocarcinoma of
the
head of pancreas
between 1993 and 2001, and had pre- and postoperative measurements of C-reactive protein, were included in the study.
The majority of patients had stage III disease (International Union Against
Cancer
Criteria, IUCC), positive circumferential margin involvement (R1), tumour size greater than 25 mm with perineural and lymph node invasion and died within the follow-up period.
The results of the present study indicate that, in patients who have undergone potentially curative resection for ductal
adenocarcinoma of
the
head of pancreas
, the presence of a systemic inflammatory response predicts poor outcome.
[MeSH-major]
Carcinoma,
Pancreatic
Ductal / immunology. Inflammation / complications.
Pancreatic
Neoplasms / immunology
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Nutr Cancer. 2000;37(1):36-40
[
10965517.001
]
[Cites]
Surg Today. 1999;29(1):16-22
[
9934826.001
]
[Cites]
Lancet. 2001 Feb 17;357(9255):539-45
[
11229684.001
]
[Cites]
Curr Oncol Rep. 2002 May;4(3):250-5
[
11937016.001
]
[Cites]
Nature. 2002 Dec 19-26;420(6917):860-7
[
12490959.001
]
[Cites]
Br J Surg. 2003 Feb;90(2):215-9
[
12555298.001
]
[Cites]
Eur J Surg Oncol. 2003 May;29(4):368-73
[
12711291.001
]
[Cites]
Ann Surg. 2003 Aug;238(2):197-202
[
12894012.001
]
[Cites]
Br J Cancer. 2004 May 4;90(9):1707-9
[
15150596.001
]
[Cites]
Anticancer Res. 1994 Mar-Apr;14(2B):657-66
[
8010724.001
]
[Cites]
Cancer. 1995 Apr 15;75(8):2077-82
[
7535184.001
]
[Cites]
Ann Surg. 1995 Jun;221(6):721-31; discussion 731-3
[
7794076.001
]
[Cites]
CA Cancer J Clin. 1996 Jan-Feb;46(1):5-27
[
8548526.001
]
[Cites]
Ann Surg. 1996 Feb;223(2):147-53
[
8597508.001
]
[Cites]
Langenbecks Arch Surg. 1998 Apr;383(2):116-20
[
9641883.001
]
[Cites]
Oncology. 2000 Nov;59(4):296-301
[
11096341.001
]
(PMID = 15597096.001).
[ISSN]
0007-0920
[Journal-full-title]
British journal of cancer
[ISO-abbreviation]
Br. J. Cancer
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
[Chemical-registry-number]
9007-41-4 / C-Reactive Protein
[Other-IDs]
NLM/ PMC2361749
13.
Caricato M, Borzomati D, Ausania F, Garberini A, Rabitti C, Tonini G, Coppola R:
Cerebellar metastasis from pancreatic adenocarcinoma. A case report.
Pancreatology
; 2006;6(4):306-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Cerebellar metastasis from
pancreatic
adenocarcinoma
. A case report.
The first discovery of a cerebellar metastasis of
pancreatic
carcinoma in a living patient is described.
Two years earlier the patient had undergone a pancreaticoduodenectomy for an
adenocarcinoma of
the
head of
the
pancreas
with a lymph node metastasis.
Clinical evaluation revealed an intracranial tumor without signs of
pancreatic
recurrence.
[MeSH-major]
Adenocarcinoma
/ secondary. Cerebellar Neoplasms / radiography. Cerebellar Neoplasms / secondary.
Pancreatic
Neoplasms / pathology
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright (c) 2006 S. Karger AG, Basel and IAP.
(PMID = 16636605.001).
[ISSN]
1424-3903
[Journal-full-title]
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
[ISO-abbreviation]
Pancreatology
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Switzerland
[Chemical-registry-number]
0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine
14.
Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kobayashi S, Kojima M, Miyauchi H, Asano T:
Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
J Hepatobiliary Pancreat Sci
; 2010 Nov;17(6):798-802
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Inferior
head
resection of the
pancreas
for intraductal papillary mucinous neoplasms.
Thus, a variety of types of partial
pancreatic
resections have been advocated for treating these low-grade malignant tumors.
METHODS: We performed a retrospective review of the clinicopathologic features and surgical outcome in 15 patients who underwent inferior
head
resection for IPMN at the Chiba University Hospital and National
Cancer
Center Hospital East between July 1994 and January 2007.
Subsequent pancreatoduodenectomy was performed in one patient because of noninvasive carcinoma with multiple mucous lakes in the
pancreatic
parenchyma.
Pancreatic
fistula occurred in 7 (47%) patients.
Two patients died of
pancreatic
ductal
adenocarcinoma
, 30 and 78 months after inferior
head
resection.
CONCLUSIONS:
Pancreatic
endocrine and exocrine function was well preserved after inferior
head
resection.
Pancreatic
fistula occurred more frequently after inferior
head
resection than with conventional pancreatoduodenectomy.
[MeSH-major]
Adenocarcinoma
, Mucinous / surgery. Carcinoma,
Pancreatic
Ductal / surgery. Carcinoma, Papillary / surgery. Pancreatectomy / methods.
Pancreatic
Neoplasms / surgery
[MeSH-minor]
Biopsy.
Diagnosis
, Differential. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Neoplasm Staging. Retrospective Studies. Treatment Outcome
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19727540.001).
[ISSN]
1868-6982
[Journal-full-title]
Journal of hepato-biliary-pancreatic sciences
[ISO-abbreviation]
J Hepatobiliary Pancreat Sci
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Multicenter Study
[Publication-country]
Japan
15.
Hav M, Lem D, Chhut SV, Kong R, Pauwels P, Cuvelier C, Piet P:
Clear-cell variant of solid-pseudopapillary neoplasm of the pancreas: a case report and review of the literature.
Malays J Pathol
; 2009 Dec;31(2):137-41
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Clear-cell variant of solid-pseudopapillary neoplasm of the
pancreas
: a case report and review of the literature.
Solid-pseudopapillary neoplasm (SPN) of the
pancreas
is a rare neoplasm reported to have a favourable prognosis because of its slow-growing behaviour.
Its clear cell variant creates challenges in distinction from other clear cell tumours in the
pancreas
.
Exploratory laparotomy revealed a 5.2 cm well-demarcated tumour in the
head of
the
pancreas
, which was treated with Whipple procedure.
Difficulties are recognized in differentiating clear-cell SPN from "sugar" tumours, metastatic renal cell carcinoma, clear-cell variant of
pancreatic
endocrine neoplasm and ductal
adenocarcinoma
.
When facing such difficulties, nuclear and cytoplamic beta-catenin, nuclear E-cadherin expressions and absence of membranous E-cadherin staining are useful in differentiating clear-cell SPN from other clear cell tumours in the
pancreas
.
[MeSH-major]
Carcinoma, Papillary / pathology.
Pancreatic
Neoplasms / pathology
[MeSH-minor]
Adult. Biomarkers, Tumor / analysis. Carcinoma, Islet Cell /
diagnosis
. Carcinoma,
Pancreatic
Ductal /
diagnosis
. Carcinoma, Renal Cell /
diagnosis
. Carcinoma, Renal Cell / secondary. Cell Nucleus / chemistry. Cell Nucleus / pathology. Cytoplasm / chemistry. Cytoplasm / pathology.
Diagnosis
, Differential. Female. Humans. Perivascular Epithelioid Cell Neoplasms /
diagnosis
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20514858.001).
[ISSN]
0126-8635
[Journal-full-title]
The Malaysian journal of pathology
[ISO-abbreviation]
Malays J Pathol
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Malaysia
[Chemical-registry-number]
0 / Biomarkers, Tumor
16.
Moral A, Muñoz-Guijosa C, González JA, Magarzo J, Hernández A, Artigas V, Trias M:
[Intraductal papillary mucinous neoplasms of the pancreas].
Cir Esp
; 2005 May;77(5):258-62
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Intraductal papillary mucinous neoplasms of the
pancreas
].
INTRODUCTION: Mucin-producing
pancreatic
tumors account for 1% of all malignant tumors of the
pancreas
.
Notable among these are intraductal papillary mucinous neoplasms of the
pancreas
, due to their variable clinical behavior, increased frequency, and the controversy surrounding the most suitable treatment and diagnostic methods.
PATIENTS AND METHOD: We performed a prospective review of patients with a
diagnosis of
intraductal papillary mucinous neoplasm of the
pancreas
between 1996 and 2001.
The most frequent localization was the
pancreatic
head
.
Seven patients underwent
pancreatic
resection and only one patient was not surgically treated.
CONCLUSION: Intraductal papillary mucinous neoplasms of the
pancreas
generally appear in the sixth decade of life.
These neoplasms typically occur in the
head of
the
pancreas
.
[MeSH-major]
Adenocarcinoma
, Mucinous. Carcinoma, Papillary.
Pancreatic
Neoplasms
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16420930.001).
[ISSN]
0009-739X
[Journal-full-title]
Cirugía española
[ISO-abbreviation]
Cir Esp
[Language]
spa
[Publication-type]
English Abstract; Journal Article
[Publication-country]
Spain
17.
Sasaki E, Tsunoda N, Hatanaka Y, Mori N, Iwata H, Yatabe Y:
Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers.
Mod Pathol
; 2007 Feb;20(2):208-14
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Previously, we used the reverse transcription-polymerase chain reaction (RT-PCR) to show that mammaglobin (MGB1) can serve as a differential marker of breast
cancer
metastasis from primary lung
cancer
.
Of the other cancers examined, including 29 of the
head
and neck, eight of the thyroid, 106 of the lung, 35 of the gastrointestinal tract, three of the
pancreas
, 14 of the uterine cervix and 13 of the ovary, none were positive for MGB1 except a proportion of salivary gland tumors (6/11, 55%) and endometrial cancers (3/23, 13%).
In terms of practical
diagnosis
, MGB1 immunohistochemistry can serve as a differential marker of breast
cancer
metastasis from primary lung
cancer
for two reasons.
Firstly, HER2-positive breast
cancer
frequently lacks estrogen receptor expression, but MGB1 is expressed in about half of this subtype.
[MeSH-major]
Adenocarcinoma
/ metabolism. Breast Neoplasms / metabolism. Neoplasm Proteins / metabolism. Uteroglobin / metabolism
[MeSH-minor]
Biomarkers, Tumor / metabolism. Cell Count.
Diagnosis
, Differential. Disease-Free Survival. Female. Humans. Immunoenzyme Techniques. Japan / epidemiology. Lung Neoplasms /
diagnosis
. Lung Neoplasms / metabolism. Lung Neoplasms / secondary. Mammaglobin A. Neoplasm Staging. Receptors, Estrogen / metabolism. Survival Rate. Tissue Array Analysis
MedlinePlus Health Information.
consumer health - Breast Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
antibodies-online.
View related products from antibodies-online.com
(subscription/membership/fee required).
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17192791.001).
[ISSN]
0893-3952
[Journal-full-title]
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
[ISO-abbreviation]
Mod. Pathol.
[Language]
eng
[Publication-type]
Journal Article; Research Support, Non-U.S. Gov't
[Publication-country]
United States
[Chemical-registry-number]
0 / Biomarkers, Tumor; 0 / Mammaglobin A; 0 / Neoplasm Proteins; 0 / Receptors, Estrogen; 0 / SCGB2A2 protein, human; 9060-09-7 / Uteroglobin
18.
Zacharias T, Jaeck D, Oussoultzoglou E, Neuville A, Bachellier P:
Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.
J Gastrointest Surg
; 2007 Mar;11(3):350-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal
adenocarcinoma of
the
pancreas
.
Pancreaticoduodenectomy remains the only potentially curative treatment for
adenocarcinoma of
the
pancreas
.
The aim of this study was to analyze prognostic factors impacting survival after R0 pancreaticoduodenectomy for
adenocarcinoma
in the
head of
the
pancreas
.
Between 1995 and 2002, a potentially curative (R0) pancreaticoduodenectomy with pancreatogastrostomy for ductal
adenocarcinoma
in the
head of
the
pancreas
was performed in 81 patients (42 women and 39 men) with a mean age of 64 years (range 35-84).
The main risk factor associated with poor survival after an R0 pancreaticoduodenectomy for
adenocarcinoma
in the
head of pancreas
was lymph node status: The presence of two or more positive lymph nodes was associated with decreased survival.
[MeSH-major]
Adenocarcinoma
/ surgery. Carcinoma,
Pancreatic
Ductal / surgery.
Pancreatic
Neoplasms / surgery. Pancreaticoduodenectomy
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Am J Surg. 2001 Aug;182(2):120-9
[
11574081.001
]
[Cites]
Ann Surg. 1998 Oct;228(4):508-17
[
9790340.001
]
[Cites]
Surgery. 1995 Jan;117(1):50-5
[
7809836.001
]
[Cites]
Ann Surg. 2002 Sep;236(3):355-66; discussion 366-8
[
12192322.001
]
[Cites]
Arch Surg. 2007 Feb;142(2):172-9; discussion 180
[
17309969.001
]
[Cites]
Br J Surg. 1993 Dec;80(12):1575-8
[
7507785.001
]
[Cites]
Ann Surg. 2003 Jan;237(1):74-85
[
12496533.001
]
[Cites]
World J Surg. 1999 Sep;23(9):926-9
[
10449822.001
]
[Cites]
Ann Surg. 2002 Aug;236(2):137-48
[
12170018.001
]
[Cites]
Hepatogastroenterology. 2002 Jan-Feb;49(43):258-62
[
11941970.001
]
[Cites]
Br J Surg. 2005 Sep;92(9):1150-4
[
16035134.001
]
[Cites]
Ann Surg. 1990 Apr;211(4):447-58
[
2322039.001
]
[Cites]
Am J Surg. 2006 Jun;191(6):726-32; discussion 733-4
[
16720139.001
]
[Cites]
Br J Surg. 1996 May;83(5):625-31
[
8689203.001
]
[Cites]
J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79
[
11307091.001
]
[Cites]
Eur J Cancer. 2004 Mar;40(4):549-58
[
14962722.001
]
[Cites]
Dig Surg. 2004;21(3):202-9
[
15218236.001
]
[Cites]
Am J Gastroenterol. 2001 Sep;96(9):2609-15
[
11569683.001
]
[Cites]
Arch Surg. 2004 Mar;139(3):327-35
[
15006893.001
]
[Cites]
Ann Surg. 1999 May;229(5):613-22; discussion 622-4
[
10235519.001
]
[Cites]
Br J Surg. 2003 Sep;90(9):1131-6
[
12945082.001
]
[Cites]
Arch Pathol Lab Med. 2002 Oct;126(10):1169-73
[
12296752.001
]
[Cites]
Ann Surg. 1997 Sep;226(3):248-57; discussion 257-60
[
9339931.001
]
[Cites]
J Gastrointest Surg. 2006 Jun;10(6):813-22
[
16769537.001
]
[Cites]
Surgery. 1997 Sep;122(3):553-66
[
9308613.001
]
[Cites]
World J Surg. 1995 May-Jun;19(3):410-4; discussion 414-5
[
7638998.001
]
[Cites]
Hepatogastroenterology. 1998 May-Jun;45(21):855-66
[
9684147.001
]
[Cites]
Pancreas. 2003 Apr;26(3):243-9
[
12657950.001
]
[Cites]
Ann Surg. 1996 Jun;223(6):718-25; discussion 725-8
[
8645045.001
]
(PMID = 17458610.001).
[ISSN]
1091-255X
[Journal-full-title]
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
[ISO-abbreviation]
J. Gastrointest. Surg.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
19.
Murakami Y, Uemura K, Ohge H, Hayashidani Y, Sudo T, Sueda T:
Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma.
Surgery
; 2006 Sep;140(3):448-53
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the
pancreas
differentiated by ovarian-type stroma.
BACKGROUND: Intraductal papillary-mucinous neoplasms (IPMN) and mucinous cystic neoplasms (MCN) of the
pancreas
have similar clinicopathologic findings.
METHODS: Medical records for 77 patients with
pancreatic
cystic neoplasms with mucin secretion were reviewed.
RESULTS: IPMNs consisted of 32 adenomas, 12 borderline neoplasms, 13 adenocarcinomas in situ, and 13 invasive adenocarcinomas; MCNs included 6 adenomas and 1 invasive
adenocarcinoma
.
The location of the
pancreatic
mass differed, with 76% 0f IPMNs occurring in the
head
, while 86% of MCNs occurred in the body or tail.
Mass mean size was significantly smaller (28 mm vs 78 mm, P < .001), and mean diameter of the main
pancreatic
duct was larger (6.8 mm vs 3.1 mm, P < .001) in IPMN than in MCN.
Communication between the cyst and main
pancreatic
duct was more frequent in IPMNs (67/70) than in MCNs (1/7).
[MeSH-major]
Adenocarcinoma
/ pathology.
Adenocarcinoma
, Mucinous / pathology. Adenoma / pathology. Carcinoma,
Pancreatic
Ductal / pathology. Carcinoma, Papillary / pathology. Stromal Cells / pathology
[MeSH-minor]
Adult. Aged.
Diagnosis
, Differential. Disease Progression. Female. Humans. Male. Middle Aged. Ovary / cytology. Prognosis. Retrospective Studies. Survival Rate
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentIn]
Surgery. 2007 Apr;141(4):545-6
[
17383536.001
]
(PMID = 16934608.001).
[ISSN]
0039-6060
[Journal-full-title]
Surgery
[ISO-abbreviation]
Surgery
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
20.
Sugimoto K, Okada K, Nakahira S, Okamura S, Miki H, Nakata K, Suzuki R, Yoshimura M, Uji K, Yoshida A, Tamura S:
[A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].
Gan To Kagaku Ryoho
; 2009 Feb;36(2):321-3
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[A case of metastatic
pancreatic cancer
after combination chemotherapy with uracil-tegafur and gemcitabine].
We report a case
of pancreas head
cancer
with liver metastasis treated with uracil-tegafur (UFT) and gemcitabine combined chemotherapy.
The histopathological
diagnosis
was
adenocarcinoma
, so we inserted a self-expandable metallic stent (EMS) in this inoperable
pancreas head
cancer
.
Renewed liver metastases did not appear, and the
pancreas head
tumor partially responded.
[MeSH-major]
Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Deoxycytidine / analogs & derivatives.
Pancreatic
Neoplasms / drug therapy.
Pancreatic
Neoplasms / pathology. Tegafur / therapeutic use. Uracil / therapeutic use
Genetic Alliance.
consumer health - Pancreatic cancer
.
Genetic Alliance.
consumer health - Metastatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19223756.001).
[ISSN]
0385-0684
[Journal-full-title]
Gan to kagaku ryoho. Cancer & chemotherapy
[ISO-abbreviation]
Gan To Kagaku Ryoho
[Language]
jpn
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Japan
[Chemical-registry-number]
0W860991D6 / Deoxycytidine; 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil; B76N6SBZ8R / gemcitabine
21.
Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB:
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Ann Surg
; 2008 Mar;247(3):456-62
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Long-term survival after pancreatoduodenectomy for
pancreatic
adenocarcinoma
: is cure possible?
OBJECTIVE: To determine long-term survival after pancreatoduodenectomy for
pancreatic
ductal
adenocarcinoma
and to identify clinical factors associated with long-term survival.
SUMMARY BACKGROUND DATA: The prognosis for long-term survival even after potentially curative resection for
pancreatic
adenocarcinoma
is thought to be poor.
Clinical factors determining short-term survival after
pancreatic
resection are well studied, but prognostic factors predicting long-term survival with a potential for cure are poorly understood.
METHODS: A case-control study was conducted of 357 patients who underwent pancreatoduodenectomy for
pancreatic
ductal
adenocarcinoma
between 1981 and 2001.
Histologic specimens were reanalyzed to confirm
diagnosis
.
Five-year survival was no guarantee of cure because 16% of this subset died of
pancreatic cancer
up to 7.8 years after operation.
CONCLUSION: Pancreatoduodenectomy for
adenocarcinoma
in the
head of pancreas
can provide long-term survival in a subset of patients, particularly in the absence of lymph node metastasis.
[MeSH-major]
Adenocarcinoma
/ mortality.
Adenocarcinoma
/ surgery.
Pancreatic
Neoplasms / mortality.
Pancreatic
Neoplasms / surgery. Pancreaticoduodenectomy
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
COS Scholar Universe.
author profiles
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18376190.001).
[ISSN]
0003-4932
[Journal-full-title]
Annals of surgery
[ISO-abbreviation]
Ann. Surg.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Serum Albumin
22.
Calculli L, Pezzilli R, Brindisi C, Morabito R, Casadei R, Zompatori M:
Pancreatic and extrapancreatic lesions in patients with intraductal papillary mucinous neoplasms of the pancreas: a single-centre experience.
Radiol Med
; 2010 Apr;115(3):442-52
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Pancreatic
and extrapancreatic lesions in patients with intraductal papillary mucinous neoplasms of the
pancreas
: a single-centre experience.
RESULTS:
Pancreatic
IPMN was localised in the
head
in 43 patients (30.3%), in the body in 13 (9.2%), in the tail in ten (7.0%), in the
head
-body in 17 (12.0%), in the body-tail in 15 (10.6%) diffuse throughout the gland in 44 (31.0%).
Twenty patients (14.1%) had associated
pancreatic
or extrapancreatic diseases.
In evaluating the distribution of
pancreatic
or extrapancreatic diseases according to IPMN type, we found that this was not significantly different among types I, II and III (p=0.776).
CONCLUSIONS: The majority of
pancreatic
and extrapancreatic cancers occur before the
diagnosis of
IPMNs is made and is not related to the type of IPMN.
[MeSH-major]
Adenocarcinoma
, Mucinous / pathology. Carcinoma,
Pancreatic
Ductal / pathology. Carcinoma, Papillary / pathology. Diagnostic Imaging. Neoplasms, Multiple Primary / pathology. Neoplasms, Second Primary / pathology.
Pancreatic
Neoplasms / pathology
MedlinePlus Health Information.
consumer health - Diagnostic Imaging
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Abdom Imaging. 2007 May-Jun;32(3):374-80
[
16967247.001
]
[Cites]
J Gastrointest Surg. 2007 Mar;11(3):338-44
[
17458608.001
]
[Cites]
J Magn Reson Imaging. 2005 Mar;21(3):237-44
[
15723374.001
]
[Cites]
Radiology. 2006 Feb;238(2):560-9
[
16436817.001
]
[Cites]
Pancreatology. 2006;6(1-2):17-32
[
16327281.001
]
[Cites]
N Engl J Med. 1993 May 20;328(20):1433-7
[
8479461.001
]
[Cites]
Gastroenterology. 2007 Jul;133(1):72-9; quiz 309-10
[
17631133.001
]
[Cites]
Abdom Imaging. 2006 May-Jun;31(3):320-5
[
16333711.001
]
[Cites]
AJR Am J Roentgenol. 2000 Feb;174(2):441-7
[
10658722.001
]
[Cites]
Hepatogastroenterology. 2007 Jul-Aug;54(77):1579-81
[
17708304.001
]
[Cites]
Int J Cancer. 2009 Aug 1;125(3):666-73
[
19382179.001
]
[Cites]
Surgery. 2006 Jun;139(6):749-54
[
16782429.001
]
[Cites]
Hepatobiliary Pancreat Dis Int. 2008 Apr;7(2):192-5
[
18397857.001
]
[Cites]
J Gastrointest Surg. 2008 Apr;12(4):645-50
[
18097728.001
]
[Cites]
J Am Coll Surg. 2007 May;204(5):803-13; discussion 813-4
[
17481488.001
]
[Cites]
J Gastroenterol. 2008;43(3):181-5
[
18373159.001
]
[Cites]
Clin Gastroenterol Hepatol. 2006 Apr;4(4):460-8
[
16616351.001
]
[Cites]
Radiology. 1986 Dec;161(3):697-700
[
3786719.001
]
[Cites]
Radiographics. 2005 Nov-Dec;25(6):1451-68; discussion 1468-70
[
16284127.001
]
[Cites]
Radiol Med. 2008 Apr;113(3):414-28
[
18493777.001
]
[Cites]
World J Surg. 2008 Feb;32(2):271-8; discussion 279-80
[
18027021.001
]
[Cites]
Ann Surg Oncol. 2005 Feb;12(2):124-32
[
15827792.001
]
[Cites]
Ann Surg. 1998 Nov;228(5):685-91
[
9833807.001
]
[Cites]
Korean J Radiol. 2003 Jul-Sep;4(3):157-62
[
14530644.001
]
[Cites]
Radiographics. 2001 Mar-Apr;21(2):323-37; discussion 337-40
[
11259696.001
]
[Cites]
Am J Surg. 2007 Sep;194(3):304-7
[
17693271.001
]
[Cites]
Clin Radiol. 2006 Sep;61(9):776-83
[
16905386.001
]
[Cites]
Am J Gastroenterol. 2008 Nov;103(11):2878-82
[
18853975.001
]
[Cites]
J Gastrointest Surg. 2008 Jan;12(1):101-9
[
17917784.001
]
(PMID = 20082228.001).
[ISSN]
1826-6983
[Journal-full-title]
La Radiologia medica
[ISO-abbreviation]
Radiol Med
[Language]
eng; ita
[Publication-type]
Journal Article
[Publication-country]
Italy
[Chemical-registry-number]
0 / Contrast Media
23.
Turculeanu A, Avrămescu C, Bălăşoiu M, Pleşea E, Simionescu C, Popescu CF:
Immuno-histopathological correlations in exocrine pancreatic cancer.
Rom J Morphol Embryol
; 2005;46(2):137-44
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Immuno-histopathological correlations in exocrine
pancreatic cancer
.
OBJECTIVE: Study of CA19-9 antigen from the immunological point of view, at the patients with
pancreatic cancer
, and his relation with the histopathological aspects.
MATERIAL AND METHOD: The determinations have been done at the time of the
diagnosis
and after the treatment of the patients with
pancreatic cancer
(25).
RESULTS: The values of the CA19-9 marker have been increased at the time of the
diagnosis
either in
pancreatic cancer
of the
head
and mid.
At the moment of the
diagnosis
the CA19-9 marker has higher values (150-400 U/ml) in
cancer
of the
pancreatic
body than in
cancer
of the
head of
the
pancreas
(40-200 U/ml).
Correlating the size of the tumor with the value of the CA19-9 marker in the case of
pancreatic cancer
we have been shown the highest serum values (300-400 U/ml) at patients whose tumor was 3 cm bigger.
The highest values of the CA 19-9 marker were found in cases of mid
pancreas adenocarcinoma
.
CONCLUSION: CA19-9 marker values higher than normal cause problems to digestive
cancer
(especially
pancreatic
).
The high values of CA 19-9 suggest an
adenocarcinoma
.
[MeSH-major]
CA-19-9 Antigen / analysis.
Pancreatic
Neoplasms / immunology.
Pancreatic
Neoplasms / pathology
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16287000.001).
[ISSN]
1220-0522
[Journal-full-title]
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
[ISO-abbreviation]
Rom J Morphol Embryol
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Romania
[Chemical-registry-number]
0 / Biomarkers, Tumor; 0 / CA-19-9 Antigen
24.
Pickartz T, Mayerle J, Kraft M, Evert M, Evert K, Kühn JP, Heidecke CD, Lerch MM:
[Chronic pancreatitis as a risk factor for the development of pancreatic cancer--diagnostic challenges].
Med Klin (Munich)
; 2010 Apr;105(4):281-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Chronic pancreatitis as a risk factor for the development of
pancreatic cancer
--diagnostic challenges].
Patients with chronic pancreatitis are burdened with an increased risk of developing
pancreatic cancer
.
Strategies or guidelines for the surveillance and early detection of
pancreatic
adenocarcinoma
in patients with chronic pancreatitis are not established, because available clinical, serologic or imaging techniques are still of limited sensitivity and specificity.
Despite these limitations do patients with chronic pancreatitis and suspected
pancreatic cancer
need a careful and sometimes repeated diagnostic work-up.
A clear benefit of surveillance programs outside of clinical trials for the early detection of
pancreatic cancer
has not been demonstrated.
A 51-year-old patient with chronic pancreatitis is reported who developed
cancer
of the
pancreatic
head
while undergoing repeated imaging studies.
[MeSH-major]
Carcinoma,
Pancreatic
Ductal /
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
. Pancreatitis, Alcoholic /
diagnosis
[MeSH-minor]
Anastomosis, Roux-en-Y. Disease Progression. Early
Diagnosis
. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged.
Pancreas
/ pathology. Pancreatectomy. Tomography, X-Ray Computed. Ultrasonography
Genetic Alliance.
consumer health - Pancreatic cancer
.
Genetic Alliance.
consumer health - Pancreatitis
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Surgery. 1997 Jul;122(1):53-9
[
9225915.001
]
[Cites]
Gastroenterology. 1952 May;21(1):54-63
[
14926813.001
]
[Cites]
J Biol Chem. 2002 Feb 15;277(7):5404-10
[
11719509.001
]
[Cites]
Am J Gastroenterol. 2009 Sep;104(9):2175-81
[
19491823.001
]
[Cites]
Gut. 2009 Oct;58(10):1410-8
[
19470496.001
]
[Cites]
Gut. 2007 Oct;56(10):1460-9
[
17872573.001
]
[Cites]
Curr Gastroenterol Rep. 2004 Apr;6(2):104-10
[
15191687.001
]
[Cites]
Chirurg. 2004 Jul;75(7):731-47; quiz 748
[
15205751.001
]
[Cites]
Br J Surg. 1999 Feb;86(2):189-93
[
10100785.001
]
[Cites]
Am J Gastroenterol. 2004 Jul;99(7):1258-66
[
15233663.001
]
[Cites]
Clin Gastroenterol Hepatol. 2006 Aug;4(8):1010-6; quiz 934
[
16843735.001
]
[Cites]
Int J Pancreatol. 2000 Apr;27(2):93-103
[
10862508.001
]
[Cites]
N Engl J Med. 1993 May 20;328(20):1433-7
[
8479461.001
]
[Cites]
JAMA. 2001 Jul 11;286(2):169-70
[
11448279.001
]
[Cites]
Gastrointest Endosc. 2002 Jul;56(1):66-71
[
12085037.001
]
[Cites]
Am J Gastroenterol. 2008 Jan;103(1):111-9
[
18184119.001
]
[Cites]
Am J Gastroenterol. 1990 Oct;85(10):1427-8
[
2220745.001
]
[Cites]
Int J Biochem Cell Biol. 2004 Aug;36(8):1386-92
[
15147717.001
]
[Cites]
Clin Gastroenterol Hepatol. 2004 Mar;2(3):252-61
[
15017610.001
]
[Cites]
Am J Gastroenterol. 2004 May;99(5):844-50
[
15128348.001
]
[Cites]
Gastrointest Endosc. 1998 Jul;48(1):11-7
[
9684658.001
]
[Cites]
Nat Clin Pract Gastroenterol Hepatol. 2007 Jun;4(6):314-23
[
17541445.001
]
[Cites]
Nat Genet. 1996 Oct;14(2):141-5
[
8841182.001
]
[Cites]
Lancet Oncol. 2009 Jan;10(1):88-95
[
19111249.001
]
[Cites]
Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1295-9
[
15618835.001
]
[Cites]
Pancreatology. 2001;1(5):405-15
[
12120217.001
]
[Cites]
Pancreas. 2003 Nov;27(4):321-6
[
14576495.001
]
[Cites]
Pancreas. 2009 Nov;38(8):846-8
[
19855232.001
]
[Cites]
Med Clin North Am. 2000 May;84(3):531-47, vii
[
10872412.001
]
[Cites]
J Natl Cancer Inst. 1997 Mar 19;89(6):442-6
[
9091646.001
]
[Cites]
J Natl Cancer Inst. 1994 Apr 20;86(8):625-7
[
8145277.001
]
[Cites]
J Eval Clin Pract. 2009 Feb;15(1):62-8
[
19239583.001
]
[Cites]
Clin Gastroenterol Hepatol. 2006 Jun;4(6):766-81; quiz 665
[
16682259.001
]
(PMID = 20455050.001).
[ISSN]
1615-6722
[Journal-full-title]
Medizinische Klinik (Munich, Germany : 1983)
[ISO-abbreviation]
Med. Klin. (Munich)
[Language]
ger
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Germany
25.
De Filippo M, Bocchi C, Quartieri L, Corradi D, Zompatori M:
Mangafodipir-DPDP enhanced MRI visualization of a pancreatic adenocarcinoma previously undetected by extracellular contrast enhanced CT and MRI.
Acta Biomed
; 2007 Dec;78(3):225-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Mangafodipir-DPDP enhanced MRI visualization of a
pancreatic
adenocarcinoma
previously undetected by extracellular contrast enhanced CT and MRI.
We report a case
of adenocarcinoma
of the
head of
the
pancreas
, occult at extracellular contrast enhanced MDCT and magnetic resonance imaging (MRI), which was detected by MRI only with the use of a tissue-specific contrast agent (Mangafodipir trisodium Mn- DPDP).
The histological examination after duodenopancreatectomy confirmed the
diagnosis
.
Contrast-enhanced multi-detector computed tomography (MDCT) is currently considered to be the reference method for diagnosing and staging of
pancreatic
adenocarcinoma
.
The technological evolution of magnetic resonance imaging and the development of organ-specific contrast media for liver and
pancreas
have led to a progressively more extensive use of this method for the investigation of suspected lesions.
[MeSH-major]
Adenocarcinoma
/
diagnosis
.
Adenocarcinoma
/ radiography. Contrast Media. Edetic Acid / analogs & derivatives. Magnetic Resonance Imaging / methods.
Pancreatic
Neoplasms /
diagnosis
.
Pancreatic
Neoplasms / radiography. Pyridoxal Phosphate / analogs & derivatives. Tomography, X-Ray Computed
[MeSH-minor]
Cholangiopancreatography, Endoscopic Retrograde. Female. Humans. Middle Aged.
Pancreas
/ pathology. Pancreaticoduodenectomy
MedlinePlus Health Information.
consumer health - CT Scans
.
MedlinePlus Health Information.
consumer health - MRI Scans
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
Hazardous Substances Data Bank.
Disodium EDTA
.
Hazardous Substances Data Bank.
ETHYLENEDIAMINE TETRAACETIC ACID
.
Hazardous Substances Data Bank.
DISODIUM CALCIUM EDTA
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18330084.001).
[ISSN]
0392-4203
[Journal-full-title]
Acta bio-medica : Atenei Parmensis
[ISO-abbreviation]
Acta Biomed
[Language]
eng
[Publication-type]
Case Reports; Comparative Study; Journal Article
[Publication-country]
Italy
[Chemical-registry-number]
0 / Contrast Media; 5V5IOJ8338 / Pyridoxal Phosphate; 9G34HU7RV0 / Edetic Acid; P28BIW0UTB / N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
26.
Carter RR, Woodall CE 3rd, McNally ME, Talboy GE, Lankachandra KM, Van Way CW 3rd:
Mixed ductal-endocrine carcinoma of the pancreas with synchronous papillary carcinoma-in-situ of the common bile duct: a case report and literature review--synchronous pancreatic and bile duct tumors.
Am Surg
; 2008 Apr;74(4):338-40
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Mixed ductal-endocrine carcinoma of the
pancreas
with synchronous papillary carcinoma-in-situ of the common bile duct: a case report and literature review--synchronous
pancreatic
and bile duct tumors.
This report is a case of a 58-year-old woman with a mixed ductal-endocrine carcinoma of the
pancreas
and a synchronous carcinoma-in-situ of the common bile duct.
Biopsies from this lesion showed
adenocarcinoma
.
Subsequently, pancreatoduodenectomy was performed for the
diagnosis of
peri-ampullary carcinoma.
Gross examination revealed a 2-cm irregular, ulcerated lesion obstructing the distal 0.5 cm of the common bile duct within the
head of
the
pancreas
.
On histopathological examination, it was discovered that this lesion contained two separate neoplasms: papillary carcinoma-in-situ of the intraparenchymal portion of the common bile duct and a mixed ductal-endocrine carcinoma of the
pancreas
.
Mixed ductal-endocrine carcinoma of the
pancreas
is very rare.
[MeSH-major]
Carcinoma in Situ / pathology. Carcinoma,
Pancreatic
Ductal / pathology. Common Bile Duct Neoplasms / pathology. Neoplasms, Multiple Primary / pathology.
Pancreatic
Neoplasms / pathology
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
The Weizmann Institute of Science GeneCards and MalaCards databases.
gene/protein/disease-specific - MalaCards for mixed ductal-endocrine carcinoma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18453301.001).
[ISSN]
0003-1348
[Journal-full-title]
The American surgeon
[ISO-abbreviation]
Am Surg
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
United States
[Number-of-references]
8
27.
Huo Z, Yang D, Chang XY, Wan JW, Chen J:
[Intraductal papillary mucinous neoplasm of pancreas: a clinicopathologic and immunohistochemical study of 19 cases].
Zhonghua Bing Li Xue Za Zhi
; 2008 Oct;37(10):670-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Intraductal papillary mucinous neoplasm
of pancreas
: a clinicopathologic and immunohistochemical study of 19 cases].
OBJECTIVE: To study the clinicopathologic features and
diagnosis of
intraductal papillary mucinous neoplasm (IPMN) of the
pancreas
.
It affected patients in older age group (mean age = 59) and was located mainly in the
head of pancreas
(60%).
Histologically, the tumor consisted of papillary proliferations protruding into and expanding the
pancreatic
ducts.
Invasion into the surrounding
pancreatic
parenchyma was noted in 12 cases and chronic pancreatitis was present in 16 cases.
The prognosis after surgical resection however is better than that of conventional
pancreatic
adenocarcinoma
.
Early recognition by radiologic examination (including ERCP) and
pancreatic
cytology would be helpful in early
diagnosis
.
[MeSH-major]
Carcinoma,
Pancreatic
Ductal / pathology. Carcinoma, Papillary / pathology. Immunohistochemistry / trends.
Pancreatic
Neoplasms / pathology
[MeSH-minor]
Adaptor Proteins, Signal Transducing / analysis.
Adenocarcinoma
, Mucinous /
diagnosis
.
Adenocarcinoma
, Mucinous / metabolism. Adult. Aged. Cell Cycle Proteins / analysis. Cholangiopancreatography, Endoscopic Retrograde. Female. Humans. Ki-67 Antigen / analysis. Male. Middle Aged.
Pancreas
/ metabolism.
Pancreas
/ pathology. Pancreatectomy.
Pancreatic
Ducts / metabolism.
Pancreatic
Ducts / pathology. Prognosis. Receptor, ErbB-2 / analysis. Treatment Outcome
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
The Lens.
Cited by Patents in
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19094485.001).
[ISSN]
0529-5807
[Journal-full-title]
Zhonghua bing li xue za zhi = Chinese journal of pathology
[ISO-abbreviation]
Zhonghua Bing Li Xue Za Zhi
[Language]
chi
[Publication-type]
English Abstract; Journal Article
[Publication-country]
China
[Chemical-registry-number]
0 / Adaptor Proteins, Signal Transducing; 0 / CDCA5 protein, human; 0 / Cell Cycle Proteins; 0 / Ki-67 Antigen; EC 2.7.10.1 / Receptor, ErbB-2
28.
Koizumi K, Fujii T, Matsumoto A, Sugiyama R, Suzuki S, Sukegawa R, Ozawa K, Orii F, Taruishi M, Saitoh Y, Sotokawa M, Takada A:
[Synchronous double invasive ductal carcinomas of the pancreas with multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas].
Nihon Shokakibyo Gakkai Zasshi
; 2009 Jan;106(1):98-105
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Synchronous double invasive ductal carcinomas of the
pancreas
with multifocal branch duct intraductal papillary mucinous neoplasms of the
pancreas
].
A 52-year-old man with a history of distal gastrectomy for gastric
cancer
was admitted to our hospital because of jaundice.
CT scan revealed double tumors in the
pancreatic
head
and body concomitant with multicystic lesions of the
pancreas
.
Final histological
diagnosis
was double invasive ductal carcinomas of the
pancreas head
and tail with multifocal branch duct intraductal papillary mucinous adenomas of the
pancreas
.
The present case suggests that entire
pancreas
might have malignant potential in patients with intraductal papillary mucinous neoplasms.
[MeSH-major]
Adenocarcinoma
, Mucinous / surgery. Carcinoma,
Pancreatic
Ductal / surgery. Carcinoma, Papillary / surgery. Neoplasms, Multiple Primary.
Pancreatic
Neoplasms / surgery
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19122428.001).
[ISSN]
0446-6586
[Journal-full-title]
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
[ISO-abbreviation]
Nihon Shokakibyo Gakkai Zasshi
[Language]
jpn
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Japan
29.
Sata N, Koizumi M, Tsukahara M, Yoshizawa K, Kurihara K, Nagai H:
Single-branch resection of the pancreas.
J Hepatobiliary Pancreat Surg
; 2005;12(1):71-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Single-branch resection of the
pancreas
.
The treatment of intraductal papillary mucinous tumors (IPMT) of the
pancreas
is still controversial.
In this report we describe a single-branch resection of the
pancreas
(SBRP), which is a new method for the removal of branch-type IPMT of the
head of
the
pancreas
.
A multilobular cystic lesion (50 x 40 mm) in the
head of
the
pancreas
was incidentally detected in an asymptomatic 40-year-old man who underwent a routine ultrasound examination.
The tumor was carefully removed along the border of the cyst and the normal parenchyma, with complete preservation of the main
pancreatic
duct and the common bile duct.
A
pancreatic
fistula developed during the postoperative period, but was well-controlled by endoscopic naso-
pancreatic
drainage.
SBRP is a technically feasible procedure and this operation represents a minimally invasive alternative to any other segmental resection of the
pancreas
.
[MeSH-major]
Adenocarcinoma
, Mucinous / surgery.
Adenocarcinoma
, Papillary / surgery. Pancreatectomy / methods.
Pancreatic
Neoplasms / surgery
[MeSH-minor]
Adult.
Diagnosis
, Differential. Diagnostic Imaging. Humans. Male
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15754104.001).
[ISSN]
0944-1166
[Journal-full-title]
Journal of hepato-biliary-pancreatic surgery
[ISO-abbreviation]
J Hepatobiliary Pancreat Surg
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Japan
30.
Sultana A, Shore S, Raraty MG, Vinjamuri S, Evans JE, Smith CT, Lane S, Chauhan S, Bosonnet L, Garvey C, Sutton R, Neoptolemos JP, Ghaneh P:
Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I(131) KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma.
BMC Cancer
; 2009 Feb 25;9:66
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I(131) KAb201 antibodies given intra-arterially or intravenously in patients with unresectable
pancreatic
adenocarcinoma
.
BACKGROUND: Advanced
pancreatic cancer
has a poor prognosis, and the current standard of care (gemcitabine based chemotherapy) provides a small survival advantage.
This study aimed to evaluate the safety and tolerability of KAb201, an anti-carcinoembryonic antigen monoclonal antibody, labelled with I(131) in
pancreatic cancer
(ISRCTN 16857581).
METHODS: Patients with histological/cytological proven inoperable
adenocarcinoma of
the
head of pancreas
were randomised to receive KAb 201 via either the intra-arterial or intravenous delivery route.
[MeSH-major]
Adenocarcinoma
/ diagnostic imaging. Carcinoembryonic Antigen / administration & dosage. Immunotoxins / administration & dosage. Iodine Radioisotopes / administration & dosage.
Pancreatic
Neoplasms / radiotherapy. Radioimmunotherapy / methods
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Clin Cancer Res. 1999 Oct;5(10 Suppl):3232s-3242s
[
10541369.001
]
[Cites]
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
[
18287387.001
]
[Cites]
Clin Cancer Res. 2000 Feb;6(2):406-14
[
10690517.001
]
[Cites]
Teratog Carcinog Mutagen. 2001;21(1):45-57
[
11135320.001
]
[Cites]
Cancer Res. 2001 Sep 15;61(18):6851-9
[
11559561.001
]
[Cites]
Eur J Cancer. 2001 Oct;37 Suppl 8:S4-66
[
11602373.001
]
[Cites]
Cancer. 2002 Feb 15;94(4 Suppl):1373-81
[
11877768.001
]
[Cites]
Cancer. 2002 Feb 15;94(4):902-10
[
11920457.001
]
[Cites]
J Clin Oncol. 2002 Aug 1;20(15):3270-5
[
12149301.001
]
[Cites]
Clin Colorectal Cancer. 2002 May;2(1):31-42
[
12453334.001
]
[Cites]
Aliment Pharmacol Ther. 2003 Dec;18(11-12):1049-69
[
14653825.001
]
[Cites]
Int J Cancer. 2004 Apr 20;109(4):618-26
[
14991585.001
]
[Cites]
J Natl Cancer Inst. 1976 Jul;57(1):11-22
[
794493.001
]
[Cites]
Ann N Y Acad Sci. 1983;417:75-85
[
6200051.001
]
[Cites]
Cancer Metastasis Rev. 1987;6(4):559-93
[
3327633.001
]
[Cites]
Cell. 1989 Apr 21;57(2):327-34
[
2702691.001
]
[Cites]
J Surg Oncol. 1991 Jul;47(3):148-54
[
2072697.001
]
[Cites]
J Nucl Med. 1997 Jun;38(6):858-70
[
9189130.001
]
[Cites]
J Clin Oncol. 1997 Jun;15(6):2403-13
[
9196156.001
]
[Cites]
J Nucl Med. 1998 Jan;39(1):34-42
[
9443735.001
]
[Cites]
Hepatogastroenterology. 1998 Jul-Aug;45(22):1125-9
[
9756018.001
]
[Cites]
Hybridoma. 1999 Apr;18(2):183-91
[
10380018.001
]
[Cites]
Surgery. 2005 Jun;137(6):597-605
[
15962401.001
]
[Cites]
Nat Biotechnol. 2005 Sep;23(9):1147-57
[
16151408.001
]
[Cites]
Ann Nucl Med. 2005 Jul;19(5):355-65
[
16164191.001
]
[Cites]
J Nucl Med. 2006 Feb;47(2):196-9
[
16455623.001
]
[Cites]
J Nucl Med. 2006 Feb;47(2):247-55
[
16455630.001
]
[Cites]
J Clin Oncol. 2006 Feb 10;24(5):823-34
[
16380412.001
]
[Cites]
J Clin Oncol. 2006 Mar 20;24(9):1395-403
[
16505413.001
]
[Cites]
J Clin Oncol. 2006 Aug 20;24(24):3946-52
[
16921047.001
]
[Cites]
Q J Nucl Med Mol Imaging. 2006 Dec;50(4):248-64
[
17043623.001
]
[Cites]
Curr Drug Discov Technol. 2006 Dec;3(4):231-43
[
17430101.001
]
[Cites]
J Clin Oncol. 2007 May 20;25(15):1960-6
[
17452677.001
]
[Cites]
J Clin Oncol. 2007 Jun 20;25(18):2607-15
[
17577041.001
]
[Cites]
J Natl Cancer Inst. 2000 Feb 2;92(3):205-16
[
10655437.001
]
(PMID = 19243606.001).
[ISSN]
1471-2407
[Journal-full-title]
BMC cancer
[ISO-abbreviation]
BMC Cancer
[Language]
eng
[Databank-accession-numbers]
ISRCTN/ ISRCTN16857581
[Grant]
United Kingdom / Medical Research Council / / G9900432; United Kingdom / Cancer Research UK / /
[Publication-type]
Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
[Publication-country]
England
[Chemical-registry-number]
0 / Antibodies, Monoclonal; 0 / Antibodies, Neoplasm; 0 / Carcinoembryonic Antigen; 0 / Immunotoxins; 0 / Iodine Radioisotopes
[Other-IDs]
NLM/ PMC2656541
31.
Obuchi T, Sasaki A, Shimooki O, Minakawa Y, Abe T, Nitta H, Otsuka K, Koeda K, Ikeda K, Wakabayashi G:
[Local recurrence after surgical resection of pancreatic cancer effectively treated with combined chemoradiotherapy].
Gan To Kagaku Ryoho
; 2009 Jun;36(6):991-4
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Local recurrence after surgical resection of
pancreatic cancer
effectively treated with combined chemoradiotherapy].
We report a patient for whom systemic chemotherapy using gemcitabine was effective against local recurrence of
pancreatic cancer
.
A 59-year-old man underwent pancreatoduodenectomy for
pancreatic
head
cancer
.
The
diagnosis
was moderately-differentiated tubular
adenocarcinoma
(tubular type, pT2, pN0, fM0, fStage II ).
Ten months after surgery, the patient had a CT examination which revealed a mass at the cut-end of the
pancreas
.
Twenty-one months after chemotherapy, CT examination revealed regrowth at the same location at the cut-end of the
pancreas
, and so radiotherapy was performed at a total 63 Gy.
[MeSH-major]
Adenocarcinoma
/ therapy.
Pancreatic
Neoplasms / therapy
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19542722.001).
[ISSN]
0385-0684
[Journal-full-title]
Gan to kagaku ryoho. Cancer & chemotherapy
[ISO-abbreviation]
Gan To Kagaku Ryoho
[Language]
jpn
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Japan
[Chemical-registry-number]
0 / Antimetabolites, Antineoplastic; 0 / Biomarkers, Tumor; 0 / CA-19-9 Antigen; 0W860991D6 / Deoxycytidine; 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil; B76N6SBZ8R / gemcitabine; 1-UFT protocol
32.
Inagaki M, Goto J, Tokusashi Y, Miyokawa N, Yokoyama K, Ikeue S, Kasai S:
Multifocal pancreatic intraepithelial neoplasia (PanIN) lesions of the branch ducts associated with lobular parenchymal atrophy in a Japanese patient diagnosed to have familial pancreatic cancer.
Clin J Gastroenterol
; 2009 Apr;2(2):103-108
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Multifocal
pancreatic
intraepithelial neoplasia (PanIN) lesions of the branch ducts associated with lobular parenchymal atrophy in a Japanese patient diagnosed to have familial
pancreatic cancer
.
This report presents a case of Japanese familial
pancreatic cancer
(FPC) with multifocal
pancreatic
intraepithelial neoplasia (PanIN) lesions of the branch ducts probably associated with lobular parenchymal atrophy.
The risk of
pancreatic cancer
is significantly increased in those associated with FPC, and this risk increases with increasing numbers of affected first-degree relatives, but there have been four Japanese cases reported.
A 63-year-old Japanese male was referred to the hospital for evaluation and treatment of a
pancreatic
head
tumor.
His family history included
pancreatic cancer
in two-first-degree relatives and three-second-degree relatives.
The histological findings of the main tumor showed a moderately differentiated tubular
adenocarcinoma
in the
head of
the
pancreas
without metastasis of the resected lymph nodes.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Pancreatology. 2007;7(4):341-6
[
17703080.001
]
[Cites]
Am J Surg Pathol. 2004 Aug;28(8):977-87
[
15252303.001
]
[Cites]
Gut. 2007 Oct;56(10):1460-9
[
17872573.001
]
[Cites]
Nat Genet. 2000 Jun;25(2):213-6
[
10835640.001
]
[Cites]
Curr Treat Options Oncol. 2005 Sep;6(5):437-45
[
16107246.001
]
[Cites]
Cancer Res. 2002 Jul 1;62(13):3789-93
[
12097290.001
]
[Cites]
Cancer Res. 1996 Dec 1;56(23):5360-4
[
8968085.001
]
[Cites]
Am J Pathol. 1999 Jun;154(6):1835-40
[
10362809.001
]
[Cites]
Am J Surg Pathol. 2001 May;25(5):579-86
[
11342768.001
]
[Cites]
Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):253-83
[
16549327.001
]
[Cites]
Am J Surg Pathol. 2006 Sep;30(9):1067-76
[
16931950.001
]
[Cites]
Ann Surg. 2002 Dec;236(6):730-7
[
12454511.001
]
[Cites]
Gan No Rinsho. 1984 Aug;30(10):1331-6
[
6481970.001
]
[Cites]
Ann Surg. 2007 Dec;246(6):966-74; discussion 974-5
[
18043098.001
]
[Cites]
PLoS Med. 2006 Dec;3(12):e516
[
17194196.001
]
[Cites]
Nat Genet. 1996 Oct;14(2):141-5
[
8841182.001
]
[Cites]
J Hepatobiliary Pancreat Surg. 2004;11(6):434-7
[
15619022.001
]
[Cites]
Mod Pathol. 2007 Feb;20 Suppl 1:S61-70
[
17486053.001
]
[Cites]
Pancreatology. 2007;7(5-6):514-25
[
17912015.001
]
[Cites]
Br J Cancer. 1985 Aug;52(2):271-3
[
4027169.001
]
[Cites]
Gut. 2007 Aug;56(8):1134-52
[
17625148.001
]
[Cites]
Cancer Res. 2004 Apr 1;64(7):2634-8
[
15059921.001
]
(PMID = 26192174.001).
[ISSN]
1865-7257
[Journal-full-title]
Clinical journal of gastroenterology
[ISO-abbreviation]
Clin J Gastroenterol
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Japan
[Keywords]
NOTNLM ; Familial pancreatic cancer / Lobular parenchymal atrophy / PanIN / Pancreatoduodenectomy
33.
Grenacher L, Klauss M:
[Computed tomography of pancreatic tumors].
Radiologe
; 2009 Feb;49(2):107-23
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Computed tomography of
pancreatic
tumors].
Computed tomography (CT) and in particular multi-detector row computed tomography (MDCT), also known as multislice CT (MSCT), is ideally suited for detecting
pancreatic
tumors because of the high spatial resolution.The method of choice is hydro-CT which involves distension of the stomach and duodenum by administration of 1-1.5 l water as a negative contrast medium under medically induced hypotension by administration of buscopan.
The patient is laid on the right side at an angle of 30-45 degrees in order to obtain an artefact-free image of the close anatomical relationship around the
pancreas head
.
After the correct
diagnosis of
an
adenocarcinoma
has been made only 20% of all patients are shown to have a surgically resectable disease, but the overall survival rate is significantly higher after resection in combination with a multimodal tumor therapy strategy.
The reason is that the correct
diagnosis of
the resectability of the tumor is one of the main criteria for overall survival of these patients.
Currently practically all
pancreatic
tumors can be detected using MDCT and the detection rate varies between 70% and 100% (most recent literature references give a sensitivity of 89% and specificity up to 99%).
In some rare cases the differentiation between focal necrotizing pancreatitis and
pancreatic
carcinoma can be difficult even with sophisticated protocols.
MDCT is an ideal tool for the detection of neuroendocrine tumors, metastases and for the differentiation of cystic
pancreatic
lesions such as pseudocysts, microcystic adenomas or intraductal papillary mucinous neoplasms (IPMN).
Particularly, the differentiation of the latter into benign, borderline or malignant transformation is not always possible, but indirect signs, such as small nodules adjacent to the ductal wall, the diameter of the
pancreatic
duct, or a direct communication between cystic lesions and duct can be detected because of the high spatial resolution and is comparable to the findings in MRI.
[MeSH-major]
Image Processing, Computer-Assisted. Imaging, Three-Dimensional.
Pancreatic
Neoplasms / diagnostic imaging. Tomography, Spiral Computed
[MeSH-minor]
Adenocarcinoma
/ diagnostic imaging.
Adenocarcinoma
/ mortality.
Adenocarcinoma
/ pathology.
Adenocarcinoma
/ surgery.
Adenocarcinoma
, Mucinous / diagnostic imaging.
Adenocarcinoma
, Mucinous / mortality.
Adenocarcinoma
, Mucinous / pathology.
Adenocarcinoma
, Mucinous / surgery. Carcinoma,
Pancreatic
Ductal / diagnostic imaging. Carcinoma,
Pancreatic
Ductal / mortality. Carcinoma,
Pancreatic
Ductal / pathology. Carcinoma,
Pancreatic
Ductal / surgery. Carcinoma, Papillary / diagnostic imaging. Carcinoma, Papillary / mortality. Carcinoma, Papillary / pathology. Carcinoma, Papillary / surgery.
Diagnosis
, Differential. Disease-Free Survival. Humans. Neuroendocrine Tumors / diagnostic imaging. Neuroendocrine Tumors / mortality. Neuroendocrine Tumors / pathology. Neuroendocrine Tumors / surgery.
Pancreas
/ diagnostic imaging.
Pancreas
/ pathology. Pancreatectomy.
Pancreatic
Pseudocyst / diagnostic imaging. Prognosis. Sensitivity and Specificity
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Br J Radiol. 2006 Nov;79(947):880-7
[
16822803.001
]
[Cites]
AJR Am J Roentgenol. 2002 Sep;179(3):717-24
[
12185052.001
]
[Cites]
Radiology. 2008 Sep;248(3):876-86
[
18632526.001
]
[Cites]
Ann Surg. 2005 Sep;242(3):413-9; discussion 419-21
[
16135927.001
]
[Cites]
Ann Surg. 1997 Oct;226(4):393-405; discussion 405-7
[
9351708.001
]
[Cites]
J Gastrointest Surg. 2007 Mar;11(3):338-44
[
17458608.001
]
[Cites]
Pancreatology. 2008;8(3):236-51
[
18497542.001
]
[Cites]
Radiologe. 2003 Apr;43(4):293-300
[
12721645.001
]
[Cites]
J Comput Assist Tomogr. 2005 Jul-Aug;29(4):438-45
[
16012297.001
]
[Cites]
Pancreas. 2005 Apr;30(3):218-22
[
15782097.001
]
[Cites]
Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9
[
15166958.001
]
[Cites]
N Engl J Med. 1992 Feb 13;326(7):455-65
[
1732772.001
]
[Cites]
Am Surg. 2000 Apr;66(4):378-85; discussion 386
[
10776876.001
]
[Cites]
Radiologe. 1998 Apr;38(4):279-86
[
9622822.001
]
[Cites]
Radiographics. 2005 Nov-Dec;25(6):1471-84
[
16284129.001
]
[Cites]
Eur Radiol. 2004 Jul;14 (7):1188-95
[
15083335.001
]
[Cites]
Abdom Imaging. 2006 Sep-Oct;31(5):568-74
[
16465578.001
]
[Cites]
J Clin Gastroenterol. 2008 Mar;42(3):284-94
[
18223495.001
]
[Cites]
Eur Radiol. 2006 Aug;16(8):1709-18
[
16550353.001
]
[Cites]
Pancreatology. 2006;6(1-2):17-32
[
16327281.001
]
[Cites]
Digestion. 2003;68(1):24-33
[
12949436.001
]
[Cites]
J Comput Assist Tomogr. 2005 Mar-Apr;29(2):170-5
[
15772532.001
]
[Cites]
Radiology. 2000 Jul;216(1):163-71
[
10887243.001
]
[Cites]
Eur Radiol. 2003 Jan;13(1):149-56
[
12541123.001
]
[Cites]
Radiologe. 2008 Aug;48(8):752-63
[
18633589.001
]
[Cites]
Eur J Surg Oncol. 2007 Aug;33(6):678-84
[
17207960.001
]
[Cites]
AJR Am J Roentgenol. 1997 Aug;169(2):459-64
[
9242754.001
]
[Cites]
Eur J Radiol. 2007 Jun;62(3):371-7
[
17433598.001
]
[Cites]
Chirurg. 2003 Mar;74(3):202-7
[
12647076.001
]
[Cites]
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30
[
16514137.001
]
[Cites]
Cancer. 2006 Jun 25;108(3):163-73
[
16550572.001
]
[Cites]
Histopathology. 2008 Apr;52(5):539-51
[
17903202.001
]
[Cites]
N Engl J Med. 2004 Sep 16;351(12):1218-26
[
15371579.001
]
[Cites]
Radiologe. 1996 May;36(5):397-405
[
8778924.001
]
[Cites]
J Magn Reson Imaging. 2007 Jul;26(1):86-93
[
17659551.001
]
[Cites]
Dtsch Med Wochenschr. 2007 Apr 13;132(15):813-7
[
17427092.001
]
[Cites]
Arch Surg. 1998 Jan;133(1):61-5
[
9438761.001
]
[Cites]
Ann Surg Oncol. 2006 Jan;13(1):75-85
[
16372157.001
]
[Cites]
Pancreatology. 2008;8(2):199-203
[
18434757.001
]
[Cites]
Radiology. 2006 Mar;238(3):912-9
[
16439566.001
]
[Cites]
World J Surg. 2006 Aug;30(8):1553-9
[
16773248.001
]
[Cites]
AJR Am J Roentgenol. 2003 Feb;180(2):475-80
[
12540455.001
]
[Cites]
Pancreas. 2006 Aug;33(2):111-8
[
16868475.001
]
[Cites]
JOP. 2007 Mar 10;8(2):214-22
[
17356246.001
]
[Cites]
Pancreatology. 2008;8(2):135-41
[
18382099.001
]
[Cites]
AJR Am J Roentgenol. 2003 May;180(5):1311-23
[
12704043.001
]
[Cites]
Pancreatology. 2008;8(2):204-10
[
18434758.001
]
[Cites]
Radiologe. 2006 May;46(5):421-37; quiz 438
[
16715226.001
]
[Cites]
Rofo. 1998 Mar;168(3):211-6
[
9551105.001
]
[Cites]
Ann Surg. 2004 May;239(5):678-85; discussion 685-7
[
15082972.001
]
[Cites]
AJR Am J Roentgenol. 1990 Nov;155(5):995-6
[
2120971.001
]
[Cites]
Surg Clin North Am. 1995 Oct;75(5):1001-16
[
7660245.001
]
[Cites]
Ann Surg. 2004 Mar;239(3):400-8
[
15075659.001
]
[Cites]
J Gastrointest Surg. 1999 May-Jun;3(3):233-43
[
10481116.001
]
[Cites]
Eur Radiol. 2007 Mar;17(3):638-49
[
17021700.001
]
[Cites]
N Engl J Med. 2004 Mar 18;350(12):1200-10
[
15028824.001
]
[Cites]
AJR Am J Roentgenol. 2006 Dec;187(6):1513-20
[
17114545.001
]
[Cites]
Pancreatology. 2009;9(5):621-30
[
19657217.001
]
[Cites]
Ann Surg. 2007 Oct;246(4):644-51; discussion 651-4
[
17893501.001
]
[Cites]
Radiology. 1993 Mar;186(3):799-802
[
8381551.001
]
[Cites]
Pancreatology. 2001;1(6):648-55
[
12120249.001
]
[Cites]
J Gastrointest Surg. 1998 Sep-Oct;2(5):472-82
[
9843608.001
]
[Cites]
J Gastrointest Surg. 2008 Jan;12(1):101-9
[
17917784.001
]
(PMID = 19137277.001).
[ISSN]
1432-2102
[Journal-full-title]
Der Radiologe
[ISO-abbreviation]
Radiologe
[Language]
ger
[Publication-type]
Journal Article; Review
[Publication-country]
Germany
[Number-of-references]
71
34.
Minchom A, Chan S, Melia W, Shah R:
An unusual case of pancreatic cancer with leptomeningeal infiltration.
J Gastrointest Cancer
; 2010 Jun;41(2):107-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
An unusual case of
pancreatic cancer
with leptomeningeal infiltration.
INTRODUCTION:
Pancreatic cancer
is a common malignancy and often presents at an advanced stage.
We aim to describe an unusual case of leptomeningeal involvement from
pancreatic cancer
.
CT scan of the abdomen showed subtle narrowing of the common bile duct and
pancreatic
ducts.
Endoscopic ultrasound showed a 5-cm lesion in the
head of
the
pancreas
with
adenocarcinoma
cells on fine needle aspiration.
DISCUSSION: This case represents the unusual presentation of advanced leptomeningeal carcinomatosis in a locally early stage
pancreatic
adenocarcinoma
.
[MeSH-major]
Adenocarcinoma
/ secondary. Meningeal Carcinomatosis / secondary.
Pancreatic
Neoplasms /
diagnosis
.
Pancreatic
Neoplasms / pathology
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
Hazardous Substances Data Bank.
CYTARABINE
.
Hazardous Substances Data Bank.
HYDROCORTISONE
.
Hazardous Substances Data Bank.
METHOTREXATE
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Neurology. 2006 Mar 14;66(5):783; author reply 783
[
16534138.001
]
[Cites]
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
[
15761078.001
]
[Cites]
Ann Oncol. 2004;15 Suppl 4:iv285-91
[
15477323.001
]
[Cites]
Neurochirurgia (Stuttg). 1980 Jan;23(1):13-7
[
7352044.001
]
[Cites]
Cancer Treat Rev. 1999 Apr;25(2):103-19
[
10395835.001
]
[Cites]
Gan To Kagaku Ryoho. 2008 Dec;35(13):2413-6
[
19098414.001
]
[Cites]
Acta Neurol (Napoli). 1975 Jul-Aug;30(4):359-67
[
1229842.001
]
[Cites]
Neurosurgery. 2000 Jul;47(1):49-54; discussion 54-5
[
10917346.001
]
[Cites]
Cancer Treat Res. 2005;125:147-58
[
16211888.001
]
[Cites]
Ann Oncol. 2008 Jul;19(7):1224-30
[
18381371.001
]
[Cites]
Ann Oncol. 1996 Oct;7(8):773-86
[
8922190.001
]
(PMID = 20069465.001).
[ISSN]
1941-6636
[Journal-full-title]
Journal of gastrointestinal cancer
[ISO-abbreviation]
J Gastrointest Cancer
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Anti-Inflammatory Agents; 0 / Antimetabolites, Antineoplastic; 04079A1RDZ / Cytarabine; WI4X0X7BPJ / Hydrocortisone; YL5FZ2Y5U1 / Methotrexate
35.
Schima W, Ba-Ssalamah A, Kölblinger C, Kulinna-Cosentini C, Puespoek A, Götzinger P:
Pancreatic adenocarcinoma.
Eur Radiol
; 2007 Mar;17(3):638-49
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Pancreatic
adenocarcinoma
.
Adenocarcinoma
is the most common malignant
pancreatic
tumor, affecting the
head of
the
pancreas
in 60-70% of cases.
By the time
of diagnosis
, at least 80% of tumors are unresectable.
Helical computed tomography (CT) is very effective in detecting and staging
adenocarcinoma
, with a sensitivity of up to 90% for detection and an accuracy of 80-90% for staging, but it has limitations in detecting small cancers.
MDCT has been found to be at least equivalent to contrast-enhanced magnetic resonance imaging (MRI) for detecting
adenocarcinoma
.
Mangafodipir-enhanced MRI reveals a very high tumor-
pancreas
contrast, which helps in diagnosing small cancers.
It is the technique of choice for image-guided biopsy if a histologic
diagnosis
is required for further therapy.
[MeSH-major]
Adenocarcinoma
/
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
. Tomography, X-Ray Computed
MedlinePlus Health Information.
consumer health - CT Scans
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Radiology. 2000 Mar;214(3):849-55
[
10715057.001
]
[Cites]
Radiology. 2003 Oct;229(1):81-90
[
14519871.001
]
[Cites]
Eur Radiol. 2004 Jan;14(1):14-20
[
14730384.001
]
[Cites]
AJR Am J Roentgenol. 2002 Sep;179(3):717-24
[
12185052.001
]
[Cites]
Gastrointest Endosc. 2002 Aug;56(2):218-24
[
12145600.001
]
[Cites]
Abdom Imaging. 1997 Jul-Aug;22(4):429-33
[
9157866.001
]
[Cites]
Ann Intern Med. 2004 Nov 16;141(10 ):753-63
[
15545675.001
]
[Cites]
Ann Surg. 1997 Oct;226(4):393-405; discussion 405-7
[
9351708.001
]
[Cites]
J Comput Assist Tomogr. 2005 Jul-Aug;29(4):438-45
[
16012297.001
]
[Cites]
Abdom Imaging. 1997 Mar-Apr;22(2):204-7
[
9013536.001
]
[Cites]
AJR Am J Roentgenol. 2005 Sep;185(3):700-3
[
16120921.001
]
[Cites]
Am J Surg. 1991 Jan;161(1):120-4; discussion 124-5
[
1987845.001
]
[Cites]
N Engl J Med. 1992 Feb 13;326(7):455-65
[
1732772.001
]
[Cites]
Pancreatology. 2001;1(6):610-24
[
12120244.001
]
[Cites]
AJR Am J Roentgenol. 1998 Mar;170(3):649-52
[
9490946.001
]
[Cites]
Eur Radiol. 2005 Nov;15 Suppl 4:D96-9
[
16479656.001
]
[Cites]
J Clin Gastroenterol. 2001 Mar;32(3):231-4
[
11246351.001
]
[Cites]
Radiologe. 1998 Apr;38(4):279-86
[
9622822.001
]
[Cites]
Radiology. 1997 Nov;205(2):513-8
[
9356637.001
]
[Cites]
Eur Radiol. 2006 Aug;16(8):1709-18
[
16550353.001
]
[Cites]
J Comput Assist Tomogr. 2005 Mar-Apr;29(2):170-5
[
15772532.001
]
[Cites]
Br J Surg. 2004 Nov;91(11):1410-27
[
15499648.001
]
[Cites]
J Gastrointest Surg. 2003 Jan;7(1):118-26; discussion 127-8
[
12559193.001
]
[Cites]
Radiology. 1991 Aug;180(2):337-9
[
1906189.001
]
[Cites]
N Engl J Med. 1993 May 20;328(20):1433-7
[
8479461.001
]
[Cites]
AJR Am J Roentgenol. 2004 Mar;182(3):619-23
[
14975959.001
]
[Cites]
Br J Radiol. 2000 Nov;73(875):1165-9
[
11144793.001
]
[Cites]
Ann Surg. 1990 Apr;211(4):447-58
[
2322039.001
]
[Cites]
Radiology. 1993 Mar;186(3):795-8
[
8430190.001
]
[Cites]
Radiographics. 2005 Jul-Aug;25(4):949-65
[
16009817.001
]
[Cites]
Radiology. 2001 Oct;221(1):107-16
[
11568327.001
]
[Cites]
AJR Am J Roentgenol. 1999 Dec;173(6):1513-8
[
10584794.001
]
[Cites]
AJR Am J Roentgenol. 1998 May;170(5):1315-22
[
9574609.001
]
[Cites]
Eur Radiol. 2005 Jun;15(6):1256-62
[
15627187.001
]
[Cites]
Radiology. 2002 Sep;224(3):764-8
[
12202711.001
]
[Cites]
Radiology. 1996 Jun;199(3):697-701
[
8637990.001
]
[Cites]
Invest Radiol. 1999 Sep;34(9):589-95
[
10485075.001
]
[Cites]
Int J Cancer. 1994 Nov 15;59(4):494-504
[
7960219.001
]
[Cites]
Br J Radiol. 1998 May;71(845):492-6
[
9691893.001
]
[Cites]
Eur Radiol. 2003 Dec;13 Suppl 5:M42-9
[
14989611.001
]
[Cites]
Radiology. 2002 Dec;225(3):759-65
[
12461258.001
]
[Cites]
Radiology. 1998 Feb;206(2):373-8
[
9457188.001
]
[Cites]
AJR Am J Roentgenol. 1997 Jul;169(1):119-23
[
9207510.001
]
[Cites]
Radiology. 1991 Jan;178(1):95-9
[
1984331.001
]
[Cites]
Eur Radiol. 1996;6(1):14-8
[
8797944.001
]
[Cites]
AJR Am J Roentgenol. 2000 Mar;174(3):677-84
[
10701608.001
]
[Cites]
Am J Gastroenterol. 2005 Dec;100(12 ):2658-61
[
16393216.001
]
[Cites]
Eur Radiol. 2002 Dec;12(12):2998-3008
[
12439582.001
]
[Cites]
Radiology. 2006 Nov;241(2):441-8
[
16982815.001
]
[Cites]
AJR Am J Roentgenol. 2004 Feb;182(2):419-25
[
14736675.001
]
[Cites]
Arch Surg. 1990 Feb;125(2):230-3
[
2154172.001
]
[Cites]
Radiologe. 2006 May;46(5):421-37; quiz 438
[
16715226.001
]
[Cites]
Radiology. 1997 Mar;202(3):655-62
[
9051012.001
]
[Cites]
J Magn Reson Imaging. 2000 Aug;12 (2):261-8
[
10931589.001
]
[Cites]
Radiology. 1995 May;195(2):327-32
[
7724748.001
]
[Cites]
AJR Am J Roentgenol. 1997 Jun;168(6):1439-43
[
9168704.001
]
[Cites]
Ann Surg. 2005 Aug;242(2):235-43
[
16041214.001
]
[Cites]
Ann Surg. 2004 Nov;240(5):738-45
[
15492552.001
]
[Cites]
J Natl Cancer Inst. 1997 Mar 19;89(6):442-6
[
9091646.001
]
[Cites]
World J Surg. 1999 Sep;23(9):913-9
[
10449820.001
]
[Cites]
Rofo. 2004 Nov;176(11):1624-33
[
15497081.001
]
[Cites]
J Comput Assist Tomogr. 2002 Sep-Oct;26(5):743-9
[
12439309.001
]
[Cites]
Radiology. 1995 Nov;197(2):381-5
[
7480681.001
]
[Cites]
Radiology. 2001 Jul;220(1):97-102
[
11425979.001
]
[Cites]
Cancer. 2003 Oct 25;99(5):285-92
[
14579295.001
]
(PMID = 17021700.001).
[ISSN]
0938-7994
[Journal-full-title]
European radiology
[ISO-abbreviation]
Eur Radiol
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
Germany
[Chemical-registry-number]
0 / Contrast Media
[Number-of-references]
65
36.
Liszka Ł, Pajak J, Zielińska-Pajak E, Gołka D, Mrowiec S, Lampe P:
Different approaches to assessment of lymph nodes and surgical margin status in patients with ductal adenocarcinoma of the pancreas treated with pancreaticoduodenectomy.
Pathology
; 2010 Feb;42(2):138-46
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Different approaches to assessment of lymph nodes and surgical margin status in patients with ductal
adenocarcinoma of
the
pancreas
treated with pancreaticoduodenectomy.
AIM: To develop a method of gross examination of pancreaticoduodenectomy specimens with
pancreatic
ductal
adenocarcinoma
, allowing adequate assessment of the entire
pancreatic
surface as a surgical margin, which would not affect the lymph node yield.
(1) period 2006-2007, when the
pancreatic
surface (except for the transection margin and superior mesenteric artery margin) was not examined;.
(2) period January-September 2008, when the posterior
pancreatic
surface (posterior circumferential radial margin) was examined using an improved method based on sampling of 2.0-2.5 mm thick consecutive slices perpendicular to the duodenal axis; and (3) period October 2008 - June 2009, when the whole surface of the
pancreatic
head
was sampled using the approach mentioned above.
CONCLUSIONS: The newly proposed approach allowed adequate assessment of the entire
pancreatic
head
surface as a surgical margin and reduced the risk of under-detection of R1 status.
[MeSH-major]
Carcinoma,
Pancreatic
Ductal / secondary. Lymph Nodes / pathology.
Pancreatic
Neoplasms / pathology. Pancreaticoduodenectomy
[MeSH-minor]
Aged. Female. Humans. Lymphatic Metastasis /
diagnosis
. Male. Middle Aged. Neoplasm, Residual. Retrospective Studies
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20085515.001).
[ISSN]
1465-3931
[Journal-full-title]
Pathology
[ISO-abbreviation]
Pathology
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
England
37.
Rana SS, Bhasin DK, Jain K, Nada R, Sinha SK, Singh K:
Endoscopic diagnosis of squamous cell carcinoma of the pancreas invading the stomach.
JOP
; 2009;10(2):181-3
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Endoscopic
diagnosis of
squamous cell carcinoma of the
pancreas
invading the stomach.
CONTEXT: Squamous cell carcinoma of the
pancreas
is an unusual tumor due to the absence of squamous cells in the normal
pancreas
.
Its clinical presentation is similar to that
of adenocarcinoma
of the
pancreas
and is usually diagnosed intraoperatively or at autopsy.
Contrast-enhanced computerized tomography revealed a heterogeneous enhancing mass in the
head of pancreas
and upper gastrointestinal endoscopy revealed an ulcerated polypoidal lesion in the stomach; the endoscopic biopsies taken from this region revealed infiltration of the lamina propria with malignant squamous cells.
CONCLUSION: A rare case of squamous cell carcinoma of the
head of
the
pancreas
presenting with obstructive jaundice and gastric outlet obstruction and in which
diagnosis
was established by endoscopic biopsies of the stomach has been described.
[MeSH-major]
Carcinoma, Squamous Cell /
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
. Stomach / pathology
[MeSH-minor]
Diagnosis
, Differential. Endoscopy, Gastrointestinal. Humans. Male. Middle Aged
Genetic Alliance.
consumer health - Carcinoma, Squamous Cell
.
Genetic Alliance.
consumer health - Stomach carcinoma
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19287113.001).
[ISSN]
1590-8577
[Journal-full-title]
JOP : Journal of the pancreas
[ISO-abbreviation]
JOP
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Italy
38.
Arcari A, Anselmi E, Bernuzzi P, Bertè R, Lazzaro A, Moroni CF, Trabacchi E, Vallisa D, Vercelli A, Cavanna L:
Primary pancreatic lymphoma. Report of five cases.
Haematologica
; 2005 Feb;90(2):ECR09
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Primary
pancreatic
lymphoma. Report of five cases.
Primary
pancreatic
lymphoma (PPL) is a very rare disease.
None of these patients had evidence of extrapancreatic disease and they were categorized as PPL involving
pancreas
only (stage IE, 3 patients) or
pancreas
and peripancreatic lymph nodes (stage IIE, 2 patients).
Imaging techniques showed a mass of the
pancreatic
head
in all cases.
The histological
diagnosis
(3 diffuse-large cell non-Hodgkin's lymphoma and 2 lymphoplasmacytic lymphoma/immunocytoma) was made by ultrasound-guided fine needle aspiration biopsy and tissue core fine-needle biopsy in three patients and by surgery in the remaining two patients.
1) imaging techniques can suggest the suspicion of PPL but are unable to distinguish PPL from
pancreatic
adenocarcinoma
;.
2) histological
diagnosis
can be easily obtained by percutaneous US-guided tissue core biopsy;.
3) surgery can be avoided both for
diagnosis
and therapy but the treatment of choice of PPL may only be evaluated on a larger series of patients.
[MeSH-major]
Lymphoma, Non-Hodgkin /
diagnosis
. Lymphoma, Non-Hodgkin / therapy.
Pancreatic
Neoplasms /
diagnosis
.
Pancreatic
Neoplasms / therapy
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15713583.001).
[ISSN]
1592-8721
[Journal-full-title]
Haematologica
[ISO-abbreviation]
Haematologica
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Italy
39.
Yang YM, Wan YL, Tian XD, Zhuang Y, Huang YT:
Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.
Chin Med J (Engl)
; 2005 Nov 20;118(22):1863-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for
adenocarcinoma of
the
head of
the
pancreas
.
BACKGROUND: Nowadays, there is a remarkable rise in resectability rate of periampullary
adenocarcinoma
and the mortality and morbidity of the pancreaticoduodenectomy procedure have been reduced remarkably, while the 5 year survival rates of patients with carcinoma of the
head of
the
pancreas
are still below 25%.
We conducted this retrospective study to evaluate the clinical outcome of radical pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy as a surgical therapy for
adenocarcinoma of
the
head of
the
pancreas
.
METHODS: Twenty cases with
adenocarcinoma of
the
head of
the
pancreas
were treated by standard pancreaticoduodenectomy (removing only the peripancreatic lymph nodes en bloc with the tumour) from 1994 to 1997, and 46 cases with the same disease underwent extended retroperitoneal lymphadenectomy associated with standard pancreaticoduodenectomy from 1998 to 2002.
Of the 46 cases in the radical group, 26% (12/46) had metastatic
adenocarcinoma
in the resected retroperitoneal lymph nodes.
[MeSH-major]
Adenocarcinoma
/ surgery. Lymph Node Excision.
Pancreatic
Neoplasms / surgery. Pancreaticoduodenectomy
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16313840.001).
[ISSN]
0366-6999
[Journal-full-title]
Chinese medical journal
[ISO-abbreviation]
Chin. Med. J.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
China
40.
Fabregat J, Busquets J, Peláez N, Jorba R, García-Borobia F, Masuet C, Valls C, Ruiz-Osuna S, Serrano T, Galán M, Cambray M, Laquente B, Ramos E, Rafecas A:
[Surgical treatment of pancreatic adenocarcinoma using cephalic duodenopancreatectomy (Part 2). Long term follow up after 204 cases].
Cir Esp
; 2010 Dec;88(6):374-82
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Surgical treatment of
pancreatic
adenocarcinoma
using cephalic duodenopancreatectomy (Part 2). Long term follow up after 204 cases].
[Transliterated title]
Tratamiento quirúrgico del
adenocarcinoma
pancreático mediante duodenopancreatectomía cefálica (parte 2). Seguimiento a largo plazo tras 204 casos.
INTRODUCTION: Surgery is the accepted treatment in
adenocarcinoma of
the
head of
the
pancreas
; however, the long-term survival continues to be low.
The aim of this study is to define prognostic factors of long-term survival after cephalic duodenopancreatectomy due to
pancreatic
adenocarcinoma
.
MATERIAL AND METHODS: We have collected data on the treatment
of adenocarcinoma
of the
head of
the
pancreas
(ADHP) by means of a cephalic duodenopancreatectomy (CDP) performed n the Bellvitge University Hospital (Barcelona) from 1991 to 2007.
CONCLUSIONS: Surgery
of head
of the
pancreas adenocarcinoma
must include an adequate lymphadectomy, and must be performed with a low morbidity and without the need of a peri-operative transfusion.
[MeSH-major]
Adenocarcinoma
/ surgery.
Pancreatic
Neoplasms / surgery. Pancreaticoduodenectomy
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright © 2010 AEC. Published by Elsevier Espana. All rights reserved.
[CommentIn]
Cir Esp. 2011 Jun-Jul;89(6):411; author reply 412
[
21550599.001
]
(PMID = 21030012.001).
[ISSN]
1578-147X
[Journal-full-title]
Cirugía española
[ISO-abbreviation]
Cir Esp
[Language]
spa
[Publication-type]
English Abstract; Journal Article
[Publication-country]
Spain
41.
Ellsmere J, Mortele K, Sahani D, Maher M, Cantisani V, Wells W, Brooks D, Rattner D:
Does multidetector-row CT eliminate the role of diagnostic laparoscopy in assessing the resectability of pancreatic head adenocarcinoma?
Surg Endosc
; 2005 Mar;19(3):369-73
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Does multidetector-row CT eliminate the role of diagnostic laparoscopy in assessing the resectability of
pancreatic
head adenocarcinoma
?
BACKGROUND: We hypothesized that the high-quality images from multidetector-row computed tomography (MDCT) would lead to improved sensitivity and specificity for predicting resectable
pancreatic
head adenocarcinoma
, thus diminishing the value of staging laparoscopy.
CONCLUSIONS: Despite the improvements in image quality obtained with multidetector-row technology, CT imaging remains a relatively nonspecific test for predicting resectability in patients with
adenocarcinoma of
the
head of
the
pancreas
.
Minimally invasive modalities with higher specificity, particularly laparoscopy, continue to have an important role in staging
pancreatic
head adenocarcinoma
.
[MeSH-major]
Adenocarcinoma
/
diagnosis
.
Adenocarcinoma
/ surgery. Laparoscopy.
Pancreatic
Neoplasms /
diagnosis
.
Pancreatic
Neoplasms / surgery. Tomography, X-Ray Computed
MedlinePlus Health Information.
consumer health - CT Scans
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Br J Surg. 2001 Mar;88(3):325-37
[
11260096.001
]
[Cites]
Ann Surg. 1995 Jun;221(6):721-31; discussion 731-3
[
7794076.001
]
[Cites]
Am J Surg. 1999 May;177(5):428-32
[
10365885.001
]
[Cites]
J Gastrointest Surg. 2000 May-Jun;4(3):233-7; discussion 238-9
[
10769085.001
]
[Cites]
Radiology. 2001 Oct;221(1):93-106
[
11568326.001
]
[Cites]
Ann Surg. 1993 Feb;217(2):144-8
[
8094952.001
]
[Cites]
AJR Am J Roentgenol. 1999 Dec;173(6):1513-8
[
10584794.001
]
[Cites]
Am J Surg. 1994 Jan;167(1):104-11; discussion 111-3
[
7906097.001
]
[Cites]
J Am Coll Surg. 1998 Jun;186(6):675-82
[
9632157.001
]
[Cites]
Radiology. 2002 Dec;225(3):759-65
[
12461258.001
]
[Cites]
Radiology. 1998 Feb;206(2):373-8
[
9457188.001
]
[Cites]
J Clin Oncol. 1997 Mar;15(3):928-37
[
9060530.001
]
[Cites]
Ann Surg. 2002 Jan;235(1):1-7
[
11753036.001
]
[Cites]
AJR Am J Roentgenol. 1997 Jun;168(6):1439-43
[
9168704.001
]
[Cites]
J Gastrointest Surg. 2001 Nov-Dec;5(6):626-33
[
12086901.001
]
(PMID = 15624058.001).
[ISSN]
1432-2218
[Journal-full-title]
Surgical endoscopy
[ISO-abbreviation]
Surg Endosc
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Germany
42.
Ohmura T, Umekita N, Ohkubo T, Tanaka S, Maeshiro T, Matsuo S, Miyamoto S, Inoue S, Kitamura M:
[Local recurrence of pancreatic cancer successfully treated with gemcitabine].
Gan To Kagaku Ryoho
; 2005 Feb;32(2):239-41
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Local recurrence of
pancreatic cancer
successfully treated with gemcitabine].
We report a patient for whom systemic chemotherapy using gemcitabine was effective against local recurrence of
pancreatic cancer
.
A 58-year-old man underwent pancreatoduodenectomy for a
pancreatic
head
cancer
.
The
diagnosis
was Stage IVb poorly-differentiated tubular
adenocarcinoma
, scirrhous type, pT4, PL (+), P0, H0, pN2.
Gastroscopy and CT examination revealed a mass at the cut-end of the
pancreas
invading the stomach.
The recurrent tumor in the stomach disappeared, and the mass at the cut-end of the
pancreas
became small.
Two years after the
diagnosis of
recurrence, he returned to work, and his chemotherapy is being continued as an outpatient.
[MeSH-major]
Adenocarcinoma
/ drug therapy. Antimetabolites, Antineoplastic / therapeutic use. Deoxycytidine / analogs & derivatives. Deoxycytidine / therapeutic use. Neoplasm Recurrence, Local / drug therapy.
Pancreatic
Neoplasms / drug therapy. Stomach Neoplasms / drug therapy
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
MedlinePlus Health Information.
consumer health - Stomach Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15751641.001).
[ISSN]
0385-0684
[Journal-full-title]
Gan to kagaku ryoho. Cancer & chemotherapy
[ISO-abbreviation]
Gan To Kagaku Ryoho
[Language]
jpn
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Japan
[Chemical-registry-number]
0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine
43.
Lin HL, Kuo LC, Chen CW, Lin YK, Lee WC:
Pancreatic tail cancer with sole manifestation of left flank pain: a very rare presentation.
Kaohsiung J Med Sci
; 2008 Jun;24(6):324-7
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Pancreatic
tail
cancer
with sole manifestation of left flank pain: a very rare presentation.
Pancreatic cancer
is sometimes called a "silent disease" because it often causes no symptoms in the early stage.
The symptoms can be quite vague and various depending on the location of
cancer
in the
pancreas
.
The anatomic site distribution is 78% in the
head of
the
pancreas
, 11% in the body, and 11% in the tail.
Pancreatic cancer
is rarely detected in the early stage, and it is very uncommon to diagnose
pancreatic
tail
cancer
during an emergency department visit.
The manifestation of
pancreatic
tail
cancer
as left flank pain is very rare and has seldom been identified in the literature.
We present a case of
pancreatic
tail
cancer
with the sole manifestation of dull left flank pain.
Radiographic evaluation with computed tomography was performed, and
pancreatic
tail tumor with multiple metastases was found unexpectedly.
We review the literature and discuss this rare presentation of
pancreatic
tail
cancer
.
[MeSH-major]
Flank Pain /
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
[MeSH-minor]
Adenocarcinoma
/
diagnosis
.
Adenocarcinoma
/ pathology. Fatal Outcome. Female. Humans. Liver Neoplasms / pathology. Liver Neoplasms / secondary. Medical Oncology / methods. Middle Aged. Neoplasm Metastasis. Prognosis. Tomography, X-Ray Computed
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18635419.001).
[ISSN]
1607-551X
[Journal-full-title]
The Kaohsiung journal of medical sciences
[ISO-abbreviation]
Kaohsiung J. Med. Sci.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
China (Republic : 1949- )
44.
Saif MW:
Primary pancreatic lymphomas.
JOP
; 2006;7(3):262-73
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Primary
pancreatic
lymphomas.
Primary
pancreatic
lymphomas are extremely rare.
Clinically, primary
pancreatic
lymphomas usually present with symptoms of carcinoma of the
pancreatic
head
.
Patients with primary
pancreatic
lymphomas are between 35 and 75 years of age and with a strong male predominance.
An accurate cytopathologic
diagnosis
by fine-needle aspiration (FNA) is imperative because the primary treatment is non-surgical.
FNA coupled with flow cytometry analysis appears to be highly accurate in the
diagnosis of
primary
pancreatic
lymphomas.
Fluorescence in-situ hybridisation technique has been established its role in the
diagnosis of
lymphoid malignancies, including primary
pancreatic
lymphomas.
The differential diagnoses of primary
pancreatic
lymphomas include secondary lymphoma,
pancreatic
endocrine neoplasm, and florid chronic pancreatitis.
Primary
pancreatic
lymphomas has a much better prognosis than
adenocarcinoma of
the
pancreas
.
[MeSH-major]
Lymphoma /
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
MedlinePlus Health Information.
consumer health - Lymphoma
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16685107.001).
[ISSN]
1590-8577
[Journal-full-title]
JOP : Journal of the pancreas
[ISO-abbreviation]
JOP
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
Italy
[Number-of-references]
40
45.
Wang H, Wieczorek RL, Zenilman ME, Desoto-Lapaix F, Ghosh BC, Bowne WB:
Castleman's disease in the head of the pancreas: report of a rare clinical entity and current perspective on diagnosis, treatment, and outcome.
World J Surg Oncol
; 2007;5:133
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Castleman's disease in the
head of
the
pancreas
: report of a rare clinical entity and current perspective on
diagnosis
, treatment, and outcome.
BACKGROUND: Castleman's disease of the
pancreas
is a very rare condition that may resemble more common disease entities as well as
pancreatic cancer
.
CASE PRESENTATION: Here we report the case of a 58-year-old African American male with an incidentally discovered lesion in the
head of
the
pancreas
.
CONCLUSION: To date, eight cases of Castleman's disease associated with the
pancreas
have been described in the world literature.
We report the first case of unicentric disease situated within the
head of
the
pancreas
.
In addition, we discuss the diagnostic dilemma Castleman's disease may present to the
pancreatic
surgeon and review current data on pathogenesis, treatment, and outcome.
[MeSH-major]
Giant Lymph Node Hyperplasia / pathology.
Pancreatic
Diseases / pathology
[MeSH-minor]
Adenocarcinoma
/ pathology.
Diagnosis
, Differential. Humans. Male. Middle Aged.
Pancreatic
Neoplasms / pathology. Pancreaticoduodenectomy. Tomography, X-Ray Computed
Genetic Alliance.
consumer health - Castleman's Disease
.
MedlinePlus Health Information.
consumer health - Pancreatic Diseases
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
N Engl J Med. 1994 Mar 3;330(9):602-5
[
8302342.001
]
[Cites]
J Comput Assist Tomogr. 1982 Dec;6(6):1193-5
[
7174940.001
]
[Cites]
Cancer. 1979 Aug;44(2):457-62
[
476562.001
]
[Cites]
Radiology. 1979 Feb;130(2):311-5
[
760140.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1978 Nov-Dec;4(11-12):1045-8
[
102620.001
]
[Cites]
AJR Am J Roentgenol. 1978 Mar;130(3):447-50
[
415545.001
]
[Cites]
Am J Clin Pathol. 1978 Jan;69(1):86-90
[
619617.001
]
[Cites]
Cancer. 1972 Mar;29(3):670-83
[
4551306.001
]
[Cites]
Can Med Assoc J. 1968 Dec 28;99(25):1259-62
[
5700853.001
]
[Cites]
Cancer. 1967 Apr;20(4):525-36
[
6019827.001
]
[Cites]
J Pediatr Hematol Oncol. 2000 Mar-Apr;22(2):180-3
[
10779037.001
]
[Cites]
Aust N Z J Surg. 1994 Mar;64(3):219-21
[
8117206.001
]
[Cites]
World J Gastroenterol. 2005 Nov 14;11(42):6725-7
[
16425374.001
]
[Cites]
Cancer. 1956 Jul-Aug;9(4):822-30
[
13356266.001
]
[Cites]
JOP. 2004 Nov;5(6):491-4
[
15536288.001
]
[Cites]
APMIS. 2005 Apr;113(4):288-95
[
15865611.001
]
[Cites]
Pancreas. 1994 Sep;9(5):668-70
[
7809024.001
]
[Cites]
Cancer Treat Rev. 1995 Jul;21(4):291-310
[
7585657.001
]
[Cites]
AIDS. 1996 Jan;10(1):61-7
[
8924253.001
]
[Cites]
Ann Hematol. 1996 Jul;73(1):47-50
[
8695726.001
]
[Cites]
J Hepatol. 1997 Jan;26(1):209-14
[
9148014.001
]
[Cites]
Cancer. 1999 Feb 1;85(3):706-17
[
10091744.001
]
[Cites]
Gastroenterol Clin Biol. 1999 Apr;23(4):536-8
[
10416122.001
]
[Cites]
Acta Chir Belg. 1993 Sep-Oct;93(5):227-9
[
8266757.001
]
[Cites]
Cancer Invest. 1993;11(6):732-42
[
8221206.001
]
[Cites]
Hum Pathol. 1993 Aug;24(8):833-9
[
8375854.001
]
[Cites]
Comput Med Imaging Graph. 1993 Mar-Apr;17(2):107-17
[
8518992.001
]
[Cites]
Am J Clin Pathol. 1992 Dec;98(6):633-6
[
1462961.001
]
[Cites]
Presse Med. 1992 Jan 18;21(2):86
[
1531532.001
]
[Cites]
Blood. 1991 Dec 1;78(11):2923-30
[
1954381.001
]
[Cites]
Cancer. 1991 Sep 15;68(6):1365-72
[
1873789.001
]
[Cites]
Hum Pathol. 1991 Jul;22(7):724-6
[
2071115.001
]
[Cites]
Br J Radiol. 1990 Aug;63(752):648-50
[
2400884.001
]
[Cites]
J Clin Invest. 1990 Aug;86(2):592-9
[
2384605.001
]
[Cites]
Am J Surg Pathol. 1990 Jul;14(7):603-14
[
2356921.001
]
[Cites]
Semin Diagn Pathol. 1988 Nov;5(4):346-64
[
2464187.001
]
[Cites]
Blood. 1989 Sep;74(4):1360-7
[
2788466.001
]
[Cites]
Surgery. 1989 Nov;106(5):884-7
[
2683174.001
]
[Cites]
Cancer. 1983 Mar 1;51(5):808-10
[
6821846.001
]
[Cites]
Am J Clin Pathol. 1985 Jan;83(1):27-33
[
3871303.001
]
[Cites]
Hum Pathol. 1985 Feb;16(2):162-72
[
2579015.001
]
[Cites]
Hum Pathol. 1985 Mar;16(3):202-5
[
3871724.001
]
[Cites]
J Comput Assist Tomogr. 1985 May-Jun;9(3):570-2
[
3886726.001
]
[Cites]
Cancer. 1985 Aug 15;56(4):876-9
[
4016679.001
]
[Cites]
J Clin Oncol. 1985 Sep;3(9):1202-16
[
4031967.001
]
[Cites]
Cancer. 1987 Nov 15;60(10):2454-8
[
3478119.001
]
(PMID = 18028547.001).
[ISSN]
1477-7819
[Journal-full-title]
World journal of surgical oncology
[ISO-abbreviation]
World J Surg Oncol
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
England
[Number-of-references]
47
[Other-IDs]
NLM/ PMC2206042
46.
Price L, Kozarek R, Agoff N:
Squamous cell carcinoma arising within a choledochal cyst.
Dig Dis Sci
; 2008 Oct;53(10):2822-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Most commonly reported malignancies include cholangiocarcinoma,
adenocarcinoma
, and gallbladder
cancer
.
Endoscopic retrograde cholangiopancreatography and direct cholangioscopy revealed a mass at the biliary bifurcation, a 4-cm choledochal cyst with multiple calculi, absence of anomalous pancreaticobiliary ductal union, and multiple calcifications in the
pancreatic
head
.
We report the associated rare finding of chronic calcific pancreatitis, without anomaly of the
pancreatic
biliary junction.
[MeSH-minor]
Adult. Biopsy. Cholangiopancreatography, Endoscopic Retrograde. Female. Humans. Pancreatitis, Chronic /
diagnosis
. Pancreatitis, Chronic / etiology
Genetic Alliance.
consumer health - Carcinoma, Squamous Cell
.
MedlinePlus Health Information.
consumer health - Bile Duct Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Nihon Geka Gakkai Zasshi. 1989 Jul;90(7):1026-31
[
2796970.001
]
[Cites]
J Hepatobiliary Pancreat Surg. 2001;8(1):92-4
[
11294296.001
]
[Cites]
Am J Surg. 2004 Jun;187(6):790-5
[
15191877.001
]
[Cites]
HPB Surg. 1991 Sep;4(3):245-9; discussion 250
[
1681890.001
]
[Cites]
Ann Surg. 1994 Nov;220(5):644-52
[
7979612.001
]
[Cites]
J Hepatobiliary Pancreat Surg. 2003;10 (5):340-4
[
14598133.001
]
[Cites]
Eur J Pediatr Surg. 2001 Feb;11(1):24-7
[
11370978.001
]
[Cites]
Hepatogastroenterology. 2004 Jul-Aug;51(58):1187-90
[
15239275.001
]
[Cites]
Arch Surg. 2004 Aug;139(8):855-60; discussion 860-2
[
15302695.001
]
[Cites]
Arch Surg. 1988 Aug;123(8):984-6
[
3395242.001
]
[Cites]
Arch Surg. 1983 Aug;118(8):986-8
[
6870530.001
]
[Cites]
Am J Surg. 1977 Aug;134(2):263-9
[
889044.001
]
[Cites]
Intern Med J. 2002 Sep-Oct;32(9-10):491
[
12380705.001
]
[Cites]
Hepatogastroenterology. 2002 Jan-Feb;49(43):100-3
[
11941929.001
]
[Cites]
Hepatogastroenterology. 2004 Sep-Oct;51(59):1504-5
[
15362787.001
]
[Cites]
Eur J Pediatr Surg. 1995 Oct;5(5):265-70
[
8555126.001
]
[Cites]
Pancreas. 1994 Sep;9(5):633-7
[
7809018.001
]
[Cites]
Pediatr Surg Int. 2005 Nov;21(11):936-8
[
16195912.001
]
(PMID = 18274902.001).
[ISSN]
0163-2116
[Journal-full-title]
Digestive diseases and sciences
[ISO-abbreviation]
Dig. Dis. Sci.
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
United States
[Number-of-references]
19
47.
Tanyi M, Olasz J, Lukács G, Tanyi JL, Tóth L, Antal-Szalmás P, Ress Z, Bubán T, András C, Damjanovich L:
A new mutation in Muir-Torre syndrome associated with familiar transmission of different gastrointestinal adenocarcinomas.
Eur J Surg Oncol
; 2009 Oct;35(10):1128-30
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
A 57 years old male patient is presented with a mucinous carcinoma of the caecum and an
adenocarcinoma of
the
pancreas head
.
His family history was significant for two cases of colon carcinoma, two cases of stomach
cancer
and a case of metacron endometrial and skin tumor as well.
[MeSH-minor]
Adenocarcinoma
, Mucinous / genetics.
Adenocarcinoma
, Mucinous / pathology. Cecal Neoplasms / genetics. Cecal Neoplasms / pathology. Family Health. Humans. Male. Middle Aged.
Pancreatic
Neoplasms / genetics.
Pancreatic
Neoplasms / pathology. Pedigree
Genetic Alliance.
consumer health - Keratoacanthoma
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19423266.001).
[ISSN]
1532-2157
[Journal-full-title]
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
[ISO-abbreviation]
Eur J Surg Oncol
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
England
[Chemical-registry-number]
0 / Adaptor Proteins, Signal Transducing; 0 / MLH1 protein, human; 0 / MLH2 protein, human; 0 / Neoplasm Proteins; 0 / Nuclear Proteins
[Number-of-references]
15
48.
Loos M, Bergmann F, Bauer A, Hoheisel JD, Esposito I, Kleeff J, Schirmacher P, Büchler MW, Klöppel G, Friess H:
Solid type clear cell carcinoma of the pancreas: differential diagnosis of an unusual case and review of the literature.
Virchows Arch
; 2007 Jun;450(6):719-26
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Solid type clear cell carcinoma of the
pancreas
: differential
diagnosis of
an unusual case and review of the literature.
Pancreatic
neoplasms have been reliably classified on the basis of their histopathology and immunophenotype.
In this study, we report on a
pancreatic
tumor whose phenotype and genotype could not be assigned to any known tumor entity.
The tumor was observed in the
pancreatic
head of
a 54-year-old woman.
DNA microarray analysis revealed a transcription profile clearly differing from that of normal
pancreatic
tissue and
pancreatic
ductal
adenocarcinoma
.
Despite metastatic behavior, the tumor displayed a more favorable course than conventional
pancreatic
ductal
adenocarcinoma
.
We suggest that this tumor be called solid type clear cell carcinoma of the
pancreas
.
[MeSH-major]
Adenocarcinoma
, Clear Cell /
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
[MeSH-minor]
Diagnosis
, Differential. Female. Gene Expression Profiling. Humans. Immunohistochemistry. Keratins / metabolism. Liver Neoplasms / diagnostic imaging. Liver Neoplasms / secondary. Microarray Analysis. Middle Aged. Mucin-1 / metabolism. Oligonucleotide Array Sequence Analysis. Reverse Transcriptase Polymerase Chain Reaction. S100 Proteins / metabolism. Tomography, Spiral Computed. Vimentin / metabolism
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
COS Scholar Universe.
author profiles
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Am J Gastroenterol. 1996 Nov;91(11):2414-7
[
8931428.001
]
[Cites]
Am J Pathol. 2000 Jan;156(1):37-43
[
10623651.001
]
[Cites]
Arch Surg. 1998 Apr;133(4):413-7; discussion 418-9
[
9565122.001
]
[Cites]
Virchows Arch. 2004 Feb;444(2):190-3
[
15046038.001
]
[Cites]
Bioinformatics. 2000 Nov;16(11):1014-22
[
11159313.001
]
[Cites]
Am J Pathol. 2002 Apr;160(4):1361-9
[
11943721.001
]
[Cites]
Nat Genet. 2001 Dec;29(4):365-71
[
11726920.001
]
[Cites]
Cancer. 2000 Sep 1;89(5):1076-88
[
10964338.001
]
[Cites]
Histopathology. 1998 May;32(5):444-8
[
9639120.001
]
[Cites]
Virchows Arch. 2003 Oct;443(4):508-17
[
12942322.001
]
[Cites]
Am J Pathol. 1993 Sep;143(3):685-98
[
8362971.001
]
[Cites]
Arch Pathol Lab Med. 2004 Jun;128(6):693-6
[
15163226.001
]
[Cites]
Virchows Arch. 1999 Jul;435(1):37-42
[
10431844.001
]
[Cites]
Br J Surg. 2000 Feb;87(2):129-31
[
10671915.001
]
[Cites]
J Clin Oncol. 2002 Dec 15;20(24):4673-8
[
12488412.001
]
[Cites]
Virchows Arch. 2004 May;444(5):447-53
[
15014986.001
]
[Cites]
J Pathol. 1992 Jan;166(1):7-12
[
1538276.001
]
[Cites]
Pathologica. 1992 Jul-Aug;84(1092):531-7
[
1491895.001
]
[Cites]
Ann Surg Oncol. 2002 Aug;9(7):675-9
[
12167582.001
]
[Cites]
Bioinformatics. 2002 Mar;18(3):423-33
[
11934741.001
]
[Cites]
J Hepatobiliary Pancreat Surg. 1998;5(4):383-91
[
9931387.001
]
[Cites]
Pathol Int. 2001 Sep;51(9):686-90
[
11696171.001
]
[Cites]
Am J Surg Pathol. 2000 Sep;24(9):1300-4
[
10976707.001
]
[Cites]
Am J Pathol. 2002 Mar;160(3):953-62
[
11891193.001
]
[Cites]
Am J Pathol. 1993 May;142(5):1534-43
[
8494051.001
]
[Cites]
Am J Surg Pathol. 2005 Apr;29(4):512-9
[
15767807.001
]
[Cites]
Am J Surg Pathol. 2000 Jun;24(6):761-74
[
10843278.001
]
[Cites]
Pancreatology. 2004;4(6):587-97
[
15557762.001
]
[Cites]
Virchows Arch. 2004 Sep;445(3):231-5
[
15517367.001
]
[Cites]
Virchows Arch. 2000 May;436(5):473-80
[
10881741.001
]
[Cites]
Am J Surg Pathol. 2006 Oct;30(10):1237-42
[
17001153.001
]
[Cites]
Virchows Arch. 2006 May;448(5):561-9
[
16523258.001
]
[Cites]
Cell Mol Life Sci. 2003 Jun;60(6):1180-99
[
12861384.001
]
[Cites]
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10781-6
[
11535808.001
]
[Cites]
Hum Pathol. 1984 Jul;15(7):677-83
[
6745910.001
]
[Cites]
Cancer. 1998 Oct 1;83(7):1292-9
[
9762928.001
]
(PMID = 17453235.001).
[ISSN]
0945-6317
[Journal-full-title]
Virchows Archiv : an international journal of pathology
[ISO-abbreviation]
Virchows Arch.
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
Germany
[Chemical-registry-number]
0 / MUC1 protein, human; 0 / Mucin-1; 0 / S100 Proteins; 0 / Vimentin; 68238-35-7 / Keratins
[Number-of-references]
39
49.
Fujimori N, Nakamura T, Oono T, Igarashi H, Takahata S, Nakamura M, Tanaka M, Hayashi A, Aishima S, Ishigami K, Ogoshi K, Ito T, Takayanagi R:
Adenocarcinoma involving the whole pancreas with multiple pancreatic masses.
Intern Med
; 2010;49(15):1527-32
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Adenocarcinoma
involving the whole
pancreas
with multiple
pancreatic
masses.
A 77-year-old man was referred to our hospital for further investigation of
pancreatic
masses.
Imaging studies revealed hypovascular masses in the
pancreatic
head
and body.
Total pancreatectomy was performed under the
diagnosis of
double primary
pancreatic
carcinomas.
Macroscopic examination revealed 3 nodules: one each in the
pancreatic
head
, body, and tail.
Incidentally, we also identified an
adenocarcinoma of
the common bile duct (CBD).
The final
diagnosis
was synchronous double
cancer
involving the whole
pancreas
and the CBD.
[MeSH-major]
Adenocarcinoma
/
diagnosis
. Common Bile Duct Neoplasms /
diagnosis
. Neoplasms, Multiple Primary /
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20686284.001).
[ISSN]
1349-7235
[Journal-full-title]
Internal medicine (Tokyo, Japan)
[ISO-abbreviation]
Intern. Med.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Japan
50.
Chan M, Scaife C, Thaker HM, Adler DG:
Adenocarcinoma of the pancreas undetected by multidetector CT, endoscopic ultrasound, or intraoperative ultrasound.
JOP
; 2009;10(5):554-6
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Adenocarcinoma of
the
pancreas
undetected by multidetector CT, endoscopic ultrasound, or intraoperative ultrasound.
CONTEXT: Patients with known or suspected
pancreatic
adenocarcinoma
are typically evaluated with noninvasive imaging studies and endoscopic ultrasound.
Some patients have
pancreatic
adenocarcinomas that cannot be detected using any of these methods.
Multiple endoscopic ultrasound and triple phase
pancreatic
protocol CT exams were negative for a mass lesion and revealed a normal
pancreas
.
Intraoperative ultrasound of the
pancreas
was also felt to be normal.
Intraoperative biopsy of the
head of
the
pancreas
revealed a small, moderately to poorly differentiated
adenocarcinoma
, not visible on any of her imaging studies.
CONCLUSION: Some
pancreatic
adenocarcinomas may defy detection using modern imaging modalities.
[MeSH-major]
Adenocarcinoma
/
diagnosis
. Diagnostic Errors.
Pancreatic
Neoplasms /
diagnosis
[MeSH-minor]
Cholangiopancreatography, Endoscopic Retrograde / methods. Delayed
Diagnosis
. Endosonography / methods. Female. Humans. Intraoperative Period. Middle Aged. Tomography, X-Ray Computed / methods. Ultrasonography, Interventional
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19734637.001).
[ISSN]
1590-8577
[Journal-full-title]
JOP : Journal of the pancreas
[ISO-abbreviation]
JOP
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Italy
51.
Dhall D, Suriawinata AA, Tang LH, Shia J, Klimstra DS:
Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.
Hum Pathol
; 2010 May;41(5):643-52
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
The patients with autoimmune pancreatitis usually present with jaundice and a
pancreatic
head
mass, presumed to have
pancreatic cancer
, and they often undergo
pancreatic
resection.
Elevated serum IgG4 levels (>135 mg/dL) help to distinguish autoimmune pancreatitis from
pancreatic cancer
.
However, when the biopsy from a
pancreatic
mass shows dense chronic inflammation and fibrosis and the serum IgG4 level is not available, it presents a diagnostic dilemma whether it represents autoimmune pancreatitis or peritumoral pancreatitis.
We performed IgG4 immunohistochemistry on 25 cases of autoimmune pancreatitis-lymphoplasmacytic sclerosing pancreatitis, 7 cases of autoimmune pancreatitis with granulocytic epithelial lesions, 8 cases of nonspecific pancreatitis, 15 cases of pancreatitis associated with
pancreatic
ductal
adenocarcinoma
, and 5 biopsies of
pancreatic
adenocarcinoma
with variable inflammation.
[MeSH-major]
Autoimmune Diseases /
diagnosis
. Carcinoma,
Pancreatic
Ductal /
diagnosis
. Immunoglobulin G / immunology.
Pancreas
/ immunology.
Pancreatic
Neoplasms /
diagnosis
. Pancreatitis /
diagnosis
[MeSH-minor]
Adolescent. Adult. Aged. Aged, 80 and over. Antigens, CD / immunology.
Diagnosis
, Differential. Female. Humans. Immunohistochemistry. Male. Middle Aged. Plasma Cells / immunology
Genetic Alliance.
consumer health - Pancreatitis
.
MedlinePlus Health Information.
consumer health - Autoimmune Diseases
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
MedlinePlus Health Information.
consumer health - Pancreatitis
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Copyright]
Copyright 2010 Elsevier Inc. All rights reserved.
(PMID = 20149413.001).
[ISSN]
1532-8392
[Journal-full-title]
Human pathology
[ISO-abbreviation]
Hum. Pathol.
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Antigens, CD; 0 / Immunoglobulin G
52.
Shtilbans V, Wu M, Burstein DE:
Current overview of the role of Akt in cancer studies via applied immunohistochemistry.
Ann Diagn Pathol
; 2008 Apr;12(2):153-60
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Current overview of the role of Akt in
cancer
studies via applied immunohistochemistry.
The following review summarizes the use of phospho-AKT immunohistochemistry as a potentially valuable tool in
cancer
prognostication in a wide spectrum of common and uncommon malignancies, including squamous carcinoma of cervix and
of head
and neck;
adenocarcinoma of
endometrium, ovarian, breast, prostate, kidney, colon, and
pancreas
; carcinomas of lung and thyroid; and hematopoietic, soft tissue, and central nervous system neoplasms.
To date, the findings overall suggest that the major use of p-AKT immunohistochemical staining lies in prognostication and possibly in individualization of therapy rather than in differential
diagnosis
.
COS Scholar Universe.
author profiles
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18325479.001).
[ISSN]
1092-9134
[Journal-full-title]
Annals of diagnostic pathology
[ISO-abbreviation]
Ann Diagn Pathol
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
United States
[Chemical-registry-number]
0 / Biomarkers, Tumor; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt
[Number-of-references]
79
53.
Pai RK, West RB:
MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study.
Appl Immunohistochem Mol Morphol
; 2009 May;17(3):202-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Distinguishing between reactive mesothelial proliferations and
adenocarcinoma
is often very difficult.
MOC-31 and Ber-EP4 are antibodies which target the epithelial cell adhesion molecule (Ep-CAM, TACSTD1) expressed in epithelial cells, and both are useful in distinguishing metastatic
adenocarcinoma
from reactive mesothelial cells.
We analyzed the immunohistochemical expression of MOC-31 and Ber-EP4 using tissue microarrays containing invasive ductal carcinoma (191 cases), invasive lobular carcinoma (44 cases), and 102 other carcinoma types comprising primary carcinomas of lung, gynecologic tract,
pancreas
, colon, gastric, esophageal, prostate,
head
and neck, hepatic, and renal origin.
With the exception of 1 case of esophageal
adenocarcinoma
, all other adenocarcinomas (86 of 87 cases) exhibited diffuse staining with both Ber-EP4 and MOC-31.
Genetic Alliance.
consumer health - invasive ductal carcinoma
.
Genetic Alliance.
consumer health - Invasive lobular carcinoma
.
MedlinePlus Health Information.
consumer health - Breast Cancer
.
COS Scholar Universe.
author profiles
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19391212.001).
[ISSN]
1533-4058
[Journal-full-title]
Applied immunohistochemistry & molecular morphology : AIMM
[ISO-abbreviation]
Appl. Immunohistochem. Mol. Morphol.
[Language]
ENG
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
United States
[Chemical-registry-number]
0 / Antibodies; 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Cell Adhesion Molecules; 0 / EPCAM protein, human
54.
Akatsu T, Kameyama K, Nogami Y, Kawachi S, Kitajima M, Kitagawa Y:
Neoplastic endocrine differentiation of pancreatic ductal adenocarcinoma in a metastatic lymph node: report of a case.
Surg Today
; 2007;37(11):1009-12
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Neoplastic endocrine differentiation of
pancreatic
ductal
adenocarcinoma
in a metastatic lymph node: report of a case.
The occurrence of non-neoplastic, scattered endocrine cells in
pancreatic
ductal
adenocarcinoma
(DAC) is thought to be a general phenomenon.
Conversely, neoplastic endocrine differentiation (NED) of
pancreatic
DAC is extremely unusual.
We report a case of NED in a metastatic lymph node from
pancreatic
DAC.
This case is distinct because the main tumor of the
pancreas
was composed purely of DAC without endocrine differentiation, and the NED was found in only one of four metastatic peripancreatic lymph nodes.
The patient was a 61-year-old woman who underwent pylorus-preserving pancreaticoduodenectomy for
pancreatic
head
cancer
.
Some authors reported that
pancreatic
DAC with endocrine differentiation was associated with a better prognosis than DAC without endocrine differentiation.
However, more cases must be studied to investigate the impact of NED of metastatic lymph nodes in
pancreatic
DAC.
[MeSH-major]
Carcinoma,
Pancreatic
Ductal / secondary.
Pancreatic
Neoplasms / pathology. Pancreaticoduodenectomy / methods
[MeSH-minor]
Diagnosis
, Differential. Endoscopy, Gastrointestinal. Female. Follow-Up Studies. Humans. Lymphatic Metastasis. Middle Aged. Tomography, X-Ray Computed
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Surgery. 1994 Dec;116(6):1123-9; discussion 1129-30
[
7985097.001
]
[Cites]
Histopathology. 1981 Nov;5(6):599-613
[
6119287.001
]
[Cites]
Ann Surg. 2003 May;237(5):650-7; discussion 657-9
[
12724631.001
]
[Cites]
Semin Diagn Pathol. 2000 May;17(2):104-8
[
10839610.001
]
[Cites]
Am J Clin Pathol. 1993 Sep;100(3):223-30
[
8379530.001
]
[Cites]
Pathol Res Pract. 1996 Sep;192(9):901-8
[
8950756.001
]
[Cites]
Arch Pathol Lab Med. 2000 Feb;124(2):284-6
[
10656740.001
]
[Cites]
Virchows Arch. 2002 Sep;441(3):249-55
[
12242521.001
]
[Cites]
Am J Surg. 1984 Jan;147(1):25-31
[
6691547.001
]
[Cites]
Virchows Arch. 2003 Mar;442(3):258-65
[
12647216.001
]
[Cites]
Gastroenterology. 1990 Jun;98(6):1655-65
[
1692551.001
]
[Cites]
Arch Surg. 1998 Jan;133(1):13-6; discussion 17
[
9438752.001
]
[Cites]
Arch Pathol Lab Med. 2000 Jun;124(6):832-5
[
10835515.001
]
[Cites]
Surgery. 1995 Dec;118(6):957-65; discussion 965-6
[
7491540.001
]
[Cites]
Virchows Arch A Pathol Anat Histopathol. 1988;413(5):399-405
[
2459841.001
]
[Cites]
Virchows Arch. 1999 Dec;435(6):606-11
[
10628803.001
]
[Cites]
Cancer. 2000 Dec 1;89(11):2230-6
[
11147593.001
]
(PMID = 17952537.001).
[ISSN]
0941-1291
[Journal-full-title]
Surgery today
[ISO-abbreviation]
Surg. Today
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Japan
55.
Ray B, New NE, Wedgwood KR:
Clear cell carcinoma of exocrine pancreas: a rare tumor with an unusual presentation.
Pancreas
; 2005 Mar;30(2):184-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Clear cell carcinoma of exocrine
pancreas
: a rare tumor with an unusual presentation.
Metastatic clear cell carcinomas are relatively common from primary tumors arising in the kidney, female genital tract, adrenal cortex, and lung, but they rarely occur from primary tumors of the
pancreas
.
We report a case of metastatic
pancreatic
tumor with marked clear cell changes in a 46-year-old white man presenting with a pseudocyst of the
pancreas
.
At laparotomy, there was a hard area in the
head of
the
pancreas
and another hard nodule was present in the omentum.
The histologic and immunohistochemical test of the excised omental nodule exhibited features consistent with clear cell carcinoma from
pancreatic
primary.
To our knowledge, this is the first report of a metastatic clear cell
pancreatic
tumor with such an unusual presentation.
[MeSH-major]
Adenocarcinoma
, Clear Cell / secondary. Omentum / pathology.
Pancreas
, Exocrine / pathology.
Pancreatic
Neoplasms / pathology.
Pancreatic
Pseudocyst / pathology
[MeSH-minor]
Diagnosis
, Differential. Humans. Male. Middle Aged. Tomography, X-Ray Computed
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15714142.001).
[ISSN]
1536-4828
[Journal-full-title]
Pancreas
[ISO-abbreviation]
Pancreas
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
56.
Jiang KR, Miao Y:
[Standard with extended pancreaticoduodenectomy for adenocarcinoma of the head of the pancreas: a meta-analysis].
Zhonghua Wai Ke Za Zhi
; 2007 Jan 1;45(1):9-16
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Standard with extended pancreaticoduodenectomy for
adenocarcinoma of
the
head of
the
pancreas
: a meta-analysis].
OBJECTIVE: To compare standard with extended pancreaticoduodenectomy for
adenocarcinoma of
the
head of
the
pancreas
: a meta-analysis of randomized controlled trials and prospective studies.
METHODS: Randomized controlled trials and prospective studies comparing standard with extended pancreaticoduodenectomy for
pancreatic cancer
of head
were identified using a systematic search of Medline, the Cochrane Library Databases and CBMDisc covering articles published from 1996 to 2005.
Whipple procedure is also of choice for
pancreatic
head
carcinoma and extended pancreaticoduodenectomy is indicated for lymph node positive patient (A-level).
[MeSH-major]
Pancreatic
Neoplasms / surgery. Pancreaticoduodenectomy / methods
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17403281.001).
[ISSN]
0529-5815
[Journal-full-title]
Zhonghua wai ke za zhi [Chinese journal of surgery]
[ISO-abbreviation]
Zhonghua Wai Ke Za Zhi
[Language]
chi
[Publication-type]
English Abstract; Journal Article; Meta-Analysis
[Publication-country]
China
57.
Schmid RM:
[Pancreatic cancer].
Praxis (Bern 1994)
; 2006 Nov 1;95(44):1709-12
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[
Pancreatic cancer
].
Pancreatic cancer
is the fourth leading cause of death due to
cancer
.
The most common
cancer
in the
pancreas
is ductal
adenocarcinoma
.
Pancreatic cancer
is characterized by alterations in K-Ras, INK4a, Tp53 and SMAD4.
Similar to colon
cancer
a
cancer
progression model for
pancreatic cancer
has been proposed.
The precursor lesions are called
pancreatic
intraepithelial neoplasia.
Patients with tumors in the
head of
the
pancreas
may present deep jaundice without pain.
Multidetector CT incorporating dual-phase imaging in the arterial and venous phases of enhancement is the preferred imaging modality for the
diagnosis
and staging of
pancreatic cancer
.
[MeSH-major]
Carcinoma,
Pancreatic
Ductal /
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
[MeSH-minor]
Carcinoma in Situ /
diagnosis
. Carcinoma in Situ / pathology. Carcinoma in Situ / surgery. Cyclin-Dependent Kinase Inhibitor p16 / genetics. Deoxycytidine / analogs & derivatives. Deoxycytidine / therapeutic use. Gene Expression Regulation, Neoplastic / genetics. Genes, ras / genetics. Humans. Palliative Care.
Pancreas
/ pathology. Pancreatectomy. Prognosis. Smad4 Protein / genetics. Tomography, X-Ray Computed. Tumor Suppressor Protein p53 / genetics
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17111879.001).
[ISSN]
1661-8157
[Journal-full-title]
Praxis
[ISO-abbreviation]
Praxis (Bern 1994)
[Language]
ger
[Publication-type]
English Abstract; Journal Article
[Publication-country]
Switzerland
[Chemical-registry-number]
0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / SMAD4 protein, human; 0 / Smad4 Protein; 0 / TP53 protein, human; 0 / Tumor Suppressor Protein p53; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine
58.
Inagaki M, Obara M, Suzuki S, Ishizaki A, Takahashi K, Matsumoto K, Haneda M, Tokusashi Y, Miyokawa N, Kasai S:
Mucinous carcinoma of Vater's ampulla with a unique extension along the main pancreatic duct.
J Hepatobiliary Pancreat Surg
; 2007;14(5):518-21
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Mucinous carcinoma of Vater's ampulla with a unique extension along the main
pancreatic
duct.
We report a case of mucinous carcinoma of Vater's ampulla with a unique extension along only the main
pancreatic
duct (MPD) and microinvasion to the
pancreas
.
Abdominal computed tomography (CT) demonstrated swelling in the
head of
the
pancreas
with a mass in the duodenum.
A biopsy specimen of the tumor showed moderately differentiated
adenocarcinoma
.
A pylorus-preserving pancreaticoduodenectomy with a regional lymphadenectomy was performed, under a preoperative
diagnosis of adenocarcinoma of
Vater's ampulla with direct invasion into the
head of
the
pancreas
.
Microscopically, the tumor consisted of two components: moderately differentiated
adenocarcinoma
in the peripheral region of the tumor Vater's papilla and mucinous carcinoma in the central region of the tumor.
The mucinous carcinoma component uniquely extended along only the MPD with microinvasion to the
pancreas
.
Immunohistochemically, both the moderately differentiated
adenocarcinoma
and the mucinous carcinoma were positive for cytokeratin 20 (CK20) and negative for cytokeratin 7 (CK7) which is the pattern of intestinal-type carcinoma of Vater's ampulla.
We concluded that the original site of this tumor may have been the duodenal epithelium of Vater's ampulla originally moderately differentiated
adenocarcinoma
-which subsequently changed to mucinous carcinoma that extended along only the MPD with microinvasion to the
pancreas
.
[MeSH-major]
Adenocarcinoma
, Mucinous / pathology. Ampulla of Vater / pathology. Common Bile Duct Neoplasms / pathology.
Pancreatic
Ducts / pathology.
Pancreatic
Neoplasms / pathology
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17909724.001).
[ISSN]
0944-1166
[Journal-full-title]
Journal of hepato-biliary-pancreatic surgery
[ISO-abbreviation]
J Hepatobiliary Pancreat Surg
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Japan
59.
Sugimoto M, Yasuda H, Koda K, Suzuki M, Yamazaki M, Tezuka T, Kosugi C, Higuchi R, Takenoue T, Yamamoto S, Watayo Y, Yagawa Y, Tsuchiya T:
Virtual CO2 MDCT pancreatography: a new feasible technique for minimally invasive pancreatectomy in intraductal papillary mucinous neoplasms.
Hepatogastroenterology
; 2008 Jan-Feb;55(81):270-4
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
BACKGROUND/AIMS: Less invasive
pancreatic
head
resection, such as duodenum-preserving
pancreatic
head
resection (DPPHR) has been introduced for the treatment of pancreatoduodenal lesions, especially for benign conditions, for reducing surgical stress and maintaining exocrine and endocrine function of the residual
pancreas
in consideration of postoperative quality of life (QOL).
METHODOLOGY: We investigated the feasibility of a new technique employing three-dimensional (3D) virtual pancreatography using multi-detector CT (MDCT) with carbon dioxide (CO2) gas as a negative contrast agent for detection of intraductal papillary mucinous neoplasm (IPMN) of the
pancreas
requiring minimally invasive surgery.
RESULTS: Contrast-enhanced MDCT scan of the abdomen diagnosed 4- to 20-mm multilocular septated cysts in the
head
-uncinate process of the
pancreas
.
Endoscopic retrograde pancreatography (ERP) showed multiple cystic lesions in the
head
-uncinate process with mild dilatation in the remaining
pancreatic
duct.
For localizing
diagnosis of
these small and multiple
pancreatic
cysts, we placed an endoscopic
pancreatic
stent (EPS), and MDCT with injection of CO2 via EPS was examined for the virtual CO2 pancreatography, consisting of OsiriX software system employing 3D virtual anatomic reconstruction with CO2 gas as a negative contrast agent.
Virtual CO2 MDCT pancreatography demonstrated that all cystic lesions of the
pancreas
were contained within the area of the
head
-uncinate process of the
pancreas
.
We performed DPPHR, and surgical margin of the patient's remnant
pancreas
was determined as non-malignant by intraoperative histology.
There was no residual
pancreatic
cyst and tumor after surgery.
The resected tumor was diagnosed as branch duct type intraductal papillary mucinous
adenocarcinoma
.
According to our minimally invasive DPPHR obtained by virtual CO2 pancreatography, the
pancreatic
endocrine and exocrine functions of this patient were maintained at almost the same levels as those in his preoperative status.
With respect to preservation of the endocrine and exocrine functions of the
pancreas
, DPPHR is a highly effective surgical procedure due to limited surgical resection.
CONCLUSIONS: Our new technique of virtual CO2 MDCT pancreatography is a feasible procedure for preservation of the remnant
pancreatic
function.
This is the first report of virtual CO2 pancreatography providing minimally invasive
pancreatic
surgery.
[MeSH-major]
Adenocarcinoma
, Mucinous / surgery.
Adenocarcinoma
, Papillary / surgery. Carcinoma,
Pancreatic
Ductal / radiography. Carcinoma,
Pancreatic
Ductal / surgery. Pancreatectomy / methods.
Pancreatic
Neoplasms / radiography.
Pancreatic
Neoplasms / surgery. Tomography, X-Ray Computed / methods
[MeSH-minor]
Carbon Dioxide. Cholangiopancreatography, Endoscopic Retrograde. Dilatation, Pathologic. Feasibility Studies. Humans.
Pancreatic
Ducts / pathology
MedlinePlus Health Information.
consumer health - CT Scans
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
Hazardous Substances Data Bank.
Carbon dioxide
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18507123.001).
[ISSN]
0172-6390
[Journal-full-title]
Hepato-gastroenterology
[ISO-abbreviation]
Hepatogastroenterology
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Greece
[Chemical-registry-number]
142M471B3J / Carbon Dioxide
60.
Sanada Y, Yoshida K, Itoh M, Okita R, Okada M:
Invasive ductal carcinoma of the pancreas showing exophytic growth.
Hepatobiliary Pancreat Dis Int
; 2009 Feb;8(1):97-102
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Invasive ductal carcinoma of the
pancreas
showing exophytic growth.
BACKGROUND: Invasive
pancreatic
carcinoma generally appears as poorly defined mass reflecting the infiltrative growth.
We aimed to identify the histological and immunohistochemical features in a rare case of
pancreatic
carcinoma showing exophytic growth.
METHODS: A 67-year-old woman presented with a mass of 5.0 cm in diameter in the
pancreatic
head
.
Magnetic resonance cholangiopancreatography revealed neither encasement nor dilation of the main
pancreatic
duct.
An incorrect preoperative
diagnosis
was made of solid pseudopapillary tumor of the
pancreas
.
RESULTS: The
head of
the
pancreas
contained a well-circumscribed encapsulated mass of 5.0 cm in diameter, comprising 50%
adenocarcinoma
, with mucinous carcinoma in the center and anaplastic carcinoma at the periphery.
[MeSH-major]
Adenocarcinoma
, Mucinous / pathology. Carcinoma,
Pancreatic
Ductal / pathology.
Pancreatic
Ducts / pathology.
Pancreatic
Neoplasms / pathology
Genetic Alliance.
consumer health - invasive ductal carcinoma
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19208524.001).
[ISSN]
1499-3872
[Journal-full-title]
Hepatobiliary & pancreatic diseases international : HBPD INT
[ISO-abbreviation]
HBPD INT
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
China
[Chemical-registry-number]
0 / Carcinoembryonic Antigen; 0 / Mucin-1
61.
M'sakni I, Rammeh S, Chelbi E, Sayari S, Zaouech A, Baltagi-Ben Jilani S, Zermani R:
[Adenocarcinoma and gastro-intestinal stromal tumor: fortuitous association or a single carcinogenic agent? A report of 2 cases].
Ann Chir
; 2006 Oct;131(8):464-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[
Adenocarcinoma
and gastro-intestinal stromal tumor: fortuitous association or a single carcinogenic agent? A report of 2 cases].
One is of a 44-year-old man presenting a high grade gastric stromal tumor associated with an
adenocarcinoma of
the large bowel.
The other is of a 68-year-old man presenting an
adenocarcinoma of
the
head of
the
pancreas
associated with a low grade gastric stromal tumor.
The hypothesis that the association is due to a simple coincidence particularly in areas with high rates of digestive
cancer
is proposed.
[MeSH-major]
Adenocarcinoma
. Colonic Neoplasms. Gastrointestinal Stromal Tumors. Neoplasms, Multiple Primary.
Pancreatic
Neoplasms
[MeSH-minor]
Adult. Colectomy. Colon / pathology. Colonoscopy. Humans. Male. Middle Aged.
Pancreas
/ pathology. Radiography, Abdominal. Tomography, X-Ray Computed
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16527243.001).
[ISSN]
0003-3944
[Journal-full-title]
Annales de chirurgie
[ISO-abbreviation]
Ann Chir
[Language]
fre
[Publication-type]
Case Reports; Comparative Study; English Abstract; Journal Article
[Publication-country]
France
62.
Tanaka H, Takamori H, Eto S, Ozaki N, Akaboshi S, Nakahara O, Ida S, Furuhashi S, Abe S, Horino K, Beppu T, Baba H:
[Acute liver injury with hepatic encephalopathy associated with gemcitabine administration for adjuvant chemotherapy in an HBV carrier with pancreatic cancer].
Gan To Kagaku Ryoho
; 2010 Sep;37(9):1783-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Acute liver injury with hepatic encephalopathy associated with gemcitabine administration for adjuvant chemotherapy in an HBV carrier with
pancreatic cancer
].
Imagings revealed
cancer
of the
head of
the
pancreas
.
We performed pancreaticoduodenectomy for
pancreatic cancer
.
The histopathological
diagnosis
was tubular
adenocarcinoma of
the
pancreas
.
[MeSH-major]
Deoxycytidine / analogs & derivatives. Hepatic Encephalopathy / chemically induced. Hepatitis B / complications. Liver / injuries.
Pancreatic
Neoplasms / drug therapy
Genetic Alliance.
consumer health - Hepatic encephalopathy
.
Genetic Alliance.
consumer health - Liver cancer
.
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Hepatitis B
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20841947.001).
[ISSN]
0385-0684
[Journal-full-title]
Gan to kagaku ryoho. Cancer & chemotherapy
[ISO-abbreviation]
Gan To Kagaku Ryoho
[Language]
jpn
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Japan
[Chemical-registry-number]
0 / Amino Acids, Branched-Chain; 0W860991D6 / Deoxycytidine; 4618-18-2 / Lactulose; B76N6SBZ8R / gemcitabine
63.
Fukatsu H, Kawamoto H, Tsutsumi K, Fujii M, Kato H, Hirao K, Kurihara N, Ogawa T, Ishida E, Okamoto Y, Okada H, Sakaguchi K:
Santorinicele in a patient with unresectable pancreatic cancer.
Intern Med
; 2008;47(1):33-5
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Santorinicele in a patient with unresectable
pancreatic cancer
.
A santorinicele is defined as a focal cystic dilatation of the terminal portion of the dorsal
pancreatic
duct at the minor papilla; most cases have been reported in patients with
pancreas
divisum.
It has been suggested that a santorinicele results from a combination of a minor papilla obstruction which prevents the flow of
pancreatic
juice and a weakness of the duodenal wall where the dorsal
pancreatic
duct terminates.
However, these conditions can occur in patients with invasive ductal
cancer
in the
pancreatic
head
.
We encountered a rare case of a santorinicele with unresectable
adenocarcinoma of
the
pancreatic
head
in an 81-year-old woman.
[MeSH-major]
Adenocarcinoma
/ complications.
Pancreatic
Cyst / etiology.
Pancreatic
Ducts.
Pancreatic
Neoplasms / complications
[MeSH-minor]
Aged, 80 and over. Cholangiopancreatography, Endoscopic Retrograde. Dilatation, Pathologic /
diagnosis
. Dilatation, Pathologic / etiology. Female. Humans
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18176002.001).
[ISSN]
1349-7235
[Journal-full-title]
Internal medicine (Tokyo, Japan)
[ISO-abbreviation]
Intern. Med.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Japan
64.
Baierlein SA, Wistop A, Looser C, Bussmann C, von Flüe M, Peterli R:
Primary pancreatic neoplasia or metastasis from colon carcinoma?
Acta Gastroenterol Belg
; 2008 Oct-Dec;71(4):401-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Primary
pancreatic
neoplasia or metastasis from colon carcinoma?
INTRODUCTION: The
pancreas
is an unusual but occasionally favored target for metastasis from other primary cancers.
CASE REPORT: We report the case of a 77-year old man with a mass in the
pancreatic
head
five years after anterior resection for
adenocarcinoma of
the colon and three years after resection of a lung metastasis.
DISCUSSION: It is rare to have solitary metastases to the
pancreas
which clinically may mimic a primary neoplasm of the
pancreas
.
Clinical features, as well as MRI and PET findings in patients with
pancreatic
metastasis from colon carcinoma are similar to those of primary
pancreatic
ductal
adenocarcinoma
.
The
diagnosis of
metastasis should be considered when patients have a
pancreatic
mass and a history of non-
pancreatic
malignant lesions.
Radical resection may prolong survival in patients if the
pancreas
is the only locus for metastasis at the time
of diagnosis
.
[MeSH-major]
Adenocarcinoma
/
diagnosis
.
Adenocarcinoma
/ secondary. Colonic Neoplasms / pathology. Neoplasms, Second Primary /
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
.
Pancreatic
Neoplasms / secondary
[MeSH-minor]
Aged.
Diagnosis
, Differential. Humans. Male
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19317283.001).
[ISSN]
1784-3227
[Journal-full-title]
Acta gastro-enterologica Belgica
[ISO-abbreviation]
Acta Gastroenterol. Belg.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Belgium
65.
Farnell MB, Aranha GV, Nimura Y, Michelassi F:
The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence.
J Gastrointest Surg
; 2008 Apr;12(4):651-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
The role of extended lymphadenectomy for
adenocarcinoma of
the
head of
the
pancreas
: strength of the evidence.
Standard pancreaticoduodenectomy continues to be the operation of choice for
adenocarcinoma of
the
head of
the
pancreas
.
[MeSH-major]
Adenocarcinoma
/ surgery. Lymph Node Excision / methods.
Pancreatic
Neoplasms / surgery
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Surg Gynecol Obstet. 1992 Sep;175(3):259-65
[
1514162.001
]
[Cites]
Ann Surg. 1998 Oct;228(4):508-17
[
9790340.001
]
[Cites]
J Gastrointest Surg. 2005 Dec;9(9):1191-204; discussion 1204-6
[
16332474.001
]
[Cites]
Ann Surg. 2002 Sep;236(3):355-66; discussion 366-8
[
12192322.001
]
[Cites]
World J Surg. 1995 Jul-Aug;19(4):653-9; discussion 660
[
7676716.001
]
[Cites]
Adv Surg. 1994;27:257-72
[
7908159.001
]
[Cites]
Surg Clin North Am. 1995 Oct;75(5):905-12
[
7660253.001
]
[Cites]
Surgery. 1995 Jun;117(6):616-23
[
7778025.001
]
[Cites]
Surgery. 2005 Oct;138(4):618-28; discussion 628-30
[
16269290.001
]
[Cites]
Ann Surg. 1999 May;229(5):613-22; discussion 622-4
[
10235519.001
]
[Cites]
Arch Surg. 1997 Jul;132(7):771-6; discussion 777
[
9230864.001
]
[Cites]
Surgery. 1973 Feb;73(2):307-20
[
4265314.001
]
[Cites]
J Gastrointest Surg. 2003 Jan;7(1):1-9; discussion 9-11
[
12559179.001
]
[Cites]
Surgery. 1997 Mar;121(3):244-9
[
9068665.001
]
[Cites]
Arch Surg. 2005 Jun;140(6):584-9; discussion 589-91
[
15967906.001
]
[Cites]
Cancer. 1989 Sep 1;64(5):1132-7
[
2547508.001
]
[Cites]
Ann Surg. 1988 Aug;208(2):215-20
[
2840866.001
]
[Cites]
Am J Gastroenterol. 1985 Jun;80(6):459-62
[
4003374.001
]
[Cites]
Cancer. 1978 Mar;41(3):880-7
[
638975.001
]
[Cites]
Br J Surg. 2007 Mar;94(3):265-73
[
17318801.001
]
(PMID = 18085343.001).
[ISSN]
1091-255X
[Journal-full-title]
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
[ISO-abbreviation]
J. Gastrointest. Surg.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article; Review
[Publication-country]
United States
[Number-of-references]
22
66.
Shima Y, Yagi T, Inagaki M, Sadamori H, Tanaka N, Horimi T, Hamazaki S:
Intraductal oncocytic papillary neoplasm of the pancreas with celiac artery compression syndrome and a jejunal artery aneurysm: report of a case.
Surg Today
; 2005;35(1):86-90
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Intraductal oncocytic papillary neoplasm of the
pancreas
with celiac artery compression syndrome and a jejunal artery aneurysm: report of a case.
A 79-year-old woman presented with epigastralgia, and computed tomography showed a 3-cm multiloculated mass with a mural nodule in the
head of
the
pancreas
.
We made a preoperative
diagnosis of
intraductal papillary
adenocarcinoma of
the
pancreatic
head
and performed a laparotomy.
Microscopically, the tumor had papillary intracystic growth, and was lined by plump cells with abundant eosinophilic cytoplasm, consistent with a
diagnosis of
intraductal oncocytic papillary neoplasm.
We discuss this recently recognized entity of papillary neoplasm of the
pancreas
, and the importance of managing hepatic blood flow during pancreaticoduodenectomy in celiac artery compression syndrome.
[MeSH-major]
Adenocarcinoma
, Papillary / surgery. Arterial Occlusive Diseases / radiography. Celiac Artery. Jejunum / blood supply.
Pancreatic
Neoplasms / surgery. Pancreaticoduodenectomy / methods
[MeSH-minor]
Abdominal Pain /
diagnosis
. Abdominal Pain / etiology. Aged. Aneurysm / radiography. Aneurysm / surgery. Angiography. Female. Follow-Up Studies. Humans. Risk Assessment. Severity of Illness Index. Tomography, X-Ray Computed. Treatment Outcome
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15622472.001).
[ISSN]
0941-1291
[Journal-full-title]
Surgery today
[ISO-abbreviation]
Surg. Today
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
Japan
[Number-of-references]
16
67.
Bach P, Möhring C, Krawzak HW, Goepel M:
[Retroperitoneal extravasation as the primary symptom of a pancreatic carcinoma].
Urologe A
; 2007 Nov;46(11):1548-50
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Retroperitoneal extravasation as the primary symptom of a
pancreatic
carcinoma].
Adenocarcinoma of
the
pancreas
has a low 5-year survival rate of approximately 5%.
Early diagnostics of
pancreatic
carcinoma during early tumor stages is made difficult by the lack of symptoms.
In particular, individuals suffering from carcinomas located within the
pancreatic
tail are at high risk of a missed
diagnosis
.
The early symptoms are usually nonspecific (e.g., nonspecific upper abdominal complaints, decrease in weight, loss of appetite, and impaired performance) and are characteristic only in carcinomas of the
pancreatic
head
with painless icterus.
An
adenocarcinoma of
the
pancreatic
tail was diagnosed in this case report based on a large retroperitoneal extravasation missing further symptoms.
[MeSH-major]
Adenocarcinoma
, Mucinous / diagnostic imaging. Extravasation of Diagnostic and Therapeutic Materials / diagnostic imaging.
Pancreatic
Neoplasms / diagnostic imaging
[MeSH-minor]
Aorta, Abdominal / pathology.
Diagnosis
, Differential. Duodenum / pathology. Gastroenterostomy. Humans. Male. Middle Aged. Neoplasm Invasiveness / pathology. Neoplasm Staging. Palliative Care. Retroperitoneal Space / diagnostic imaging. Tomography, X-Ray Computed. Ureter / pathology. Urinoma / diagnostic imaging. Urography
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Hinyokika Kiyo. 1998 Nov;44(11):809-11
[
9893227.001
]
[Cites]
Hinyokika Kiyo. 1999 Jan;45(1):53-5
[
10086268.001
]
[Cites]
Hinyokika Kiyo. 2006 Mar;52(3):211-4
[
16617876.001
]
[Cites]
Hinyokika Kiyo. 1987 Jul;33(7):1100-4
[
3318332.001
]
[Cites]
Hinyokika Kiyo. 1992 Jul;38(7):829-32
[
1524010.001
]
[Cites]
Hinyokika Kiyo. 1992 Jan;38(1):51-4
[
1546570.001
]
[Cites]
Hinyokika Kiyo. 2001 Oct;47(10 ):735-7
[
11758357.001
]
[Cites]
J Spinal Cord Med. 2003 Winter;26(4):404-8
[
14992344.001
]
(PMID = 17786402.001).
[ISSN]
0340-2592
[Journal-full-title]
Der Urologe. Ausg. A
[ISO-abbreviation]
Urologe A
[Language]
ger
[Publication-type]
Journal Article
[Publication-country]
Germany
68.
Pine JK, Fusai KG, Young R, Sharma D, Davidson BR, Menon KV, Rahman SH:
Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas.
Eur J Surg Oncol
; 2009 Jun;35(6):605-10
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Serum C-reactive protein concentration and the prognosis of ductal
adenocarcinoma of
the
head of pancreas
.
BACKGROUND: The prognostic role of serum C-reactive protein in
pancreatic cancer
has received increasing attention; however the confounding effects of biliary obstruction have not been addressed in previous studies.
We sought to determine the prognostic importance of serum CRP prior to biliary intervention in the prognosis of
pancreatic
adenocarcinoma
.
METHODS: A retrospective case note review of patients diagnosed with
pancreatic cancer
between 2001 and 2006.
CONCLUSION: Raised serum C-reactive protein concentration at the time of presentation of advanced
pancreatic cancer
carries a poor prognosis independent of biliary tract obstruction.
[MeSH-major]
C-Reactive Protein / analysis. Carcinoma,
Pancreatic
Ductal / blood.
Pancreatic
Neoplasms / blood
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19128923.001).
[ISSN]
1532-2157
[Journal-full-title]
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
[ISO-abbreviation]
Eur J Surg Oncol
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
[Chemical-registry-number]
9007-41-4 / C-Reactive Protein
69.
Gumbs AA, Kim J, Kiehna E, Brink JA, Salem RR:
Autoimmune pancreatitis presenting as simultaneous masses in the pancreatic head and gallbladder.
JOP
; 2005 Sep;6(5):455-9
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Autoimmune pancreatitis presenting as simultaneous masses in the
pancreatic
head
and gallbladder.
CONTEXT: Autoimmune pancreatitis is a rare variant of chronic pancreatitis characterized by
pancreatic
ductal narrowing and
pancreatic
parenchymal edema on computed tomography and rarely with intermittent attacks of abdominal pain.
CASE REPORT: We describe the clinical, radiographic and histopathologic aspects of a patient who presented with synchronous masses in the
pancreatic
head
and gallbladder.
CONCLUSION: Autoimmune pancreatitis is the most common benign entity identified in patients that underwent pancreaticoduodenectomy for presumed
pancreatic
adenocarcinoma
.
Our patient with autoimmune pancreatitis presented with simultaneous inflammatory masses in the gallbladder and
pancreatic
head
, an association not previously reported.
If pre-operative
diagnosis
is not made, immunohistochemical staining of pathology specimens can confirm the
diagnosis
.
[MeSH-major]
Autoimmune Diseases /
diagnosis
. Autoimmune Diseases / pathology. Gallbladder / pathology.
Pancreas
/ pathology. Pancreatitis /
diagnosis
. Pancreatitis / pathology
[MeSH-minor]
Acute Disease. Aged. Edema /
diagnosis
. Edema / pathology. Female. Humans. Immunoglobulin G / analysis. Immunoglobulin G / blood. Immunohistochemistry. Tomography, X-Ray Computed
Genetic Alliance.
consumer health - Pancreatitis
.
MedlinePlus Health Information.
consumer health - Autoimmune Diseases
.
MedlinePlus Health Information.
consumer health - Pancreatitis
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16186668.001).
[ISSN]
1590-8577
[Journal-full-title]
JOP : Journal of the pancreas
[ISO-abbreviation]
JOP
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Italy
[Chemical-registry-number]
0 / Immunoglobulin G
70.
Garcea G, Dennison AR, Ong SL, Pattenden CJ, Neal CP, Sutton CD, Mann CD, Berry DP:
Tumour characteristics predictive of survival following resection for ductal adenocarcinoma of the head of pancreas.
Eur J Surg Oncol
; 2007 Sep;33(7):892-7
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Tumour characteristics predictive of survival following resection for ductal
adenocarcinoma of
the
head of pancreas
.
AIMS: We have maintained a highly conservative policy in selecting patients with carcinoma of the
head of pancreas
for resection.
This study investigated our survival rates following
pancreatic
resection and examined clinicopathological predictors of survival.
METHODS: Sixty-two consecutive patients undergoing
pancreatic
resections for malignancy were identified from 1999 onwards.
Thirty-three underwent resection for
pancreatic
ductal
adenocarcinoma
and were included in our analysis, the remainder included resections for ampullary
adenocarcinoma
(n=20) or other malignancies (n=9).
RESULTS: Median survival following resection for ductal
pancreatic
adenocarcinoma
was 54 months (ampullary adenocarcinomas achieved a median survival of 62 months) and thirty-day mortality was 2.7% (n=1).
CONCLUSION: Despite the advances made in the management of
pancreatic cancer
, tumour biology still dictates long-term survival.
[MeSH-major]
Carcinoma, Ductal / mortality. Pancreatectomy / methods.
Pancreatic
Neoplasms / mortality
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17398060.001).
[ISSN]
0748-7983
[Journal-full-title]
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
[ISO-abbreviation]
Eur J Surg Oncol
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
71.
Matsubayashi H, Matsunaga K, Uesaka K, Fukutomi A, Sasaki K, Furukawa H, Ono H:
A case of pancreatic carcinoma with suspected autoimmune pancreatitis.
Clin J Gastroenterol
; 2009 Feb;2(1):59-63
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
A case of
pancreatic
carcinoma with suspected autoimmune pancreatitis.
We present a case of
pancreatic
carcinoma with strongly suspected coexisting autoimmune pancreatitis (AIP).
The patient presented with a chief complaint of icterus and weight loss, and was referred to our institution after a
pancreatic
lesion was found.
Ultrasonography demonstrated an enlarged
pancreas
with smooth borders and low internal echo density.
Enhanced computed tomography (CT) showed a sausage-shaped
pancreas
without definitive metastasis to the surrounding lymph nodes and liver.
Imaging of the
pancreatic
duct, including endoscopic retrograde pancreatography (ERP) and magnetic resonance cholangiopancreatography (MRCP), showed stenosis of the main
pancreatic
duct at the
pancreatic
head
as well as a long segment of narrowing at the body and no dilatation at the tail.
Tissues from these stenotic sites and open biopsy from
pancreatic
body showed infiltrating
adenocarcinoma
and dense fibrosis.
To date, only a small number of reports have described
pancreatic
carcinoma accompanied with AIP.
It is important to confirm
diagnosis
with histology in cases of suspicious autoimmune pancreatitis, even when the clinical images are compatible with AIP.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Gastroenterol. 2007 Aug;42(8):657-62
[
17701129.001
]
[Cites]
Intern Med. 2008;47(3):151-5
[
18239323.001
]
[Cites]
N Engl J Med. 2001 Mar 8;344(10):732-8
[
11236777.001
]
[Cites]
Scand J Gastroenterol. 2008 Jan;43(1):110-6
[
18158696.001
]
[Cites]
Gastrointest Endosc. 2007 Jan;65(1):99-108
[
17185087.001
]
[Cites]
J Gastroenterol. 2008;43(2):144-51
[
18306988.001
]
[Cites]
World J Gastroenterol. 2006 Oct 14;12(38):6225-8
[
17036401.001
]
[Cites]
Case Rep Gastroenterol. 2008 May 24;2(2):155-61
[
21490882.001
]
[Cites]
J Gastroenterol Hepatol. 2005 Nov;20(11):1707-11
[
16246190.001
]
[Cites]
Semin Diagn Pathol. 2005 Nov;22(4):309-17
[
16939059.001
]
[Cites]
Gastrointest Endosc. 2005 Jan;61(1):76-9
[
15672060.001
]
[Cites]
Pancreatology. 2007;7(2-3):163-6
[
17592229.001
]
[Cites]
Pancreas. 2006 Aug;33(2):208-9
[
16868495.001
]
[Cites]
Arch Pathol Lab Med. 2008 Jan;132(1):48-53
[
18181673.001
]
[Cites]
J Clin Oncol. 2007 Jan 20;25(3):319-25
[
17235047.001
]
[Cites]
J Gastroenterol. 2008;43(6):409-18
[
18600384.001
]
[Cites]
Am J Gastroenterol. 2003 Dec;98(12):2694-9
[
14687819.001
]
[Cites]
JOP. 2008 Jan 08;9(1):37-45
[
18182742.001
]
[Cites]
Am J Gastroenterol. 2007 Aug;102(8):1646-53
[
17555461.001
]
[Cites]
Hum Pathol. 2008 Oct;39(10):1548-51
[
18619645.001
]
(PMID = 26191812.001).
[ISSN]
1865-7257
[Journal-full-title]
Clinical journal of gastroenterology
[ISO-abbreviation]
Clin J Gastroenterol
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Japan
[Keywords]
NOTNLM ; Auto-antibody / Autoimmune pancreatitis / IgG4 / Pancreatic carcinoma
72.
Takahashi S, Homma H, Akiyama T, Mesawa S, Hirata K, Kogawa K, Takanashi K, Ishiwatari H, Kawano Y, Hayashi T, Takada K, Miyanishi K, Kato J, Niitsu Y:
[A case of intraductal papillary mucinous neoplasm with internal pancreatic fistula causing left ureteral obstruction].
Nihon Shokakibyo Gakkai Zasshi
; 2007 Aug;104(8):1236-44
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[A case of intraductal papillary mucinous neoplasm with internal
pancreatic
fistula causing left ureteral obstruction].
A 75-year-old man had been admitted to another hospital because of left abdominal pain, and was given a
diagnosis of
left hydronephrosis and acute pancreatitis.
US and EUS revealed a chronic pancreatitis-like pattern and multicystic lesion in the
pancreas head
and body.
At that time enhanced CT findings showed an extrapancreatic low density area to be inflammatory change, extending from the
pancreas
body to the left crus of the diaphragm and posteriorly the spreading from the left crus of the diaphragm via the left urinary duct into the left iliopsoas muscle, in which MRI revealed partial high intensity.
ERCP and MRCP showed focal irregular narrowing of the
pancreatic
duct of unknown cause, and we decided that an internal
pancreatic
fistula due to pancreatitis had induced left ureteral obstruction, caused by a protein plug or alcohol.
[MeSH-major]
Adenocarcinoma
, Mucinous / complications. Carcinoma,
Pancreatic
Ductal / complications.
Pancreatic
Fistula / complications.
Pancreatic
Neoplasms / complications. Ureteral Obstruction / etiology
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17675827.001).
[ISSN]
0446-6586
[Journal-full-title]
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
[ISO-abbreviation]
Nihon Shokakibyo Gakkai Zasshi
[Language]
jpn
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Japan
73.
Lopez-Tomassetti Fernandez EM, Luis HD, Malagon AM, Gonzalez IA, Pallares AC:
Recurrence of inflammatory pseudotumor in the distal bile duct: lessons learned from a single case and reported cases.
World J Gastroenterol
; 2006 Jun 28;12(24):3938-43
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Immunohistochemical study of these lesions limited to the
pancreatic
head
or distal bile duct seems to be compatible with those observed in a new entity called autoimmune pancreatitis, but usually intense fibrotic reaction (zonation) predominates producing a mass.
When this condition is limited to the
pancreatic
head
, the common bile duct might be involved by the inflammatory process and jaundice may occur often resembling
adenocarcinoma of
the
pancreas
.
Ultrasound-guided FNA confirmed our suspicious
diagnosis
.
[MeSH-minor]
Adrenal Cortex Hormones / therapeutic use. Autoimmune Diseases / classification. Autoimmune Diseases /
diagnosis
. Autoimmune Diseases / pathology. Female. Humans. Magnetic Resonance Imaging. Middle Aged. Pancreatitis / classification. Pancreatitis /
diagnosis
. Pancreatitis / pathology. Time Factors. Tomography, X-Ray Computed
MedlinePlus Health Information.
consumer health - Bile Duct Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Clin Rheumatol. 2003 Dec;22(6):467-71
[
14677031.001
]
[Cites]
JOP. 2005 Sep;6(5):455-9
[
16186668.001
]
[Cites]
Clin Gastroenterol Hepatol. 2003 Nov;1(6):453-64
[
15017645.001
]
[Cites]
Am J Surg Pathol. 2004 Sep;28(9):1193-203
[
15316319.001
]
[Cites]
Gastroenterology. 2000 Mar;118(3):573-81
[
10702209.001
]
[Cites]
N Engl J Med. 2001 Mar 8;344(10):732-8
[
11236777.001
]
[Cites]
Thorac Cardiovasc Surg. 2001 Apr;49(2):124-6
[
11339451.001
]
[Cites]
Pathol Res Pract. 2001;197(4):237-44
[
11358009.001
]
[Cites]
Hepatogastroenterology. 2001 Jul-Aug;48(40):1118-23
[
11490814.001
]
[Cites]
J Am Coll Surg. 2002 Apr;194(4):502-6
[
11949755.001
]
[Cites]
Pathologe. 2002 Mar;23(2):161-6
[
12001534.001
]
[Cites]
Gut. 2003 May;52(5):683-7
[
12692053.001
]
[Cites]
Radiology. 2003 Jun;227(3):758-63
[
12728186.001
]
[Cites]
Surg Today. 2003;33(9):714-7
[
12928854.001
]
[Cites]
J Clin Pathol. 2003 Sep;56(9):715-7
[
12944561.001
]
[Cites]
J Gastroenterol. 2003;38(10):982-4
[
14614606.001
]
[Cites]
JOP. 2004 Sep;5(5):360-7
[
15365204.001
]
[Cites]
Am J Gastroenterol. 2004 Oct;99(10):2038-40
[
15447769.001
]
[Cites]
N Engl J Med. 1983 Jan 13;308(2):86-8
[
6847938.001
]
[Cites]
South Med J. 1983 May;76(5):647-9
[
6844969.001
]
[Cites]
Am J Gastroenterol. 1990 Feb;85(2):203-6
[
2405646.001
]
[Cites]
Hum Pathol. 1991 Apr;22(4):387-95
[
2050373.001
]
[Cites]
Am J Surg Pathol. 1991 Dec;15(12):1146-56
[
1746682.001
]
[Cites]
Arch Pathol Lab Med. 1993 Sep;117(9):921-6
[
8368906.001
]
[Cites]
Dig Dis Sci. 1995 Apr;40(4):752-6
[
7720466.001
]
[Cites]
Am J Gastroenterol. 1995 Jul;90(7):1155-8
[
7611217.001
]
[Cites]
Am J Surg Pathol. 1995 Aug;19(8):859-72
[
7611533.001
]
[Cites]
Hum Pathol. 1995 Oct;26(10):1093-8
[
7557942.001
]
[Cites]
Ital J Gastroenterol. 1995 Jun;27(5):252-5
[
8541577.001
]
[Cites]
Pathology. 1995 Jul;27(3):284-8
[
8532398.001
]
[Cites]
Cancer. 1996 Feb 15;77(4):778-84
[
8616772.001
]
[Cites]
Am J Surg Pathol. 1996 Jun;20(6):747-53
[
8651355.001
]
[Cites]
Cancer. 1995 Nov 1;76(9):1545-9
[
8635056.001
]
[Cites]
Hum Pathol. 1996 Oct;27(10):1095-8
[
8892598.001
]
[Cites]
Am J Surg Pathol. 1997 Oct;21(10):1166-72
[
9331288.001
]
[Cites]
Pancreas. 2005 Nov;31(4):420-3
[
16258381.001
]
[Cites]
Endoscopy. 2005 Nov;37(11):1127-30
[
16281144.001
]
[Cites]
Pancreatology. 2006;6(1-2):145-54
[
16354963.001
]
[Cites]
Pathol Res Pract. 1997;193(7):519-25; discussion 526
[
9342759.001
]
[Cites]
Radiology. 1998 Feb;206(2):511-8
[
9457206.001
]
[Cites]
Am J Surg Pathol. 1998 Apr;22(4):412-8
[
9537467.001
]
[Cites]
Lancet. 1999 Jul 3;354(9172):43-4
[
10406367.001
]
[Cites]
AJR Am J Roentgenol. 1999 Oct;173(4):1049-54
[
10511176.001
]
[Cites]
Am J Surg Pathol. 2005 Feb;29(2):275-8
[
15644785.001
]
[Cites]
JOP. 2005 Jan;6(1 Suppl):97-101
[
15650292.001
]
[Cites]
World J Gastroenterol. 2005 Feb 14;11(6):922-5
[
15682495.001
]
[Cites]
Histopathology. 2005 Aug;47(2):147-58
[
16045775.001
]
[Cites]
Hum Pathol. 2005 Jul;36(7):710-7
[
16084938.001
]
[Cites]
Virchows Arch. 2004 Feb;444(2):119-26
[
14722765.001
]
(PMID = 16804988.001).
[ISSN]
1007-9327
[Journal-full-title]
World journal of gastroenterology
[ISO-abbreviation]
World J. Gastroenterol.
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
[Publication-country]
China
[Chemical-registry-number]
0 / Adrenal Cortex Hormones
[Number-of-references]
52
[Other-IDs]
NLM/ PMC4087951
74.
Adsay NV:
Cystic neoplasia of the pancreas: pathology and biology.
J Gastrointest Surg
; 2008 Mar;12(3):401-4
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Cystic neoplasia of the
pancreas
: pathology and biology.
In contrast with solid tumors, most of which are invasive ductal
adenocarcinoma
with dismal prognosis, cystic lesions of the
pancreas
are often either benign or low-grade indolent neoplasia.
For this reason,
pancreatic
cysts with mucinous differentiation ought to be evaluated carefully, preferably by experts familiar with subtle evidences of malignancy in these tumors.
The presence of ovarian-type stroma has now almost become a requirement for the
diagnosis of
MCN, and when defined as such, MCN is seen almost exclusively in women of perimenopausal age group as thick-walled multilocular cystic mass in the tail of the
pancreas
in contrast with IPMN which afflicts an elder population, both genders in almost equal numbers, and occur predominantly in the
head of
the organ.
SPT holds a distinctive place among
pancreatic
neoplasia because of its highly peculiar characteristics, undetermined cell lineage, occurrence almost exclusively in young females, association with beta-catenin pathway, and also by being a very low-grade curable malignancy.
In conclusion, cystic lesions in the
pancreas
constitute a biologically and pathologically diverse category most (but not all) of which are either benign or treatable diseases; however, a substantial subset, especially mucinous ones, has malignant potential that requires careful analysis.
[MeSH-major]
Adenoma / pathology. Carcinoma in Situ / pathology. Neoplasms, Cystic, Mucinous, and Serous / pathology.
Pancreatic
Ducts / pathology.
Pancreatic
Neoplasms / pathology. Precancerous Conditions / pathology
[MeSH-minor]
Adenocarcinoma
, Mucinous / mortality.
Adenocarcinoma
, Mucinous / pathology. Carcinoma,
Pancreatic
Ductal / pathology. Carcinoma, Papillary / mortality. Carcinoma, Papillary / pathology. Cystadenoma / pathology. Cystadenoma, Serous / pathology. Dilatation, Pathologic. Humans. Necrosis
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
ClinicalTrials.gov.
clinical trials - ClinicalTrials.gov
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Am J Surg Pathol. 2004 Aug;28(8):977-87
[
15252303.001
]
[Cites]
Am J Surg Pathol. 1989 Jan;13(1):61-6
[
2909198.001
]
[Cites]
Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9
[
15166958.001
]
[Cites]
Semin Diagn Pathol. 2000 Feb;17(1):81-8
[
10721809.001
]
[Cites]
Br J Surg. 2003 Oct;90(10):1244-9
[
14515294.001
]
[Cites]
Pancreatology. 2006;6(1-2):17-32
[
16327281.001
]
[Cites]
Semin Diagn Pathol. 2000 Feb;17(1):43-55
[
10721806.001
]
[Cites]
Am J Surg Pathol. 1999 Apr;23 (4):410-22
[
10199470.001
]
[Cites]
J Gastrointest Surg. 2003 Mar-Apr;7(3):417-28
[
12654569.001
]
[Cites]
Virchows Arch. 2004 Aug;445(2):168-78
[
15185076.001
]
[Cites]
Semin Diagn Pathol. 2000 Feb;17(1):56-65
[
10721807.001
]
[Cites]
Am J Surg Pathol. 2004 Jul;28(7):839-48
[
15223952.001
]
[Cites]
Am J Surg Pathol. 2000 Oct;24(10):1372-7
[
11023098.001
]
[Cites]
Am J Surg Pathol. 1999 Jan;23 (1):1-16
[
9888699.001
]
[Cites]
Semin Diagn Pathol. 2000 Feb;17(1):66-80
[
10721808.001
]
[Cites]
Mod Pathol. 2007 Feb;20 Suppl 1:S71-93
[
17486054.001
]
[Cites]
World J Surg. 2003 Mar;27(3):319-23
[
12607059.001
]
[Cites]
Am J Surg Pathol. 2001 Jan;25(1):26-42
[
11145249.001
]
[Cites]
Am J Clin Pathol. 1978 Mar;69(3):289-98
[
637043.001
]
(PMID = 17957438.001).
[ISSN]
1091-255X
[Journal-full-title]
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
[ISO-abbreviation]
J. Gastrointest. Surg.
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
United States
[Number-of-references]
19
75.
Todoroki T, Sano T, Yamada S, Hirahara N, Toda N, Tsukada K, Motojima R, Motojima T:
Clear cell carcinoid tumor of the distal common bile duct.
World J Surg Oncol
; 2007;5:6
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
Under suspicion of carcinoma, we resected the
head of
the
pancreas
along with 2nd portion duodenectomy and a lymph node dissection.
Immunohistochemical stains showed that neoplastic cells were positive for neuron-specific enolase (NSE), chromogranin A, synaptophysin, and
pancreatic
polypeptide and negative for inhibin, keratin, CD56, serotonin, gastrin and somatostatin.
CONCLUSION: Given the preoperative difficulty in differentiating carcinoid from carcinoma, the pancreaticoduodenectomy is an appropriate treatment choice for carcinoid tumors located within the intra-
pancreatic
bile duct.
[MeSH-major]
Carcinoid Tumor /
diagnosis
. Carcinoid Tumor / surgery. Common Bile Duct Neoplasms /
diagnosis
. Common Bile Duct Neoplasms / surgery. Pancreaticoduodenectomy / methods
[MeSH-minor]
Adenocarcinoma
, Clear Cell /
diagnosis
.
Adenocarcinoma
, Clear Cell / pathology.
Adenocarcinoma
, Clear Cell / surgery. Aged. Biopsy, Needle. Cholangiopancreatography, Endoscopic Retrograde. Cholangiopancreatography, Magnetic Resonance. Follow-Up Studies. Humans. Immunohistochemistry. Laparotomy / methods. Male. Neoplasm Staging. Risk Assessment. Tomography, X-Ray Computed. Treatment Outcome. Ultrasonography, Doppler
Genetic Alliance.
consumer health - Carcinoid Tumor
.
MedlinePlus Health Information.
consumer health - Carcinoid Tumors
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Am J Gastroenterol. 1981 Oct;76(4):360-2
[
7325150.001
]
[Cites]
Australas Radiol. 1986 Feb;30(1):34-7
[
3524535.001
]
[Cites]
J R Coll Surg Edinb. 1987 Feb;32(1):48-51
[
3031287.001
]
[Cites]
Dig Dis Sci. 1987 Jul;32(7):763-9
[
3595390.001
]
[Cites]
Gut. 1987 Oct;28(10):1296-7
[
3678958.001
]
[Cites]
Zentralbl Chir. 1987;112(18):1170-5
[
3687265.001
]
[Cites]
Chirurg. 1988 Oct;59(10):683-7
[
3058409.001
]
[Cites]
Gastrointest Radiol. 1989 Spring;14(2):151-4
[
2651196.001
]
[Cites]
Am Surg. 1990 Jun;56(6):343-6
[
2190510.001
]
[Cites]
Gut. 1990 Jun;31(6):728-9
[
2379881.001
]
[Cites]
Int Surg. 1990 Oct-Dec;75(4):262-4
[
2292489.001
]
[Cites]
Orv Hetil. 1991 Mar 17;132(11):591-4
[
2008303.001
]
[Cites]
Am J Gastroenterol. 1991 Aug;86(8):1073-6
[
1858744.001
]
[Cites]
Cancer. 1999 Nov 15;86(10):1959-65
[
10570419.001
]
[Cites]
Cancer. 2003 Feb 15;97(4):934-59
[
12569593.001
]
[Cites]
Am Surg. 2003 Feb;69(2):98-101
[
12641346.001
]
[Cites]
Arch Pathol Lab Med. 2003 Jun;127(6):745-7
[
12741904.001
]
[Cites]
Surg Today. 2003;33(7):553-5
[
14507005.001
]
[Cites]
Ulster Med J. 2004 May;73(1):59-62
[
15244130.001
]
[Cites]
Hepatogastroenterology. 2004 Sep-Oct;51(59):1295-300
[
15362737.001
]
[Cites]
Br J Surg. 1968 Feb;55(2):147-9
[
5635925.001
]
[Cites]
Cancer. 1975 Aug;36(2):560-9
[
1157019.001
]
[Cites]
Aust N Z J Surg. 1976 May;46(2):136-8
[
1067071.001
]
[Cites]
Gastrointest Radiol. 1979 Aug 15;4(3):263-4
[
488613.001
]
[Cites]
Am J Clin Pathol. 1991 Sep;96(3):341-4
[
1877530.001
]
[Cites]
Am J Surg Pathol. 1992 Aug;16(8):802-7
[
1497121.001
]
[Cites]
J Pediatr Surg. 1992 Oct;27(10):1334-5
[
1357128.001
]
[Cites]
J Clin Gastroenterol. 1995 Jun;20(4):321-4
[
7665823.001
]
[Cites]
J Clin Gastroenterol. 1996 Jul;23(1):63-5
[
8835905.001
]
[Cites]
HPB Surg. 1996;9(2):101-5
[
8871251.001
]
[Cites]
HPB Surg. 1996;10(1):41-3
[
9187551.001
]
[Cites]
Liver Transpl Surg. 1995 Mar;1(2):122-3
[
9346553.001
]
[Cites]
Surgery. 1998 Jun;123(6):712-5
[
9626325.001
]
[Cites]
Rev Hosp Clin Fac Med Sao Paulo. 1998 Jan-Feb;53(1):26-8
[
9659740.001
]
[Cites]
Can J Surg. 1999 Feb;42(1):59-63
[
10071590.001
]
[Cites]
Indian J Gastroenterol. 1999 Jul-Sep;18(3):127
[
10407572.001
]
[Cites]
Zentralbl Chir. 1961 Jul 8;86:1588-90
[
13735780.001
]
[Cites]
Oncol Rep. 2005 Mar;13(3):543-6
[
15706430.001
]
[Cites]
Acta Chir Belg. 2006 Jan-Feb;106(1):112-5
[
16612931.001
]
[Cites]
Surg Today. 2006;36(5):485-9
[
16633759.001
]
[Cites]
Virchows Arch. 2006 Jul;449(1):104-11
[
16670930.001
]
[Cites]
Br J Surg. 2000 Mar;87(3):306-13
[
10718799.001
]
[Cites]
Hepatogastroenterology. 2000 Mar-Apr;47(32):519-21
[
10791227.001
]
[Cites]
Am J Gastroenterol. 2000 Oct;95(10):2973-4
[
11051379.001
]
[Cites]
Am J Surg Pathol. 2000 Nov;24(11):1501-10
[
11075851.001
]
[Cites]
Br J Surg. 2001 Mar;88(3):364-70
[
11260100.001
]
[Cites]
Am J Surg Pathol. 2001 Oct;25(10):1334-9
[
11688471.001
]
[Cites]
Med Pediatr Oncol. 2003 Feb;40(2):137-8
[
12461807.001
]
(PMID = 17227590.001).
[ISSN]
1477-7819
[Journal-full-title]
World journal of surgical oncology
[ISO-abbreviation]
World J Surg Oncol
[Language]
eng
[Publication-type]
Case Reports; Journal Article; Review
[Publication-country]
England
[Number-of-references]
52
[Other-IDs]
NLM/ PMC1785380
[General-notes]
NLM/ Original DateCompleted: 20070802
76.
Fukumoto K, Suzuki S, Sakaguchi T, Morita Y, Oishi K, Suzuki A, Inaba K, Kamiya K, Miura K, Konno H:
Adenocarcinoma arising from gastric duplication: a case report with literature review.
Clin J Gastroenterol
; 2008 Dec;1(4):148-152
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Adenocarcinoma
arising from gastric duplication: a case report with literature review.
We report the case of a 50-year-old man with
adenocarcinoma
derived from gastric duplication.
Under the
diagnosis of
gastric duplication cysts, the oral cyst was removed with the gastric wall and the other cyst lesion firmly adhered to the bulbus was treated with distal gastrectomy.
Based on histological findings showing
adenocarcinoma
in the anal duplication cyst wall and regional lymph node metastases and
cancer
invasion into the duodenal stump, pancreatoduodenectomy was performed 9 days after the initial surgery.
Invasion into the
pancreas head
and duodenal walls was seen in the resected specimen.
This case report with literature review indicates that alimentary tract duplication cysts should be recognized as risky lesions of
cancer
development in patients aged 50 years or over.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Dig Dis Sci. 1996 Mar;41(3):627-9
[
8617148.001
]
[Cites]
Gastroenterology. 2007 Aug;133(2):659-72
[
17681184.001
]
[Cites]
Dis Colon Rectum. 2004 Dec;47(12):2208-10
[
15657675.001
]
[Cites]
Semin Pediatr Surg. 2003 Feb;12(1):46-54
[
12520472.001
]
[Cites]
Nihon Geka Gakkai Zasshi. 1995 Jun;96(6):399-401
[
7666856.001
]
[Cites]
J Clin Pathol. 2004 Apr;57(4):428-31
[
15047751.001
]
[Cites]
Pathol Int. 2000 Feb;50(2):142-5
[
10792773.001
]
[Cites]
World J Gastroenterol. 2005 Aug 28;11(32):5072-4
[
16124070.001
]
[Cites]
J Comput Assist Tomogr. 1996 May-Jun;20(3):382-5
[
8626895.001
]
[Cites]
J Surg Oncol. 1992 Aug;50(4):274-7
[
1640716.001
]
[Cites]
Ann Surg. 1955 Apr;141(4):550-5
[
14362390.001
]
[Cites]
Acta Chir Belg. 1995 Nov-Dec;95(6):298-300
[
8571725.001
]
[Cites]
Radiographics. 1993 Sep;13(5):1063-80
[
8210590.001
]
[Cites]
Nihon Shokakibyo Gakkai Zasshi. 1999 Jun;96(6):664-9
[
10396938.001
]
[Cites]
Am Surg. 2005 Jun;71(6):522-5
[
16044936.001
]
[Cites]
Surgery. 1999 Nov;126(5):939-44
[
10568195.001
]
[Cites]
JOP. 2006 Mar 09;7(2):200-4
[
16525204.001
]
[Cites]
Hospital (Rio J). 1969 Jan;75(1):1-10
[
5304683.001
]
[Cites]
In Vivo. 2005 Nov-Dec;19(6):975-8
[
16277009.001
]
[Cites]
Nihon Shokakibyo Gakkai Zasshi. 1996 Jan;93(1):34-8
[
8642757.001
]
[Cites]
Australas Radiol. 2000 May;44(2):228-31
[
10849993.001
]
(PMID = 26193693.001).
[ISSN]
1865-7257
[Journal-full-title]
Clinical journal of gastroenterology
[ISO-abbreviation]
Clin J Gastroenterol
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Japan
[Keywords]
NOTNLM ; Adenocarcinoma / Alimentary tract duplication / Cancer development / Gastric duplication cyst
77.
Salla C, Chatzipantelis P, Konstantinou P, Karoumpalis I, Sakellariou S, Pantazopoulou A, Manika Z:
Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases.
JOP
; 2007;8(6):715-24
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Endoscopic ultrasound-guided fine-needle aspiration cytology in the
diagnosis of
intraductal papillary mucinous neoplasms of the
pancreas
. A study of 8 cases.
CONTEXT: Intraductal papillary mucinous neoplasm (IPMN) is an increasingly recognized neoplasm of the
pancreas
, accounting for 5% of
pancreatic
neoplasms, it is considered difficult to diagnose by fine-needle aspiration (FNA) cytology.
OBJECTIVE: The aim of this study was to investigate the role of EUS-guided FNA cytology in the
diagnosis of
IPMN of the
pancreas
.
EUS/clinical findings, macroscopic/microscopic features of cell blocks and smears, and immunocytochemical stains accompanied by histopathologic
diagnosis
were recorded and studied.
RESULTS: EUS revealed hypoechoic masses in the
head of pancreas
(n=6) and in the body/tail (n=2), measuring from 16.6 to 35.8 mm.
In all cases, the hypoechoic mass had a distinctive distribution, involving the main
pancreatic
duct and/or the associated large branch ducts while intraductal nodules or multiple cysts were detected.
The histological
diagnosis
confirmed the FNA cytology
diagnosis
: 3 malignant IPMNs, 2 benign IPMNs and 3 borderline IPMNs.
CONCLUSIONS: The characteristic pre-operative EUS findings and cytomorphologic features, in addition to the immunocytochemical profile, were accurate indications and coincided with the final/post-operative histological
diagnosis of
IPMN.
[MeSH-major]
Adenocarcinoma
, Mucinous /
diagnosis
.
Adenocarcinoma
, Mucinous / pathology.
Adenocarcinoma
, Papillary /
diagnosis
.
Adenocarcinoma
, Papillary / pathology.
Pancreatic
Neoplasms /
diagnosis
.
Pancreatic
Neoplasms / pathology
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
NCI CPTC Antibody Characterization Program.
NCI CPTC Antibody Characterization Program
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 17993724.001).
[ISSN]
1590-8577
[Journal-full-title]
JOP : Journal of the pancreas
[ISO-abbreviation]
JOP
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Italy
[Chemical-registry-number]
0 / Mucins; EC 2.7.10.1 / Receptor, ErbB-2
78.
Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N:
Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
Hepatogastroenterology
; 2006 May-Jun;53(69):447-51
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Nodal involvement is strongest predictor of poor survival in patients with invasive
adenocarcinoma of
the
head of
the
pancreas
.
BACKGROUND/AIMS:
Pancreatic cancer
is a devastating disease with an extremely poor prognosis.
The outcome of
pancreatic
head
cancer
after surgical resection is still difficult to predict.
METHODOLOGY: Between September 1992 and December 2003, 100 consecutive patients with invasive
adenocarcinoma of
the
head of
the
pancreas
who underwent surgical resection were retrospectively analyzed to clarify the influence of clinicopathological factors.
RESULTS: The overall 1-, 3-, and 5-year survival rates for the 100 patients with
pancreatic
head
cancer
were 55%, 16%, and 6%, respectively.
Among the 16 clinicopathologic factors, 9 were significantly associated with outcome in univariate analysis: tumor type (invasive ductal
cancer
), poor histological differentiation, extrapancreatic plexus invasion, bile duct invasion, duodenal invasion, intrapancreatic nerve invasion, lymphatic invasion, venous invasion, and nodal involvement.
CONCLUSIONS: Nodal involvement was the strongest predictor of poor survival after
pancreatic
resection for invasive
adenocarcinoma of
the
head of
the
pancreas
.
[MeSH-major]
Adenocarcinoma
/ mortality.
Adenocarcinoma
/ pathology. Lymph Nodes / pathology.
Pancreatic
Neoplasms / mortality.
Pancreatic
Neoplasms / pathology
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16795990.001).
[ISSN]
0172-6390
[Journal-full-title]
Hepato-gastroenterology
[ISO-abbreviation]
Hepatogastroenterology
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
Greece
79.
Agarwal B, Krishna NB, Labundy JL, Safdar R, Akduman EI:
EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct.
Gastrointest Endosc
; 2008 Aug;68(2):237-42; quiz 334, 335
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged
pancreatic
head
or dilated
pancreatic
duct with or without a dilated common bile duct.
BACKGROUND: Incidental findings of an enlarged
head of pancreas
(HOP) or dilated
pancreatic
duct (PD) with or without a dilated common bile duct (CBD) on CT or magnetic resonance imaging (MRI), in patients without obstructive jaundice, raise suspicion for a
pancreatic
neoplasm, but their clinical significance has not been established.
OBJECTIVE: To determine the prevalence of
pancreatic
neoplasm in this patient group.
The final
diagnosis
was based on definitive cytology, surgical pathology, and clinical follow-up.
INTERVENTIONS: An EUS examination was performed by using a radial echoendoscopy followed by a linear echoendoscopy, if a focal
pancreatic
lesion was identified.
(1) The prevalence of
pancreatic
neoplasms and (2) performance characteristics of EUS-FNA for identifying malignant neoplasm, in this patient group.
RESULTS: In 110 study patients, the final
diagnosis
included
adenocarcinoma
(n = 7),
pancreatic
intraepithelial neoplasia (n = 1), neuroendocrine tumor (n = 1), tumor metastasis (n = 1), and benign cyst (n = 3).
Thirty-two patients had EUS evidence of chronic pancreatitis, and, in the remaining 65 patients, the
pancreas
was normal.
The accuracy of EUS and EUS-FNA for diagnosing
pancreatic
neoplasm in these patients was 99.1%, with 88.8% sensitivity, 100% specificity, 99% negative predicative value, and 100% positive predictive value.
CONCLUSION: A
pancreatic
neoplasm is seen in a clinically significant number of patients with "enlarged HOP" or "dilated PD with or without a dilated CBD" but without obstructive jaundice.
EUS-FNA seems highly accurate for diagnosing
pancreatic
neoplasm in these patients.
[MeSH-major]
Adenocarcinoma
/
diagnosis
. Biopsy, Fine-Needle / methods. Diagnostic Imaging / methods. Endosonography / methods.
Pancreatic
Neoplasms /
diagnosis
[MeSH-minor]
Age Distribution. Aged. Cohort Studies. Common Bile Duct / pathology. Common Bile Duct / ultrasonography. Female. Humans. Immunohistochemistry. Incidence. Magnetic Resonance Imaging / methods. Male. Middle Aged.
Pancreatic
Ducts / pathology.
Pancreatic
Ducts / ultrasonography. Pancreatitis /
diagnosis
. Pancreatitis / epidemiology. Prognosis. Retrospective Studies. Risk Factors. Sensitivity and Specificity. Sex Distribution. Survival Analysis. Tomography, X-Ray Computed / methods
MedlinePlus Health Information.
consumer health - Diagnostic Imaging
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[CommentIn]
Endoscopy. 2010 Jan;42(1):68-72
[
20066593.001
]
(PMID = 18423464.001).
[ISSN]
1097-6779
[Journal-full-title]
Gastrointestinal endoscopy
[ISO-abbreviation]
Gastrointest. Endosc.
[Language]
eng
[Publication-type]
Comparative Study; Journal Article
[Publication-country]
United States
80.
Sparks DA, Chase DM, Forsyth M, Bogen G, Arnott J:
Late presentation of a mucinous ovarian adenocarcinoma which was initially diagnosed as a primary pancreatic carcinoma: a case report and review of the literature.
J Med Case Rep
; 2010;4:90
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Late presentation of a mucinous ovarian
adenocarcinoma
which was initially diagnosed as a primary
pancreatic
carcinoma: a case report and review of the literature.
INTRODUCTION:
Adenocarcinoma of
the ovary is an aggressive neoplasm which often metastasizes to the lung or liver.
Metastases rarely occur to the
pancreas
, but a tissue
diagnosis
is required to confirm this event.
Although most tumors of the
pancreas
are primary
pancreatic
neoplasms, metastatic lesions have been reported most commonly as arising from renal cell carcinoma.
CASE PRESENTATION: We report the case of a 51-year-old Caucasian woman with ovarian mucinous
adenocarcinoma
with metastasis to the
head of
the
pancreas
that was originally misdiagnosed as a
pancreatic
primary tumor.
CONCLUSION: Mucinous ovarian adenocarcinomas rarely metastasize to the
pancreas
.
New
pancreatic
lesions should be investigated through tissue biopsy and tumor markers, while keeping an open-minded differential
diagnosis
to avoid a misdiagnosis or a delay in treatment.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Surg Gynecol Obstet. 1989 Apr;168(4):345-7
[
2928909.001
]
[Cites]
Hum Pathol. 1988 Jan;19(1):57-63
[
3335391.001
]
[Cites]
Arch Gynecol Obstet. 2005 Jun;272(1):31-4
[
15480722.001
]
[Cites]
Am Surg. 2002 Apr;68(4):337-40; discussion 340-1
[
11952243.001
]
[Cites]
Am J Gastroenterol. 1996 Nov;91(11):2414-7
[
8931428.001
]
(PMID = 20298585.001).
[ISSN]
1752-1947
[Journal-full-title]
Journal of medical case reports
[ISO-abbreviation]
J Med Case Rep
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
[Other-IDs]
NLM/ PMC2851597
81.
Naitoh H, Shoji H, Ishikawa I, Watanabe R, Furuta Y, Tomozawa S, Igarashi H, Shinozaki S, Katsura H, Onozato R, Kudoh M:
Intraductal papillary mucinous tumor of the pancreas associated with autosomal dominant polycystic kidney disease.
J Gastrointest Surg
; 2005 Jul-Aug;9(6):843-5
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Intraductal papillary mucinous tumor of the
pancreas
associated with autosomal dominant polycystic kidney disease.
CT showed multiple cysts in the liver and both kidneys along with ADPKD and a cystic mass, 4 cm in diameter, in the
pancreatic
head
.
The main
pancreatic
duct was dilated to 1 cm in diameter.
Histologic examination revealed a multiloculated cystic tumor filled with mucin in the
head of
the
pancreas
.
Microscopically, the tumor was diagnosed as
adenocarcinoma
and was found to have invaded the main
pancreatic
duct.
Although, in addition to our case, only seven cases with association between ADPKD and malignant neoplasms have been reported, five of these cases had neoplasms arising from the
pancreas
.
Therefore, we suggest that some genetic interactions may exist between ADPKD and
pancreatic
carcinogenesis.
[MeSH-major]
Adenocarcinoma
, Mucinous /
diagnosis
. Carcinoma,
Pancreatic
Ductal /
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
. Pancreaticoduodenectomy / methods. Polycystic Kidney, Autosomal Dominant /
diagnosis
[MeSH-minor]
Abdominal Pain /
diagnosis
. Abdominal Pain / etiology. Acute Disease. Adult. Biopsy, Needle. Follow-Up Studies. Humans. Immunohistochemistry. Male. Pancreatitis /
diagnosis
. Pancreatitis / etiology. Risk Assessment. Tomography, X-Ray Computed. Treatment Outcome
Genetic Alliance.
consumer health - Kidney Disease
.
Genetic Alliance.
consumer health - Polycystic Kidney Disease
.
Genetic Alliance.
consumer health - Polycystic kidney disease, adult type
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Gastroenterol. 2001 Jun;36(6):422-8
[
11428590.001
]
[Cites]
Br J Surg. 2003 Oct;90(10):1244-9
[
14515294.001
]
[Cites]
Gastroenterology. 1997 Jun;112(6):2104-7
[
9178704.001
]
[Cites]
Am J Med. 1977 Apr;62(4):616-26
[
851133.001
]
[Cites]
Adv Nephrol Necker Hosp. 1985;14:1-20
[
2983516.001
]
(PMID = 15985242.001).
[ISSN]
1091-255X
[Journal-full-title]
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
[ISO-abbreviation]
J. Gastrointest. Surg.
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
United States
82.
Thayalasekaran S, Liddicoat H, Wood E:
Thrombophlebitis migrans in a man with pancreatic adenocarcinoma: a case report.
Cases J
; 2009;2:6610
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Thrombophlebitis migrans in a man with
pancreatic
adenocarcinoma
: a case report.
It is an acquired coagulopathy that is strongly associated with malignancy, especially solid tumours of the
adenocarcinoma
type.
Ultrasound demonstrated a mass in the
head of
the
pancreas
causing common bile duct obstruction.
Histology confirmed
pancreatic
adenocarcinoma
.
CONCLUSION: Thrombophlebitis migrans is more easily recognised in patients with an established
diagnosis of
malignancy than in situations where the thrombophlebitis is first diagnosed.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Clin Dermatol. 1993 Jan-Mar;11(1):159-63
[
8339192.001
]
[Cites]
Haemostasis. 1997;27 Suppl 1:38-43
[
9439757.001
]
[Cites]
Thromb Haemost. 2006 Mar;95(3):541-5
[
16525584.001
]
[Cites]
J Clin Invest. 2003 Sep;112(6):853-62
[
12975470.001
]
[Cites]
Circulation. 2003 Jun 17;107(23 Suppl 1):I17-21
[
12814981.001
]
(PMID = 19829832.001).
[ISSN]
1757-1626
[Journal-full-title]
Cases journal
[ISO-abbreviation]
Cases J
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
England
[Other-IDs]
NLM/ PMC2709970
83.
Schima W, Ba-Ssalamah A, Plank C, Kulinna-Cosentini C, Prokesch R, Tribl B, Sautner T, Niederle B:
[Pancreas. Part II: Tumors].
Radiologe
; 2006 May;46(5):421-37; quiz 438
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[
Pancreas
. Part II: Tumors].
Adenocarcinoma
is the most common malignant
pancreatic
tumor, affecting the
head
in 60-70% of cases.
By the time
of diagnosis
, approximately 80% of tumors are unresectable.
Helical CT is very effective in detection and staging
of adenocarcinoma
, with a sensitivity of 76-92% for detection and an accuracy of 80-90% for staging, but it has limitations in the detection of small cancers (< or =2 cm).
Gadolinium-enhanced 3D gradient-echo MRI is helpful in the assessment of vascular invasion of
cancer
and in determining the etiology of cystic lesions.
Diagnosis of
insulinoma is a challenge: they are <2 cm in 90% of cases and mostly hypervascular at CT or MRI.
This review summarizes the imaging features of the most common
pancreatic
tumors and discusses the limitations of CT, MRI and endosonography.
[MeSH-major]
Adenocarcinoma
/
diagnosis
. Magnetic Resonance Imaging / methods.
Pancreatic
Neoplasms /
diagnosis
. Tomography, X-Ray Computed / methods. Ultrasonography / methods
MedlinePlus Health Information.
consumer health - CT Scans
.
MedlinePlus Health Information.
consumer health - MRI Scans
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
MedlinePlus Health Information.
consumer health - Ultrasound
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Radiology. 2003 Oct;229(1):81-90
[
14519871.001
]
[Cites]
Br J Radiol. 1998 Nov;71(851):1208-14
[
10434919.001
]
[Cites]
AJR Am J Roentgenol. 2002 Sep;179(3):717-24
[
12185052.001
]
[Cites]
Gastrointest Endosc. 2002 Aug;56(2):218-24
[
12145600.001
]
[Cites]
Abdom Imaging. 1997 Jul-Aug;22(4):429-33
[
9157866.001
]
[Cites]
Ann Surg. 2005 Sep;242(3):413-9; discussion 419-21
[
16135927.001
]
[Cites]
Ann Intern Med. 2004 Nov 16;141(10 ):753-63
[
15545675.001
]
[Cites]
Ann Surg. 1997 Oct;226(4):393-405; discussion 405-7
[
9351708.001
]
[Cites]
Clin Radiol. 1982 May 3;33(3):297-9
[
7075134.001
]
[Cites]
Radiologe. 2003 Apr;43(4):293-300
[
12721645.001
]
[Cites]
J Comput Assist Tomogr. 2005 Jul-Aug;29(4):438-45
[
16012297.001
]
[Cites]
N Engl J Med. 1992 Feb 13;326(7):455-65
[
1732772.001
]
[Cites]
Radiologe. 2003 Apr;43(4):301-5
[
12721646.001
]
[Cites]
J Clin Gastroenterol. 2001 Mar;32(3):231-4
[
11246351.001
]
[Cites]
Radiologe. 1998 Apr;38(4):279-86
[
9622822.001
]
[Cites]
Gastroenterology. 2004 May;126(5):1330-6
[
15131794.001
]
[Cites]
Radiology. 2000 Jul;216(1):163-71
[
10887243.001
]
[Cites]
Radiology. 1991 Aug;180(2):337-9
[
1906189.001
]
[Cites]
N Engl J Med. 1993 May 20;328(20):1433-7
[
8479461.001
]
[Cites]
AJR Am J Roentgenol. 2004 Mar;182(3):619-23
[
14975959.001
]
[Cites]
AJR Am J Roentgenol. 2000 Feb;174(2):441-7
[
10658722.001
]
[Cites]
Br J Radiol. 2000 Nov;73(875):1165-9
[
11144793.001
]
[Cites]
AJR Am J Roentgenol. 2003 Oct;181(4):987-92
[
14500214.001
]
[Cites]
Ann Surg. 1990 Apr;211(4):447-58
[
2322039.001
]
[Cites]
Radiology. 1993 Mar;186(3):795-8
[
8430190.001
]
[Cites]
Wien Klin Wochenschr. 2004 Jun 30;116(11-12):373-8
[
15291289.001
]
[Cites]
AJR Am J Roentgenol. 1999 Dec;173(6):1513-8
[
10584794.001
]
[Cites]
AJR Am J Roentgenol. 1998 May;170(5):1315-22
[
9574609.001
]
[Cites]
Radiology. 1988 Feb;166(2):413-6
[
3336716.001
]
[Cites]
Radiology. 2002 Sep;224(3):764-8
[
12202711.001
]
[Cites]
Int J Cancer. 1994 Nov 15;59(4):494-504
[
7960219.001
]
[Cites]
Br J Radiol. 1998 May;71(845):492-6
[
9691893.001
]
[Cites]
Eur J Radiol. 2001 May;38(2):78-93
[
11335090.001
]
[Cites]
Eur Radiol. 2001;11(10 ):1939-51
[
11702126.001
]
[Cites]
Eur J Radiol. 2001 May;38(2):113-9
[
11335093.001
]
[Cites]
Radiology. 2002 Dec;225(3):759-65
[
12461258.001
]
[Cites]
Radiographics. 1999 Nov-Dec;19(6):1447-63
[
10555668.001
]
[Cites]
Radiology. 1991 Jan;178(1):95-9
[
1984331.001
]
[Cites]
AJR Am J Roentgenol. 2000 Mar;174(3):677-84
[
10701608.001
]
[Cites]
Clin Radiol. 1994 May;49(5):295-303
[
8013189.001
]
[Cites]
Eur Radiol. 2002 Dec;12(12):2998-3008
[
12439582.001
]
[Cites]
Radiology. 2000 Dec;217(3):757-64
[
11110940.001
]
[Cites]
AJR Am J Roentgenol. 2004 Feb;182(2):419-25
[
14736675.001
]
[Cites]
Radiology. 1992 Apr;183(1):87-95
[
1312736.001
]
[Cites]
Arch Surg. 1990 Feb;125(2):230-3
[
2154172.001
]
[Cites]
AJR Am J Roentgenol. 1999 Jun;172(6):1555-9
[
10350288.001
]
[Cites]
Ann Oncol. 1999;10 Suppl 4:1-3
[
10436773.001
]
[Cites]
Radiology. 1997 Mar;202(3):655-62
[
9051012.001
]
[Cites]
J Magn Reson Imaging. 2000 Aug;12 (2):261-8
[
10931589.001
]
[Cites]
Wien Klin Wochenschr. 2003;115 Suppl 2:10-8
[
15518140.001
]
[Cites]
Radiographics. 2001 Mar-Apr;21(2):323-37; discussion 337-40
[
11259696.001
]
[Cites]
AJR Am J Roentgenol. 1997 Jun;168(6):1439-43
[
9168704.001
]
[Cites]
J Natl Cancer Inst. 1997 Mar 19;89(6):442-6
[
9091646.001
]
[Cites]
Radiologe. 1999 Jul;39(7):568-77
[
10472085.001
]
[Cites]
World J Surg. 1999 Sep;23(9):913-9
[
10449820.001
]
[Cites]
Surg Clin North Am. 1995 Oct;75(5):1001-16
[
7660245.001
]
[Cites]
J Comput Assist Tomogr. 1996 Mar-Apr;20(2):249-53
[
8606232.001
]
[Cites]
Rofo. 2004 Nov;176(11):1624-33
[
15497081.001
]
[Cites]
J Comput Assist Tomogr. 2002 Jan-Feb;26(1):126-8
[
11801915.001
]
[Cites]
J Comput Assist Tomogr. 2002 Sep-Oct;26(5):743-9
[
12439309.001
]
[Cites]
Radiology. 1995 Nov;197(2):381-5
[
7480681.001
]
[Cites]
Eur Radiol. 2001;11(7):1175-83
[
11471608.001
]
[Cites]
Cancer. 2003 Oct 25;99(5):285-92
[
14579295.001
]
(PMID = 16715226.001).
[ISSN]
0033-832X
[Journal-full-title]
Der Radiologe
[ISO-abbreviation]
Radiologe
[Language]
ger
[Publication-type]
English Abstract; Journal Article; Review
[Publication-country]
Germany
[Number-of-references]
66
84.
Sugiyama Y, Tanno S, Nishikawa T, Nakamura K, Sasajima J, Koizumi K, Mizukami Y, Karasaki H, Kasai S, Yoshida Y, Watanabe N, Okumura T, Kohgo Y:
[A case of pancreatic carcinoma presenting as pancreaticopleural fistula with pancreatic pleural effusion].
Nihon Shokakibyo Gakkai Zasshi
; 2010 May;107(5):784-91
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[A case of
pancreatic
carcinoma presenting as pancreaticopleural fistula with
pancreatic
pleural effusion].
A
diagnosis of
pancreaticopleural fistula was made, based on the findings of magnetic resonance cholangiopancreatography and endoscopic retrograde pancreatography (ERP).
After the placement of an endoscopic naso-
pancreatic
drainage tube, the pleural effusion markedly reduced.
When ERP was performed for internal drainage, the main
pancreatic
duct and stricture were biopsied and showed
pancreatic
ductal
adenocarcinoma
histologically.
CT revealed a mass in the
head of
the
pancreas
.
To the best of our knowledge this is the first case of
pancreatic
carcinoma presenting as pancreaticopleural fistula with
pancreatic
pleural effusion.
Clinicians should pay attention to the possible presence of
cancer
and pancreaticopleural fistula in patients with
pancreatic
pleural effusion.
[MeSH-major]
Adenocarcinoma
/
diagnosis
. Fistula /
diagnosis
.
Pancreatic
Fistula /
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
. Pleural Diseases /
diagnosis
. Pleural Effusion / complications
[MeSH-minor]
Diagnosis
, Differential. Humans. Male. Middle Aged
MedlinePlus Health Information.
consumer health - Fistulas
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
MedlinePlus Health Information.
consumer health - Pleural Disorders
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20460853.001).
[ISSN]
0446-6586
[Journal-full-title]
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
[ISO-abbreviation]
Nihon Shokakibyo Gakkai Zasshi
[Language]
jpn
[Publication-type]
Case Reports; English Abstract; Journal Article; Review
[Publication-country]
Japan
[Number-of-references]
17
85.
Ho Kim D, Shiozawa S, Tsuchiya A, Usui T, Inose S, Aizawa M, Yoshimatsu K, Katsube T, Naritaka Y, Ogawa K:
[A case of drug-induced interstitial pneumonitis after adjuvant chemotherapy with gemcitabine for pancreatic cancer].
Gan To Kagaku Ryoho
; 2008 Jan;35(1):133-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[A case of drug-induced interstitial pneumonitis after adjuvant chemotherapy with gemcitabine for
pancreatic cancer
].
The patient was a 48-year-old male who underwent pancreaticoduodenectomy with portal vein resection for ductal
adenocarcinoma of
the
pancreas head
.
[MeSH-major]
Deoxycytidine / analogs & derivatives. Lung Diseases, Interstitial / complications.
Pancreatic
Neoplasms / drug therapy
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Interstitial Lung Diseases
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18195543.001).
[ISSN]
0385-0684
[Journal-full-title]
Gan to kagaku ryoho. Cancer & chemotherapy
[ISO-abbreviation]
Gan To Kagaku Ryoho
[Language]
jpn
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Japan
[Chemical-registry-number]
0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine
86.
Ohtsubo K, Watanabe H, Okada G, Tsuchiyama T, Mouri H, Yamaguchi Y, Motoo Y, Okai T, Amaya K, Kitagawa H, Ohta T, Gabata T, Matsuda K, Ohta H, Sawabu N:
A case of pancreatic cancer with formation of a mass mimicking alcoholic or autoimmune pancreatitis in a young man. Possibility of diagnosis by hypermethylation of pure pancreatic juice.
JOP
; 2008;9(1):37-45
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
A case of
pancreatic cancer
with formation of a mass mimicking alcoholic or autoimmune pancreatitis in a young man. Possibility
of diagnosis
by hypermethylation of pure
pancreatic
juice.
There have been some cases of an ambiguous
diagnosis
although care was taken to differentiate between alcoholic mass-forming pancreatitis, focal type autoimmune pancreatitis and
pancreatic cancer
.
CASE REPORT: We report a case of
pancreatic cancer
mimicking alcoholic or autoimmune pancreatitis with the formation of a mass in a 32-year-old man with a history of heavy drinking.
After he stopped drinking, abdominal computed tomography showed a
pancreatic
head
mass 28 mm in diameter with little and weak enhancement in the early and delayed phases, respectively.
Endoscopic retrograde cholangiopancreatography showed an obstruction of the main
pancreatic
duct in the
pancreatic
head
and marked stenosis of the lower common bile duct.
Although a percutaneous ultrasound-guided
pancreatic
biopsy demonstrated no evidence of autoimmune pancreatitis, he was treated with prednisolone to test the efficacy of steroid therapy.
However, the
pancreatic
mass became enlarged after steroid therapy, and he underwent surgery during which the mass was found to be
pancreatic cancer
.
We retrospectively assessed DNA hypermethylation in the patient's pure
pancreatic
juice obtained on admission.
We observed hypermethylation of the
cancer
-specific gene tissue factor pathway inhibitor 2 (TFPI2).
CONCLUSION: This finding suggests that if the DNA hypermethylation of pure
pancreatic
juice had been assayed before steroid therapy, it would have supported the
diagnosis of
pancreatic cancer
, and steroid therapy could have been avoided.
[MeSH-major]
Adenocarcinoma
/
diagnosis
. Autoimmune Diseases /
diagnosis
. DNA Methylation.
Pancreatic
Juice / physiology.
Pancreatic
Neoplasms /
diagnosis
. Pancreatitis, Alcoholic /
diagnosis
[MeSH-minor]
Adult. Biopsy. Cholangiopancreatography, Endoscopic Retrograde.
Diagnosis
, Differential. Fatal Outcome. Glycoproteins / genetics. Humans. Male. Ultrasonography
Genetic Alliance.
consumer health - Pancreatic cancer
.
Genetic Alliance.
consumer health - Pancreatitis
.
MedlinePlus Health Information.
consumer health - Autoimmune Diseases
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 18182742.001).
[ISSN]
1590-8577
[Journal-full-title]
JOP : Journal of the pancreas
[ISO-abbreviation]
JOP
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Italy
[Chemical-registry-number]
0 / Glycoproteins; 0 / tissue-factor-pathway inhibitor 2
87.
Okada K, Furuuchi T, Tamada T, Sasaki T, Suwa T, Shatari T, Takenaka Y, Hori M, Sakuma M:
Pancreatobiliary fistula associated with an intraductal papillary-mucinous pancreatic neoplasm manifesting as obstructive jaundice: report of a case.
Surg Today
; 2008;38(4):371-6
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Pancreatobiliary fistula associated with an intraductal papillary-mucinous
pancreatic
neoplasm manifesting as obstructive jaundice: report of a case.
We report a pancreatobiliary fistula caused by an intraductal papillary-mucinous
pancreatic
neoplasm (IPMN), manifesting as obstructive jaundice.
Computed tomography showed dilatation of the bile duct and main
pancreatic
duct, with multiple cystic masses in the
head of
the
pancreas
.
Pancreatogram and magnetic resonance cholangiopancreatography showed diffuse dilatation of the main
pancreatic
duct and side branches without communication with the adjacent organs or duct.
We performed pancreaticoduodenectomy for IPMN of the
pancreatic
head
and a tumor-like lesion in the lower common bile duct (CBD).
Macroscopically, impacted thick mucus protruded into the CBD from the
pancreas
via a pancreatobiliary fistula.
Histologic examination revealed a pancreatobiliary fistula caused by intraductal papillary-mucinous carcinoma of the
pancreas
with mucin hypersecretion, an adenoma without interstitial infiltration, and isolated implantation of an IPMN in the bile duct mucosa around the fistula.
[MeSH-major]
Adenocarcinoma
, Mucinous / complications. Biliary Fistula / complications. Carcinoma, Papillary / complications. Jaundice, Obstructive / etiology.
Pancreatic
Fistula / complications.
Pancreatic
Neoplasms / complications. Pancreaticoduodenectomy / methods
[MeSH-minor]
Aged. Cholangiopancreatography, Endoscopic Retrograde.
Diagnosis
, Differential. Follow-Up Studies. Humans. Male
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Am J Surg Pathol. 2004 Aug;28(8):977-87
[
15252303.001
]
[Cites]
Nihon Shokakibyo Gakkai Zasshi. 1993 Dec;90(12):3081-9
[
8283821.001
]
[Cites]
Nihon Shokakibyo Gakkai Zasshi. 1985 Apr;82(4):685-90
[
4021171.001
]
[Cites]
Rom J Gastroenterol. 2005 Jun;14 (2):169-72
[
15990938.001
]
[Cites]
Am J Surg. 2000 May;179(5):349-51
[
10930477.001
]
[Cites]
Pancreatology. 2006;6(1-2):17-32
[
16327281.001
]
[Cites]
Am J Surg Pathol. 2001 May;25(5):579-86
[
11342768.001
]
[Cites]
Cancer. 1993 Aug 1;72(3):689-96
[
8392902.001
]
[Cites]
Hepatogastroenterology. 2000 Jul-Aug;47(34):1164-7
[
11020905.001
]
[Cites]
Arch Pathol Lab Med. 1995 Mar;119(3):197-8
[
7887770.001
]
[Cites]
Endoscopy. 2004 Feb;36(2):186-9
[
14765321.001
]
[Cites]
Gastroenterology. 1996 Jun;110(6):1909-18
[
8964418.001
]
[Cites]
Int J Gastrointest Cancer. 2003;34(2-3):101-6
[
15361642.001
]
[Cites]
World J Surg Oncol. 2005 Oct 19;3:70
[
16232325.001
]
[Cites]
Hepatogastroenterology. 1996 May-Jun;43(9):692-709
[
8799417.001
]
(PMID = 18368332.001).
[ISSN]
0941-1291
[Journal-full-title]
Surgery today
[ISO-abbreviation]
Surg. Today
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Japan
88.
Funamizu N, Aramaki M, Matsumoto T, Inomata M, Shibata K, Himeno Y, Yada K, Hirano S, Sasaki A, Kawano K, Kitano S:
Groove pancreatic carcinoma.
Hepatogastroenterology
; 2009 Nov-Dec;56(96):1742-4
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Groove
pancreatic
carcinoma.
The groove area is localized between the
head of
the
pancreas
, the duodenum, and the common bile duct.
Differentiating of groove pancreatitis from
pancreatic
carcinoma is often difficult.
Herein, we report a 54-year-old woman with groove
pancreatic
adenocarcinoma
presenting epigastralgia, jaundice, and vomiting.
The
diagnosis
was confirmed by computed tomography (CT), endoscopic retrograde cholangiopancreatography (ERCP), and endoscopic biopsy.
Microscopically, well-differentiated
adenocarcinoma
was mainly located in Santorini's duct, but there was no invasion to the main
pancreatic
duct.
It is very difficult to differentiate groove
pancreatic
carcinoma from groove pancreatitis.
To avoid unnecessary surgical treatment, endoscopic biopsy and observation of the duodenum are useful for
diagnosis
.
However, keeping in mind the differential
diagnosis of
pancreatic
head
carcinoma is necessary.
[MeSH-major]
Adenocarcinoma
/
diagnosis
.
Pancreatic
Neoplasms /
diagnosis
[MeSH-minor]
Diagnosis
, Differential. Female. Humans. Middle Aged. Pancreatitis, Chronic /
diagnosis
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 20214229.001).
[ISSN]
0172-6390
[Journal-full-title]
Hepato-gastroenterology
[ISO-abbreviation]
Hepatogastroenterology
[Language]
eng
[Publication-type]
Case Reports; Journal Article
[Publication-country]
Greece
89.
Fukushima N, Mukai K:
[Pathologic characteristics and evaluation of the pancreatic cancer].
Gan To Kagaku Ryoho
; 2005 May;32(5):599-604
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Pathologic characteristics and evaluation of the
pancreatic cancer
].
Ductal
adenocarcinoma
is the most common tumor type of
cancer
of the
pancreas
.
It is generally a poorly demarcated, white to grey-solid tumor located in the
pancreatic
head
.
Histologically, it is often well-to moderately-differentiated tubular
adenocarcinoma
along with marked desmoplastic change.
There are three well-defined precursors to invasive
cancer
; mucinous cystic neoplasms (MCNs), intraductal papillary mucinous neoplasms (IPMNs), and
pancreatic
intraepithelial neoplasia PanINs.
PanIN is now considered to be a precursor of
pancreatic
ductal
adenocarcinoma
based on molecular studies.
IPMNs and MCNs can form similar invasive carcinomas such as tubular
adenocarcinoma
and/or mucinous carcinoma.
Careful attention should be paid to the processes and/or criteria of pathologic
diagnosis
.
[MeSH-major]
Adenocarcinoma
/ pathology. Carcinoma,
Pancreatic
Ductal / pathology.
Pancreatic
Neoplasms / pathology
[MeSH-minor]
Adenocarcinoma
, Mucinous / pathology. Cystadenocarcinoma, Mucinous / pathology. DNA-Binding Proteins / genetics.
Diagnosis
, Differential. Gene Expression Regulation, Neoplastic. Humans. Lymphatic Metastasis. Smad4 Protein. Trans-Activators / genetics
Genetic Alliance.
consumer health - Pancreatic cancer
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
NCI CPTAC Assay Portal.
NCI CPTAC Assay Portal
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 15918557.001).
[ISSN]
0385-0684
[Journal-full-title]
Gan to kagaku ryoho. Cancer & chemotherapy
[ISO-abbreviation]
Gan To Kagaku Ryoho
[Language]
jpn
[Publication-type]
English Abstract; Journal Article
[Publication-country]
Japan
[Chemical-registry-number]
0 / DNA-Binding Proteins; 0 / SMAD4 protein, human; 0 / Smad4 Protein; 0 / Trans-Activators
90.
Calabrese L, Jereczek-Fossa BA, Jassem J, Rocca A, Bruschini R, Orecchia R, Chiesa F:
Diagnosis and management of neck metastases from an unknown primary.
Acta Otorhinolaryngol Ital
; 2005 Feb;25(1):2-12
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
Diagnosis
and management of neck metastases from an unknown primary.
Metastases in the upper and middle neck (levels I-II-III-V) are generally attributed to
head
and neck cancers, whereas the lower neck (level IV) involvement is often associated with primaries below the clavicles.
Diagnostic procedures include a careful clinical evaluation and a fiberoptic endoscopic examination of the
head
and neck mucosa, biopsies from all suspicious sites or blindly from the sites of possible origin of the primary, computerized tomography scan, and magnetic resonance.
Thoracic, and abdominal primaries (especially from lung, oesophagus, stomach, ovary or
pancreas
) should be sought in the case
of adenocarcinoma
and involvement of the lower neck.
[MeSH-major]
Carcinoma, Squamous Cell /
diagnosis
. Carcinoma, Squamous Cell / secondary.
Head
and Neck Neoplasms /
diagnosis
.
Head
and Neck Neoplasms / secondary. Neoplasms, Unknown Primary
Genetic Alliance.
consumer health - Diagnosis Unknown
.
MedlinePlus Health Information.
consumer health - Head and Neck Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
Ann Oncol. 2003 Feb;14(2):191-6
[
12562643.001
]
[Cites]
Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):411-6
[
12634970.001
]
[Cites]
Eur Arch Otorhinolaryngol. 2003 Sep;260(8):436-43
[
12684829.001
]
[Cites]
Eur Arch Otorhinolaryngol. 2003 Oct;260(9):490-3
[
12739031.001
]
[Cites]
Cancer Treat Rev. 2004 Apr;30(2):153-64
[
15023433.001
]
[Cites]
N Engl J Med. 2004 May 6;350(19):1937-44
[
15128893.001
]
[Cites]
N Engl J Med. 2004 May 6;350(19):1945-52
[
15128894.001
]
[Cites]
Cancer Treat Rev. 2004 Jun;30(4):369-84
[
15145511.001
]
[Cites]
Cancer. 1973 Apr;31(4):854-9
[
4706050.001
]
[Cites]
Radiology. 1974 Mar;110(3):659-63
[
4130047.001
]
[Cites]
Am J Surg. 1977 Oct;134(4):517-22
[
911038.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1979 Jan;5(1):73-6
[
422418.001
]
[Cites]
Clin Radiol. 1980 May;31(3):355-8
[
7428277.001
]
[Cites]
Radiology. 1984 Sep;152(3):749-53
[
6463256.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1986 May;12(5):733-40
[
3710857.001
]
[Cites]
Otolaryngol Head Neck Surg. 1986 Jun;94(5):605-10
[
3088524.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1986 Dec;12(12):2101-10
[
3793546.001
]
[Cites]
Otolaryngol Head Neck Surg. 2001 Mar;124(3):331-3
[
11241001.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):55-63
[
11316546.001
]
[Cites]
Acta Oncol. 2001;40(1):24-8
[
11321655.001
]
[Cites]
Radiother Oncol. 2001 Jun;59(3):319-21
[
11369074.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):727-33
[
11395241.001
]
[Cites]
Ann Oncol. 2001 Apr;12(4):535-40
[
11398889.001
]
[Cites]
ORL J Otorhinolaryngol Relat Spec. 2001 Jul-Aug;63(4):214-6
[
11408815.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):4-9
[
11516844.001
]
[Cites]
Ann Oncol. 2001 Aug;12(8):1057-8
[
11583184.001
]
[Cites]
Ann Oncol. 2001 Nov;12(11):1605-9
[
11822762.001
]
[Cites]
Laryngoscope. 1987 Sep;97(9):1080-4
[
3626734.001
]
[Cites]
Cancer. 1989 Jul 15;64(2):510-5
[
2736495.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1990 Feb;18(2):289-94
[
2303361.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):919-28
[
2211260.001
]
[Cites]
Am J Surg. 1990 Oct;160(4):443-6
[
2221252.001
]
[Cites]
Arch Otolaryngol Head Neck Surg. 1990 Dec;116(12):1388-93
[
2248737.001
]
[Cites]
Head Neck. 1990 Nov-Dec;12(6):463-9
[
2258284.001
]
[Cites]
Head Neck. 1991 May-Jun;13(3):177-83
[
2037468.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1992;23(4):743-9
[
1618667.001
]
[Cites]
Laryngoscope. 1992 Aug;102(8):884-90
[
1495353.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1993 Mar 15;25(4):619-22
[
8454479.001
]
[Cites]
Cancer. 1993 Sep 1;72(5):1756-61
[
8348505.001
]
[Cites]
Head Neck. 1994 Jan-Feb;16(1):58-63
[
8125789.001
]
[Cites]
Cancer Treat Rev. 1994 Apr;20(2):119-47
[
8156538.001
]
[Cites]
J Clin Oncol. 1994 Jun;12(6):1272-80
[
8201389.001
]
[Cites]
Am J Surg. 1994 Nov;168(5):395-9
[
7977958.001
]
[Cites]
Laryngoscope. 1995 May;105(5 Pt 1):548-50
[
7760677.001
]
[Cites]
Head Neck. 1995 May-Jun;17(3):190-8
[
7782203.001
]
[Cites]
Eur Arch Otorhinolaryngol. 1995;252(4):222-8
[
7546677.001
]
[Cites]
Radiother Oncol. 1995 Jun;35(3):206-11
[
7480823.001
]
[Cites]
Radiology. 1996 Jun;199(3):761-6
[
8638002.001
]
[Cites]
J Laryngol Otol. 1996 Apr;110(4):353-6
[
8733457.001
]
[Cites]
Ann Otolaryngol Chir Cervicofac. 1996;113(4):212-8
[
9033687.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):797-802
[
9128954.001
]
[Cites]
Strahlenther Onkol. 1997 Jul;173(7):362-8
[
9265258.001
]
[Cites]
Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):291-6
[
9308930.001
]
[Cites]
Clin Oncol (R Coll Radiol). 1997;9(5):322-9
[
9368728.001
]
[Cites]
Am J Clin Oncol. 1998 Apr;21(2):121-5
[
9537194.001
]
[Cites]
Clin Otolaryngol Allied Sci. 1998 Apr;23(2):158-63
[
9597287.001
]
[Cites]
Laryngoscope. 1998 Oct;108(10):1578-83
[
9778305.001
]
[Cites]
Head Neck. 1998 Dec;20(8):674-81
[
9790287.001
]
[Cites]
Head Neck. 1998 Dec;20(8):739-44
[
9790297.001
]
[Cites]
Laryngoscope. 1998 Nov;108(11 Pt 1):1605-10
[
9818813.001
]
[Cites]
Radiother Oncol. 1998 Oct;49(1):33-40
[
9886695.001
]
[Cites]
J Natl Cancer Inst. 1999 Apr 7;91(7):599-604
[
10203278.001
]
[Cites]
Cancer. 1999 Jul 1;86(1):114-8
[
10391570.001
]
[Cites]
Ann Otol Rhinol Laryngol. 1999 Jul;108(7 Pt 1):700-4
[
10435932.001
]
[Cites]
Cancer J Sci Am. 1999 Jul-Aug;5(4):214-8
[
10439166.001
]
[Cites]
Oncologist. 2005 Mar;10(3):215-24
[
15793225.001
]
[Cites]
Otolaryngol Head Neck Surg. 2000 Jan;122(1):52-5
[
10629482.001
]
[Cites]
Int J Hyperthermia. 2000 Jan-Feb;16(1):85-93
[
10669319.001
]
[Cites]
Aust N Z J Surg. 2000 Apr;70(4):263-8
[
10779057.001
]
[Cites]
J Natl Cancer Inst. 2000 May 3;92(9):709-20
[
10793107.001
]
[Cites]
Radiother Oncol. 2000 May;55(2):121-9
[
10799723.001
]
[Cites]
J Nucl Med. 2000 May;41(5):816-22
[
10809197.001
]
[Cites]
Nihon Jibiinkoka Gakkai Kaiho. 2000 May;103(5):524-8
[
10853340.001
]
[Cites]
Head Neck. 2000 Jul;22(4):336-40
[
10862015.001
]
[Cites]
Ned Tijdschr Geneeskd. 2000 Jul 8;144(28):1355-60
[
10923158.001
]
[Cites]
Otolaryngol Head Neck Surg. 2000 Sep;123(3):294-301
[
10964310.001
]
[Cites]
Otolaryngol Pol. 2000;54 Suppl 31:258-61
[
10974901.001
]
[Cites]
Head Neck. 2002 Mar;24(3):236-46
[
11891955.001
]
[Cites]
Acta Otorhinolaryngol Belg. 2002;56(1):77-82
[
11894635.001
]
[Cites]
Head Neck. 2002 Apr;24(4):361-9
[
11933178.001
]
[Cites]
Curr Opin Oncol. 2002 May;14(3):323-9
[
11981279.001
]
[Cites]
Eur Arch Otorhinolaryngol. 2002 Jul;259(6):325-33
[
12115082.001
]
[Cites]
Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):1024-30
[
12173016.001
]
[Cites]
Acta Otolaryngol. 2002 Jul;122(5):569-74
[
12206272.001
]
[Cites]
Cancer Control. 2002 Sep-Oct;9(5):387-99
[
12410178.001
]
[Cites]
Laryngoscope. 2002 Nov;112(11):2009-14
[
12439171.001
]
[Cites]
Bull Cancer. 2002 Oct;89(10):869-75
[
12441278.001
]
[Cites]
Br J Oral Maxillofac Surg. 2002 Dec;40(6):484-7
[
12464205.001
]
[Cites]
J Clin Oncol. 2002 Dec 15;20(24):4679-83
[
12488413.001
]
[Cites]
Head Neck. 2003 Feb;25(2):138-45
[
12509797.001
]
[Cites]
Acta Otorrinolaringol Esp. 2002 Oct;53(8):601-6
[
12530200.001
]
(PMID = 16080309.001).
[ISSN]
0392-100X
[Journal-full-title]
Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale
[ISO-abbreviation]
Acta Otorhinolaryngol Ital
[Language]
eng
[Publication-type]
Journal Article; Review
[Publication-country]
Italy
[Number-of-references]
102
[Other-IDs]
NLM/ PMC2639847
91.
Khan AZ, Miles WF, Singh KK:
Initial experience with laparoscopic bypass for upper gastrointestinal malignancy: a new option for palliation of patients with advanced upper gastrointestinal tumors.
J Laparoendosc Adv Surg Tech A
; 2005 Aug;15(4):374-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
PATIENTS AND METHODS: Between August 2000 and April 2002 laparoscopic gastric and biliary bypass concurrently or alone was attempted in 19 consecutive patients with unresectable carcinoma of the
head of
the
pancreas
,
adenocarcinoma of
the stomach, cholangiocarcinoma of the distal common bile duct, or
adenocarcinoma of
the duodenum.
MedlinePlus Health Information.
consumer health - Palliative Care
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16108739.001).
[ISSN]
1092-6429
[Journal-full-title]
Journal of laparoendoscopic & advanced surgical techniques. Part A
[ISO-abbreviation]
J Laparoendosc Adv Surg Tech A
[Language]
eng
[Publication-type]
Journal Article
[Publication-country]
United States
92.
Benedix F, Lippert H, Meyer F:
[Acute inguinal swelling--unusual presentation of postoperative necrotising pancreatitis].
Zentralbl Chir
; 2009 Apr;134(2):186-8
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
We report on a 61-year-old male who underwent explorative laparotomy for
pancreatic
tumour.
Intraoperatively, the
diagnosis of
a locally advanced carcinoma of the
head of
the
pancreas
was confirmed histologically.
[MeSH-major]
Adenocarcinoma
/ surgery. Edema / surgery. Inguinal Canal / surgery.
Pancreatic
Neoplasms / surgery. Pancreatitis, Acute Necrotizing / surgery. Postoperative Complications / surgery
[MeSH-minor]
Abdominal Abscess /
diagnosis
. Abdominal Abscess / pathology. Abdominal Abscess / surgery.
Diagnosis
, Differential. Hernia, Inguinal /
diagnosis
. Humans. Male. Middle Aged. Neoplasm Invasiveness. Reoperation
Genetic Alliance.
consumer health - Pancreatitis
.
MedlinePlus Health Information.
consumer health - After Surgery
.
MedlinePlus Health Information.
consumer health - Edema
.
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 19382054.001).
[ISSN]
0044-409X
[Journal-full-title]
Zentralblatt für Chirurgie
[ISO-abbreviation]
Zentralbl Chir
[Language]
ger
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
Germany
93.
Yang YM, Wan YL, Tian XD, Zhuang Y, Huang YT:
[Outcome of extended retroperitoneal lymphadenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 2005 Oct;27(5):568-71
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
[Title]
[Outcome of extended retroperitoneal lymphadenectomy in the surgical treatment
of adenocarcinoma
of the
head of
the
pancreas
].
OBJECTIVE: To evaluate the clinical outcome of extended retroperitoneal lymphadenectomy as surgical therapy for
adenocarcinoma of
the
head of
the
pancreas
.
METHODS: Twenty patients with
adenocarcinoma of
the
head of
the
pancreas
were treated by standard pancreatoduodenectomy (standard group) between 1994 and 1997, and 46 patients with the same disease underwent extended retroperitoneal lymphadenectomy associated with standard pancreatoduodenectomy (radical group) between 1998 and 2002.
Of the 46 patients in the radical group, 26.09% (12/46) had metastatic
adenocarcinoma
in the resected retroperitoneal lymph nodes.
[MeSH-major]
Adenocarcinoma
/ surgery. Lymph Node Excision / methods.
Pancreatic
Neoplasms / surgery
MedlinePlus Health Information.
consumer health - Pancreatic Cancer
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16274033.001).
[ISSN]
1000-503X
[Journal-full-title]
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
[ISO-abbreviation]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
[Language]
chi
[Publication-type]
English Abstract; Journal Article
[Publication-country]
China
94.
Bakouboula B, Morel O, Douchet MP, Chauvin M:
[Reversible cardiogenic shock under 5-fluorouracil treatment].
Ann Cardiol Angeiol (Paris)
; 2005 Aug;54(4):216-9
[Fulltext service]
Get downloadable
fulltext PDFs
of
articles closely matching to this article
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
5-fluorouracil, an antimetabolite agent, has been widely used since 1957 for treatment of varied types of
cancer
such as gastro-intestinal,
pancreas
, breast, lung,
head
and neck malignancies.
The following clinical case represents a potentially serious and rare case of completely reversible cardiogenic shock in a patient with a colo-rectal
cancer
.
A better knowledge of these complications could reduce cases of death by an earlier
diagnosis
, and a better evaluation of patients with high cardiotoxicity risk.
[MeSH-minor]
Adenocarcinoma
/ drug therapy. Antineoplastic Combined Chemotherapy Protocols / adverse effects. Cardiotonic Agents / therapeutic use. Colorectal Neoplasms / drug therapy. Dobutamine / therapeutic use. Dopamine / therapeutic use. Humans. Male. Middle Aged
Hazardous Substances Data Bank.
FLUOROURACIL
.
Hazardous Substances Data Bank.
DOPAMINE
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
(PMID = 16104623.001).
[ISSN]
0003-3928
[Journal-full-title]
Annales de cardiologie et d'angéiologie
[ISO-abbreviation]
Ann Cardiol Angeiol (Paris)
[Language]
fre
[Publication-type]
Case Reports; English Abstract; Journal Article
[Publication-country]
France
[Chemical-registry-number]
0 / Antimetabolites, Antineoplastic; 0 / Cardiotonic Agents; 3S12J47372 / Dobutamine; U3P01618RT / Fluorouracil; VTD58H1Z2X / Dopamine
95.
Cameron JL, Riall TS, Coleman J, Belcher KA:
One thousand consecutive pancreaticoduodenectomies.
Ann Surg
; 2006 Jul;244(1):10-5
[Fulltext service]
Download
fulltext PDF
of
this article and others
, as many as you want.
[Source]
The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
SUMMARY BACKGROUND DATA: A regional resection of the
head of
the
pancreas
was first performed successfully by Kausch in 1909.
A total of 405 patients underwent pancreaticoduodenectomy for
adenocarcinoma of
the
head of
the
pancreas
.
It has become an effective operation for
pancreatic cancer
in those patients in whom their tumor is margin negative and node negative.
[MeSH-minor]
Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged.
Pancreatic
Neoplasms / mortality.
Pancreatic
Neoplasms / surgery. Postoperative Complications. Survival Rate
COS Scholar Universe.
author profiles
.
[Email]
Email this result item
Email the results to the following email address:
[X] Close
[Cites]
J Gastrointest Surg. 2004 Nov;8(7):766-72; discussion 772-4
[
15531229.001
]
[Cites]
Ann Surg. 1993 Sep;218(3):229-37; discussion 237-8
[
8103982.001
]
[Cites]
Ann Surg. 2000 Sep;232(3):419-29
[
10973392.001
]
[Cites]
Ann Surg. 2002 Sep;236(3):355-66; discussion 366-8
[
12192322.001
]
[Cites]
Ann Surg. 1990 Apr;211(4):447-58
[
2322039.001
]
[Cites]
Ann Surg. 1993 May;217(5):430-5; discussion 435-8
[
8098202.001
]
[Cites]
Ann Surg. 1993 May;217(5):447-55; discussion 456-7
[
7683868.001
]
[Cites]
Rev Surg. 1963 Jul-Aug;20:221-5
[
14000261.001
]
[Cites]
Ann Surg. 1995 Jan;221(1):43-9
[
7826160.001
]
[Cites]
Arch Surg. 1995 Mar;130(3):295-9; discussion 299-300
[
7887797.001
]
[Cites]
Ann Surg. 1995 Oct;222(4):580-8; discussion 588-92
[
7574936.001
]
[Cites]
Ann Surg. 1995 Nov;222(5):638-45
[
7487211.001
]
[Cites]
Ann Surg. 1998 Jul;228(1):71-8
[
9671069.001
]
[Cites]
Ann Surg. 1998 Sep;228(3):429-38
[
9742926.001
]
[Cites]
Ann Surg. 1999 Sep;230(3):322-8; discussion 328-30
[
10493479.001
]